Sentence,class,file
Toward a healthy and harmonious life in China: stemming the rising tide of non-communicable diseases 2011. http://www.worldbank.org/content/dam/ Worldbank/document/NCD_report_en.pdf (accessed 8 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
"Theory at a glance: a guide for health promotion practice, 2005. http://www.cancer.gov/PDF/481f5d53-63df-41bc-bfaf-5aa48ee1da4d/TAAG3.pdf (accessed 29 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
"Physical activity and the environment: NICE public health guidance 8, 2008. http://www.nice.org.uk/nicemedia/live/11917/38983/38983.pdf (accessed 29 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
http://www.who.int/chp/steps/ manual/en/index.html (accessed Oct 2013).,OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
"Active design guidelines: promoting physical activity and health in design, 2011. http://www.nyc.gov/html/ddc/html/design/active_design.shtml (accessed 8 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Haynes RB, McDonald HP, Garg AX.",Non-OADS,/arxiv_data1/oa_pdf/4b/4d/ejhpharm-2013-000346.PMC3963598.pdf
"Oslo: WHO Collaborating Centre, 2010. http://www.whocc.no/atc_ddd_index/ (accessed 25 Jan 2012).",OADS,/arxiv_data1/oa_pdf/4b/4d/ejhpharm-2013-000346.PMC3963598.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2012-202709).,Non-OADS,/arxiv_data1/oa_pdf/09/e9/annrheumdis-2012-202709.PMC3963599.pdf
Physicians and institutions who contributed patients to the SCQM registry without ful ﬁlling the requirements for authorship are listed under (http://www.scqm.ch/institutions).,Non-OADS,/arxiv_data1/oa_pdf/09/e9/annrheumdis-2012-202709.PMC3963599.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Weiss G, Goodnough LT.",Non-OADS,/arxiv_data1/oa_pdf/09/e9/annrheumdis-2012-202709.PMC3963599.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Groenning BA, Raymond I, Hildebrandt PR, et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/47/annrheumdis-2012-202848.PMC3963600.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/2b/btt-8-107.PMC3964020.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 107–114Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  107Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S3838 7Biologics: the role of delivery systems in   improved therapy Nataša Škalko-Basnet Drug Transport and Delivery Research  Group, Department of Pharmacy,   University of Tromsø, Tromsø, Norway Correspondence: Nataša Škalko-Basnet   Drug Transport and Delivery Research  Group, Department of Pharmacy,  University of Tromsø, Universitetsveien  57, 9037 Tromsø, Norway   Tel +47 77 646 640   Fax +47 77 646 151   email n atasa.skalko-basnet@uit.n oAbstract:  The beginning of the 21st century saw numerous protein and peptide therapeuticals  both on the market and entering the final stages of clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/83/2b/btt-8-107.PMC3964020.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/83/2b/btt-8-107.PMC3964020.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/83/2b/btt-8-107.PMC3964020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/e7/cia-9-451.PMC3964021.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 451–458Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  451OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5853 5Efficacy and safety of Curcuma domestica  extracts  compared with ibuprofen in patients with knee  osteoarthritis: a multicenter study Vilai Kuptniratsaikul1 Piyapat Dajpratham1 Wirat Taechaarpornkul2 Montana  Buntragulpoontawee3 Pranee lukkanapichonchut4 Chirawan Chootip5 Jittima saengsuwan6 Kesthamrong Tantayakom7 supphalak laongpech8 1Department of Rehabilitation  Medicine, Faculty of Medicine Siriraj  Hospital, Mahidol University, Bangkok,  Thailand; 2sirindhorn national Medical  Rehabilitation Center, Ministry of  Public health, nonthaburi, Thailand;  3Department of Rehabilitation  Medicine, Faculty of Medicine, Chiang  Mai University, Chiang Mai, Thailand;  4Department of Rehabilitation  Medicine, Ratchaburi Hospital, Ministry  of Public health, ratchaburi, Thailand;  5Department of Rehabilitation Medicine,  Songkhla Hospital, Ministry of Public  health, songkhla, Thailand; 6Department  of Rehabilitation Medicine, Faculty  of Medicine, Khon Kaen University,  Khon Kaen, Thailand; 7Department  of Rehabilitation Medicine, Rajvithi  Hospital, Ministry of Public Health,  Bangkok, Thailand; 8Department of  rehabilitation Medicine, Vachira Phuket  Hospital, Ministry of Public Health,  Phuket, Thailand Correspondence:  Vilai Kuptniratsaikul   Department of Rehabilitation Medicine,  Faculty of Medicine Siriraj Hospital,  Mahidol University, 2 Prannok Rd,  Bangkok 10700, Thailand   Tel +66 2 419 7511   Fax +66 2 411 4813   email vilai.kup@mahidol.ac.t hObjective:  To determine the efficacy and safety of Curcuma domestica  extracts in pain   reduction and functional improvement.",Non-OADS,/arxiv_data1/oa_pdf/78/e7/cia-9-451.PMC3964021.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/78/e7/cia-9-451.PMC3964021.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/e7/cia-9-451.PMC3964021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/6b/cpaa-6-051.PMC3964022.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2014:6 51–59Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  51OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S4789 5Pharmacokinetics and pharmacodynamics   of acetylsalicylic acid after intravenous and oral  administration to healthy volunteers J nagelschmitz1 M Blunck1 J Kraetzschmar1 M ludwig1 g Wensing1 T hohlfeld2 1Bayer healthCare A g, Clinical  Pharmacology, Wuppertal, germany;   2institut für Pharmakologie und  Klinische Pharmakologie, heinrich- heine Universität Düsseldorf,   Düsseldorf, germany Correspondence: J nagelschmitz   Bayer healthCare Ag,   Clinical Pharmacology Bldg 429,  42096 Wuppertal, germany   Tel +49 202 368 815   Fax +49 202 364 110   email johannes.nagelschmitz@bayer.co mBackground:  The pharmacology of single doses of acetylsalicylic acid (ASA) administered  intravenously (250 or 500 mg) or orally (100, 300, or 500 mg) was evaluated in a randomized,  placebo-controlled, crossover study.",Non-OADS,/arxiv_data1/oa_pdf/f7/6b/cpaa-6-051.PMC3964022.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/f7/6b/cpaa-6-051.PMC3964022.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/6b/cpaa-6-051.PMC3964022.pdf
"Available from: http://www.ema.europa.eu/pdfs/human/ ich/036396en.pd f. Accessed June 6, 2011.",Non-OADS,/arxiv_data1/oa_pdf/f7/6b/cpaa-6-051.PMC3964022.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/dmso-7-107.PMC3964023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 107–120Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  107Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3764 4Comparative effectiveness of liraglutide   in the treatment of type 2 diabetes Mauro Rigato Gian Paolo Fadini Department of Medicine, University  Hospital of Padova, Padova, italy Correspondence: Gian Paolo Fadini   Department of Medicine, University   of Padova, via Giustiniani 2,   35100 Padova, italy   Tel +39 04 9821 4318   Fax +39 04 9821 2184   email gianpaolo.fadini@unipd.i tAbstract:  Type 2 diabetes is characterized by a progressive decline in beta cell function, with  consequent worsening of glycemic control.",Non-OADS,/arxiv_data1/oa_pdf/dc/1e/dmso-7-107.PMC3964023.pdf
Available from: http://www.ema.europa.eu/ ema/index.jsp?curl =pages/medicines/human/medicines/001026/ human_med_001137.jsp&mid =WC0b01ac058001d124.,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/dmso-7-107.PMC3964023.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/dc/1e/dmso-7-107.PMC3964023.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/dmso-7-107.PMC3964023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/c0/copd-9-289.PMC3964024.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 289–300International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  289RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5715 7Indirect costs in chronic obstructive pulmonary  disease:  A review of the economic burden on  employers and individuals in the United States Jeetvan G Patel1,2 Saurabh P Nagar2 Anand A Dalal2 1Pharmacy Administration and Public  Health, University of Houston,   Houston, TX, 2US Health Outcomes,   GlaxoSmithKline, Durham, NC, USA Correspondence: Jeetvan G Patel   GlaxoSmithKline, 5 Moore Drive,   Bide west, Mail Stop B.3130.3C,   Durham, NC 27709, USA   Tel +1 919 483 9852   Fax +1 919 483 7932   email jeetvan.g.patel@gsk.co mObjective : To review and summarize existing literature on the indirect burden of chronic  obstructive pulmonary disease (COPD) in the US.",Non-OADS,/arxiv_data1/oa_pdf/d8/c0/copd-9-289.PMC3964024.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d8/c0/copd-9-289.PMC3964024.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/c0/copd-9-289.PMC3964024.pdf
Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report2014_Feb07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/c0/copd-9-289.PMC3964024.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/c1/ccide-6-021.PMC3964025.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2014:6 21–27Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  21RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S4149 9The importance of preventive dental visits   from a young age: systematic review   and current perspectives vaishnavi Bhaskar1 Kathleen A McGraw2 Kimon Divaris3 1Department of Health Policy   and Management, Gillings School   of Global Public Health, 2Health   Sciences Library, 3Department of  Pediatric Dentistry, School of   Dentistry, University of North  Carolina at Chapel Hill, Chapel   Hill, NC, USA Correspondence: Kimon Divaris   Department of Pediatric Dentistry,   School of Dentistry, Brauer Hall 228,   CB 7450, University of North   Carolina at Chapel Hill, Chapel Hill,   NC 27599-7450, USA   Tel +1 919 537 3556   Fax +1 919 537 3950   email k imon_ divaris@unc.ed uBackground:  Dental caries, the most common childhood chronic disease, disproportionately  affects vulnerable parts of the population and confers substantial impacts to children, families,  and health systems.",Non-OADS,/arxiv_data1/oa_pdf/d5/c1/ccide-6-021.PMC3964025.pdf
"Available from: http://www.med.uottawa.ca/sim/data/Dental/ CDA%20Position%20-%20First%20Dental%20Visit.pd f. Accessed  November 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d5/c1/ccide-6-021.PMC3964025.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d5/c1/ccide-6-021.PMC3964025.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d5/c1/ccide-6-021.PMC3964025.pdf
"Available from: http://www.medicaid.gov/ Medicaid-CHIP-Program-Information/By-Topics/Benefits/Downloads/ Child-Dental-Guide.pd f. Accessed November 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d5/c1/ccide-6-021.PMC3964025.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/08/ceor-6-133.PMC3964026.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 133–139ClinicoEconomics and Outcomes Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/71/08/ceor-6-133.PMC3964026.pdf
"Or use: http://dvpr.es/1hRkDY lDove press submit your manuscript | www.dovepress.co m Dove press  133ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5956 8Cost-effectiveness analysis of orbital   atherectomy plus balloon angioplasty   vs balloon angioplasty alone in subjects   with calcified femoropopliteal lesions Barry Weinstock1 Raymond Dattilo2 Tiffini Diage3 1Orlando health heart institute,   Mid-Florida Cardiology specialists,   Orlando, Fl, Usa; 2Department of  Cardiology, st Francis health Center,   T opeka, K s, Usa; 3north american  science association (naM sa),   sunnyvale, C a, Usa Correspondence: Tiffini Diage   Medical Research Manager,   north american science association   (naMsa), 1307 s Mary avenue,   sunnyvale, Ca 94087, Usa   Tel +1 707 799 6732   Fax +1 650 967 1903   Email tdiage@namsa.co mIntroduction:  As cost considerations become increasingly critical when selecting optimal   endovascular treatment strategies, a cost-benefit analysis was conducted comparing the Diamond - back 360°® Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc., St Paul, MN, USA)  and balloon angioplasty (BA) vs BA alone for treatment of calcified femoropopliteal lesions.",Non-OADS,/arxiv_data1/oa_pdf/71/08/ceor-6-133.PMC3964026.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/71/08/ceor-6-133.PMC3964026.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/08/ceor-6-133.PMC3964026.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/93/cia-9-433.PMC3964027.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 433–441Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  433open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4530 0RevIew Frailty syndrome: an overview Xujiao Chen1 Genxiang Mao1 Sean X Leng2 1Department of Geriatrics, Zhejiang  Hospital, Hangzhou, People’s  Republic of China; 2Division of  Geriatric Medicine and Gerontology,   Department of Medicine, Johns  Hopkins University School of  Medicine, Baltimore, MD, USA Correspondence: Sean X Leng   Division of Geriatric Medicine and  Gerontology, Department of Medicine,  Johns Hopkins University School of  Medicine, 5501 Hopkins Bayview   Circle – Room 1A.38A, Baltimore,   MD 21224, USA   Tel +1 410 550 2494   Fax +1 410 550 3143   email s leng5@jhmi.ed uAbstract:  Frailty is a common and important geriatric syndrome characterized by   age-associated declines in physiologic reserve and function across multiorgan systems, leading  to increased vulnerability for adverse health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/45/93/cia-9-433.PMC3964027.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/45/93/cia-9-433.PMC3964027.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/93/cia-9-433.PMC3964027.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/aa/cia-9-443.PMC3964028.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 443–450Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  443RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S3978 0Managing blood pressure control in Asian   patients: safety and efficacy of losartan T ommy Tsang Cheung Bernard Man Yung Cheung Division of Clinical Pharmacology  and Therapeutics, Department of  Medicine, Li Ka Shing Faculty of  Medicine, The University of Hong  Kong, Hong Kong Correspondence: Bernard Man   Yung Cheung   Division of Clinical Pharmacology and  Therapeutics, Department of Medicine,  Queen Mary Hospital, Hong Kong   Tel +852 2255 4347   Fax +852 2818 6474   email mycheung@hku.h kAbstract:  Hypertension is common in Asian populations and is a major cause of cardiovascular  diseases.",Non-OADS,/arxiv_data1/oa_pdf/93/aa/cia-9-443.PMC3964028.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/93/aa/cia-9-443.PMC3964028.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/aa/cia-9-443.PMC3964028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/26/cmar-6-135.PMC3964029.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 135–147Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  135Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S4426 1Chemotherapy-induced peripheral neuropathy in  adults: a comprehensive update of the literature Andreas A Argyriou1,3 Athanasios P Kyritsis2 Thomas Makatsoris3 Haralabos P Kalofonos3 1Department of Neurology, “Saint  Andrew’s” General Hospital of Patras,   Greece; 2Department of Neurology,   University Hospital of ioannina,   Greece; 3Department of Medicine- Division of Oncology, University of  Patras Medical School, Rion-Patras,   Greece Correspondence: Andreas A Argyriou   Department of Neurology,   “Saint Andrew’s” State General   Hospital of Patras, Patras, Greece   Tel +30 261 022 7907   Fax +30 261 022 7909   email andargyriou@yahoo.g rAbstract:  Commonly used chemotherapeutic agents in oncology/hematology practice, causing  toxic peripheral neuropathy, include taxanes, platinum compounds, vinca alkaloids, protea - some inhibitors, and antiangiogenic/immunomodulatory agents.",Non-OADS,/arxiv_data1/oa_pdf/eb/26/cmar-6-135.PMC3964029.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/eb/26/cmar-6-135.PMC3964029.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/26/cmar-6-135.PMC3964029.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/61/copd-9-287.PMC3964030.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/76/61/copd-9-287.PMC3964030.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/61/copd-9-287.PMC3964030.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/2a/dddt-8-325.PMC3964031.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/04/2a/dddt-8-325.PMC3964031.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/2a/dddt-8-325.PMC3964031.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/a1/ceor-6-125.PMC3964032.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 125–131ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  125ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5919 4Comparative cost effectiveness of Coflex®  interlaminar stabilization versus instrumented   posterolateral lumbar fusion for the treatment   of lumbar spinal stenosis and spondylolisthesis Jordana Kate schmier1 Marci halevi2 greg Maislin3 Kevin Ong4 1health sciences, Exponent inc.,   alexandria, V a, Usa; 2Paradigm llC,   new Y ork, nY, Usa; 3Biomedical  statistical Consulting, Wynnewood,   Pa, Usa; 4Biomedical Engineering,   Exponent inc., Philadelphia, P a, Usa Correspondence: Jordana Kate schmier  Exponent inc.,   1800 Diagonal Road , suite 500,  alexandria, Va 22314, Usa   Tel +1 571 227 7241   Fax +1 571 227 7299   Email jschmier@exponent.co mIntroduction:  Symptomatic chronic low back and leg pain resulting from lumbar spinal  stenosis is expensive to treat and manage.",Non-OADS,/arxiv_data1/oa_pdf/73/a1/ceor-6-125.PMC3964032.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/73/a1/ceor-6-125.PMC3964032.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/a1/ceor-6-125.PMC3964032.pdf
Available at: http://www.cms.gov/Medicare/Medicare- Fee-for-Service-Payment/PhysicianFeeSched/PFS-Federal-Regulation- Notices-Items/CMS-1590-FC.html?DLPage=1&DLSort=3&DLSortD ir=descendin g. Accessed 25 February 2014.,Non-OADS,/arxiv_data1/oa_pdf/73/a1/ceor-6-125.PMC3964032.pdf
Available at http://www.cms.gov/Medicare/Medicare-Fee-for-Service- Payment/AcuteInpatientPPS/FY -2013-IPPS-Final-Rule-Home-Page- Items/CMS-1588-F-Text-Version.html?DLPage=1&DLSort=0&DLS ortDir=ascending.,Non-OADS,/arxiv_data1/oa_pdf/73/a1/ceor-6-125.PMC3964032.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/13/ijn-9-1443.PMC3964033.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1443–1452International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1443OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S58275cisplatin improves antitumor activity   of weekly nab-paclitaxel in patients   with metastatic breast cancer si sun1 lichen Tang2 Jian Zhang1 Fangfang lv1 Zhonghua Wang1 leiping Wang1 Qunling Zhang1 chunlei Zheng1 lixin Qiu1 Zhen Jia1 Yunhua lu1 guangyu liu2 Zhimin shao2 Biyun Wang1 Xichun hu1 1Department of Medical Oncology,   Fudan University shanghai cancer  center , Department of Oncology,   shanghai Medical college, Fudan  University, shanghai , People’s republic  of china, 2Department of Breast  surgery, Fudan University shanghai  cancer center , Department of  Oncology, shanghai Medical college,   Fudan University, shanghai , People’s  republic of china correspondence: Biyun Wang; Xichun hu   Department of Medical Oncology, Fudan  University shanghai cancer center,  270 Dong an road, 200032, shanghai,  People’s republic of china   Tel +86 21 6417 5590 5009 (Biyun Wang)         +86 21 6417 5590 5006 (Xichun hu) Fax +86 21 6443 0160   email wangbiyun@msn.co m;   huxicun@gmail.co mAbstract:  Although nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is approved to be  given every 3 weeks, weekly use of this drug is becoming a new standard of care in patients with  metastatic breast cancer (MBC).",Non-OADS,/arxiv_data1/oa_pdf/1a/13/ijn-9-1443.PMC3964033.pdf
Available from:  http://clinicaltrials.gov/show/NCT0114979 8.,Non-OADS,/arxiv_data1/oa_pdf/1a/13/ijn-9-1443.PMC3964033.pdf
Available from: http://evs.nci.nih.,Non-OADS,/arxiv_data1/oa_pdf/1a/13/ijn-9-1443.PMC3964033.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1a/13/ijn-9-1443.PMC3964033.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/13/ijn-9-1443.PMC3964033.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/e8/ijn-9-1433.PMC3964034.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1433–1442International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1433OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5878 3chlorotoxin-conjugated graphene oxide   for targeted delivery of an anticancer drug hao Wang1 Wei gu2 Ning Xiao2 ling Ye2 Qunyuan Xu1 1regeneration and repair, Key  laboratory for Neurodegenerative  Disease of The Ministry of education,   2school of chemical Biology and  Pharmaceutical sciences, capital  Medical University, Beijing, People’s  republic of china correspondence: Qunyuan Xu   regeneration and repair,   Key laboratory for Neurodegenerative  Disease of The Ministry of education,  capital Medical University, Beijing,  People’s republic of china   Tel +86 10 8391 1464   Fax +86 10 8391 1464   email xuqy@ccmu.edu.c nAbstract:  Current chemotherapy for glioma is rarely satisfactory due to low therapeutic   efficiency and systemic side effects.",Non-OADS,/arxiv_data1/oa_pdf/69/e8/ijn-9-1433.PMC3964034.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/e8/ijn-9-1433.PMC3964034.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/e8/ijn-9-1433.PMC3964034.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/09/ijwh-6-329.PMC3964154.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 329–334International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  329ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5912 6Effectiveness of the professional who carries out  the health education program: perinatal outcomes Juan Miguel Martínez- Galiano1–3 Miguel Delgado- Rodríguez2,3 1Hospital San Juan de la Cruz, Ubeda,   2Department of Health Sciences,   University of Jaén, Jaén, 3Biomedical  Research Centre Network for  Epidemiology and Public Health,   Ministry of Health, Institute of Health  Carlos III, Madrid, Spain Correspondence: Juan Miguel Martínez-  Galiano   Universidad de Jaén Campus de Las  Lagunillas, s/n Edificio B3, Despacho 413,  23071 Jaén, Spain   Email juanmimartinezg@hotmail.co mBackground:  The purpose of this study was to determine whether a maternal education program  conducted by midwives achieves better results in regard to maternal and newborn health than  when the program is conducted by other health professionals.",Non-OADS,/arxiv_data1/oa_pdf/13/09/ijwh-6-329.PMC3964154.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/13/09/ijwh-6-329.PMC3964154.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/09/ijwh-6-329.PMC3964154.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/a2/ijwh-6-327.PMC3964155.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/eb/a2/ijwh-6-327.PMC3964155.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/a2/ijwh-6-327.PMC3964155.pdf
The full terms of the License are  available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/a2/ijwh-6-327.PMC3964155.pdf
Information on how to request permission may be  found at: http://www.dovepress.com/permissions.ph p.Dove press submit your manuscript | www.dovepress.co m Dove press  Dove pres s 327open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6421 5ErrATum,Non-OADS,/arxiv_data1/oa_pdf/eb/a2/ijwh-6-327.PMC3964155.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/ndt-10-487.PMC3964156.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 487–491Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  487Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5762 7Dissociation in schizophrenia and borderline  personality disorder ondrej pec1,2 petr Bob1,3 Jiri raboch1 1Center for Neuropsychiatric  research of Traumatic Stress,   Department of psychiatry, First  Faculty of Medicine, Charles  University, prague, 2psychotherapeutic  and psychosomatic Clinic eSeT,   prague, 3Central european Institute  of T echnology, Faculty of Medicine,   Masaryk University, Brno, Czech  republic Correspondence: petr Bob   Department of psychiatry,   Charles University, First Faculty   of Medicine, Ke Karlovu 11,   12800 prague, Czech republic   email petrbob@netscape.ne tBackground:  Dissociation likely plays a key role in schizophrenia and borderline personality  disorder (BPD), although empirical studies that compare specific manifestations of these symp - toms in schizophrenia and BPD are rare.",Non-OADS,/arxiv_data1/oa_pdf/9b/d1/ndt-10-487.PMC3964156.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9b/d1/ndt-10-487.PMC3964156.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/ndt-10-487.PMC3964156.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/e1/ott-7-435.PMC3964157.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 435–440OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  435Case RepORTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5783 1Gastrointestinal tract metastasis from  tubulolobular carcinoma of the breast:   a case report and review of the literature Guixin Wang Tingjiang Wang Jian Jiang Luyao Zhou Haidong Zhao   Department of Breast surgery, The  second affiliated Hospital of Dalian  Medical University, shahekou District,   Dalian, Liaoning province, people’s  Republic of ChinaAbstract:  Metastasis  of breast cancer into the gastrointestinal tract happens rarely.",Non-OADS,/arxiv_data1/oa_pdf/42/e1/ott-7-435.PMC3964157.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/42/e1/ott-7-435.PMC3964157.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/e1/ott-7-435.PMC3964157.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 493–498Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  493Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3915 2Update on once-daily zonisamide monotherapy   in partial seizures Pegah Afra1 Bola Adamolekun2 1Department of Neurology, School   of Medicine, University of Utah,   Salt Lake City, UT, 2Department of   Neurology, University of Tennessee   Health Science Center, Memphis,   TN, USA Correspondence: Pegah Afra   Department of Neurology, University   of Utah, 175 N Medical Drive east,   5th Floor, Salt Lake City, UT 84132, USA   email pegah.afra@hsc.utah.ed uAbstract:  Zonisamide is an antiepileptic drug that is structurally different from other antiepi - leptic agents.",Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
Available from: http://us.eisai.,Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
Available from:  http://www.ds-pharma.com/news/prior/dainippon_2005/20050329.,Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
"Available from: http://www.ucb.presscentre.com/News/ UCB-files-VIMPAT -lacosamide-in-the-US-as-monotherapy-treatment- in-adult-epilepsy-patients-with-pa-46e.asp x. Accessed November 30,  2013.",Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/68/ndt-10-493.PMC3964158.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/a2/opth-8-567.PMC3964159.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 567–569Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  567Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6004 1Oculogyric crisis in a patient taking  metoclopramide Yaran Koban Metin ekinci Halil Huseyin Cagatay Zeliha Yazar Department  of Ophthalmology,   Faculty of Medicine, Kafkas University,   Kars, turkey Correspondence: Yaran Koban   Kafkas Universitesi Tıp Fak, Goz  Hastalıkları AD, 36000, Kars, Turkey   tel +90 507 707 8180   Fax +90 474 225 1193   email yarankoban@yahoo.com.a uAbstract:  Oculogyric crisis is an acute dystonic reaction of the ocular muscles characterized  by bilateral dystonic elevation of visual gaze lasting from seconds to hours.",Non-OADS,/arxiv_data1/oa_pdf/61/a2/opth-8-567.PMC3964159.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/61/a2/opth-8-567.PMC3964159.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/a2/opth-8-567.PMC3964159.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/prbm-7-103.PMC3964160.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 103–114Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  103Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S5979 2The ABCs of incentive-based treatment   in health care: a behavior analytic framework   to inform research and practice Steven e Meredith1 Brantley P Jarvis2 Bethany R Raiff3 Alana M Rojewski2 Allison Kurti2 Rachel N Cassidy2 Philip erb2 Jolene R Sy4 Jesse Dallery2 1Department of Psychiatry and  Behavioral Sciences, The Johns  Hopkins University School of  Medicine, Baltimore, MD, USA;   2Department of Psychology, University  of Florida, Gainesville, FL, USA;   3Department of Psychology, Rowan  University, Glassboro, NJ, USA; 4Saint  Louis University School of Social  work, St Louis, MO, USA Correspondence: Steven e Meredith   The Johns Hopkins University School   of Medicine, 5510 Nathan Shock Drive,   Baltimore, MD 21224, USA   Tel +1 410 550 2693   email semeredith@juh.ed uAbstract:  Behavior plays an important role in health promotion.",Non-OADS,/arxiv_data1/oa_pdf/de/1a/prbm-7-103.PMC3964160.pdf
Available from: http://www.mdrc.org/sites/default/files/full_588.,OADS,/arxiv_data1/oa_pdf/de/1a/prbm-7-103.PMC3964160.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/de/1a/prbm-7-103.PMC3964160.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/prbm-7-103.PMC3964160.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/31/ppa-8-331.PMC3964161.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 331–338Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  331Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4156 5Safety, efficacy, and patient acceptability   of rifaximin for hepatic encephalopathy Nina Kimer1 Aleksander Krag2 Lise L Gluud1 1Gastrounit, Medical Division,   Copenhagen University Hospital  Hvidovre, Hvidovre, Denmark;   2Department of Gastroenterology,   Odense University Hospital,   University of Southern Denmark,   Odense, Denmark Correspondence: Nina Kimer   Department of Gastroenterology,   Copenhagen University Hospital   Hvidovre, Kettegaard Alle 30,   2650 Hvidovre, Denmark   email nina.kimer@regionh.d kAbstract:  Hepatic encephalopathy is a complex disease entity ranging from mild cognitive   dysfunction to deep coma.",Non-OADS,/arxiv_data1/oa_pdf/fe/31/ppa-8-331.PMC3964161.pdf
Available from:  http://www.pharmacychecker.com/compare-drug-prices-online- pharmacies/rifaximin-550+mg/79995/197553/.,Non-OADS,/arxiv_data1/oa_pdf/fe/31/ppa-8-331.PMC3964161.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/fe/31/ppa-8-331.PMC3964161.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/31/ppa-8-331.PMC3964161.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/a8/ott-7-447.PMC3964162.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 447–456OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  447Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5862 2Clusterin: a key player in cancer   chemoresistance and its inhibition T omas Koltai Gerencia de efectores Sanitarios  Propios, instituto Nacional de la  Seguridad Social para Jubilados y  Pensionados, Buenos Aires, República  Argentina Correspondence: Tomas Koltai   Gerencia de efectores Sanitarios   Propios.",Non-OADS,/arxiv_data1/oa_pdf/9b/a8/ott-7-447.PMC3964162.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9b/a8/ott-7-447.PMC3964162.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/a8/ott-7-447.PMC3964162.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 189–196Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  189ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5870 7Medication transitions and polypharmacy   in older adults following acute care John-Michael gamble1,* Jill J hall2,* Thomas J Marrie3 Cheryl a sadowski2 sumit R Majumdar4 Dean T eurich5 1school of Pharmacy, Memorial  University of newfoundland,    st John’s, nl, 2Faculty of Pharmacy and  Pharmaceutical sciences, University  of alberta, edmonton, aB, 3Faculty of  Medicine, Dalhousie University, halifax,   ns, 4Faculty of Medicine and Dentistry,   5school of Public health, University of  alberta, edmonton, aB, Canada *These authors contributed equally to  this work Correspondence: Dean T eurich   school of Public health, 2-040 li Ka   shing ChRi, University of alberta,   116th street and 85th avenue,  edmonton, aB T6g 2e1, Canada   Tel +1 780 492 6333   Fax +1 780 492 7455   email deurich@ualberta.c aBackground/objective:  Medication changes at transitions of care and polypharmacy are  growing concerns that adversely impact optimal drug use.",Non-OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
Or use: http://dvpr.es/1fXmvK R,Non-OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
Available from: http://www.whocc.no/ atc_ddd_index .,OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
Available  from: https://secure.cihi.ca/free_products/HCIC_2011_seniors_report_ en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7d/35/tcrm-10-189.PMC3964163.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/95/opth-8-561.PMC3964164.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 561–566Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  561Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5821 9spectral-domain optical coherence tomography  imaging of macula-off rhegmatogenous retinal  detachment Jayanth sridhar Harry W Flynn Jr Department of Ophthalmology,   Bascom Palmer eye institute,   Miami, FL, Usa Correspondence: Jayanth sridhar   Bascom Palmer eye institute,   900 NW 17th street Miami,   FL 33136, Usa   Tel +1 305 326 6118   email jsridhar@med.miami.ed uAbstract:  The timing of repair and the utility of spectral-domain optical coherence tomography  (SD-OCT) for macula-off retinal detachment remains a controversial issue.",Non-OADS,/arxiv_data1/oa_pdf/70/95/opth-8-561.PMC3964164.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/95/opth-8-561.PMC3964164.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/95/opth-8-561.PMC3964164.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 335–341International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  335OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5737 0contraceptive knowledge and attitudes   among women seeking induced abortion   in Kathmandu, nepal emilia Berin1,* Micaela sundell1,* chanda Karki2 Jan Brynhildsen1 Mats Hammar1 1Obstetrics and gynecology,   Department of clinical and  experimental Medicine, linköping  University, linköping, sweden;   2Department of Obstetrics and  gynecology, Kathmandu Medical  college, Kathmandu, nepal *These authors contributed equally to  this work correspondence: Micaela sundell  Obstetrics and gynecology,   Department of clinical and   experimental Medicine, Faculty of   Health sciences, linköping University,  se-58185 linköping, sweden   Tel +46 73 757 3863   Fax +46 13 148 156   email micsu390@student.liu.s eObjective:  To map the knowledge about and attitudes toward birth control methods among  women in Kathmandu, Nepal, and to compare the results between women seeking an induced  abortion and a control group.",Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
"Available from: http://www.measuredhs.com/pubs/pdf/ FR257/FR257%5B13April2012%5D.pd f. Accessed January 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
Available from: http://www.engenderhealth.,Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
Available from: http://www.measuredhs.com/pubs/pdf/ FR191/FR191.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
Available from: http://www.crehpa.org.np/ download/summary_report_december_2006.pdf .,OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
Available  from: http://apps.who.int/iris/bitstream/10665/70914/1/97892415484 34_eng.pdf .,OADS,/arxiv_data1/oa_pdf/8a/dd/ijwh-6-335.PMC3964165.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/c8/ndt-10-499.PMC3964166.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 499–506Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  499OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5251 7A novel five-category multimodal T1-weighted and  T2-weighted magnetic resonance imaging-based  stratification system for the selection of spinal  arachnoid cyst treatment: a 15-year experience   of 81 cases Ji Qi Jun Yang Guihuai Wang Department of Neurosurgery, Beijing  Tiantan Hospital, Capital Medical  University, Beijing, People’s Republic  of China Correspondence: Jun Yang   Department of Neurosurgery, Beijing  Tiantan Hospital, Capital Medical  University, 6 Tiantan Xili, Dongcheng  District, Beijing 100050, People’s  Republic of China   Tel +86 139 1050 1302   Fax +86 10 6879 2431   email yangjuntiantan@126.co mBackground:  Idiopathic spinal arachnoid cysts are rare cystic masses of the spinal canal  generally classified as intra- or extradural, based on anatomical presentation.",Non-OADS,/arxiv_data1/oa_pdf/6f/c8/ndt-10-499.PMC3964166.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6f/c8/ndt-10-499.PMC3964166.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/c8/ndt-10-499.PMC3964166.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/e0/ppa-8-339.PMC3964167.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 339–351Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  339OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5801 4Factors that lessen the burden of treatment   in complex patients with chronic conditions:   a qualitative study Jennifer l ridgeway1,2 Jason s egginton1,2 Kristina Tiedje3 Mark linzer4,5 Deborah Boehm4 sara Poplau6 Djenane ramalho de  Oliveira7 laura Odell8 Victor M Montori2,9 David T eton1,2 1The Mayo clinic robert D. and  Patricia e. Kern center for the science  of health care Delivery, 2Division  of health care Policy and research,  Department of health sciences  research, Mayo clinic, rochester, M n,  UsA; 3Department of Anthropology,  Université lumière lyon 2, lyon,  France; 4Division of general internal  Medicine, hennepin county Medical  center, 5University of Minnesota  Medical school, 6Minneapolis Medical  research Foundation, Minneapolis,  Mn, UsA; 7Department of social  Pharmacy, Universidade Federal  de Minas gerais, Brazil; 8Pharmacy  services, 9Knowledge and evaluation  research Unit, Mayo clinic, rochester,  Mn, UsA correspondence: David T eton   Division of health care Policy and   research, Department of health sciences   research, Mayo clinic, 200 First street   sW, rochester, Mn 55905, UsA   Tel +1 507 293 1353   Fax +1 507 284 1731   email eton.david@mayo.ed uPurpose:  Patients with multiple chronic conditions (multimorbidity) often require ongoing  treatment and complex self-care.",Non-OADS,/arxiv_data1/oa_pdf/bc/e0/ppa-8-339.PMC3964167.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/bc/e0/ppa-8-339.PMC3964167.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/e0/ppa-8-339.PMC3964167.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 173–188Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  173Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3956 4Therapeutic interventions to reduce the risk   of progression from prediabetes to type 2   diabetes mellitus Katia Cristina Portero  McLellan1 Kathleen wyne2 evangelina Trejo villagomez2 willa A Hsueh2 1Department of Public Health,   School of Medicine, Sao Paulo State  University, Botucatu, SP , Brazil;   2Division of Diabetes, Obesity and  Lipids, Department of Medicine, The  Methodist Hospital Diabetes and  Metabolism institute, and the Houston  Methodist Research institute, weill  Cornell Medical College, Houston,   TX, USA Correspondence: willa A Hsueh   6670 Bertner Ave R8-111,   Houston, TX 77030, USA   Tel +1 713 441 2520   Fax +1 713 441 2178   email wahsueh@tmhs.or gAbstract:  Clinical trials have demonstrated that it is possible to prevent diabetes through  lifestyle  modification, pharmacological intervention, and surgery.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
"Available from:  http://www.who.int/nmh/publications/9789241597418/e n. Accessed  December 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
"Available from: http://www.who.int/dietphysicalactivity/ factsheet_recommendat ions/e n. Accessed December 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
"Available from: http://www.diabetes.fi/ files/1108/Programme_for_the_Prevention_of_Type_2_ Diabetes_ in_ Finland_2003-2010.pd f. Accessed August 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
Available  from: http://clinicaltrials.gov/show/NCT00845559.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/tcrm-10-173.PMC3964168.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 129–137Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  129ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5844 9association of hypertension and obesity with HiV  and antiretroviral therapy in a rural tertiary health  center in nigeria: a cross-sectional cohort study Olarinde Jeffrey Ogunmola1 Olatunji Yusuf Oladosu1 adeyemi Michael  Olamoyegun2 1cardiac care centre, Department   of internal Medicine, Federal Medical  center, ido ekiti, ekiti state, nigeria;   2endocrinology, Diabetes and  Metabolism Unit, Department of  internal Medicine, ladoke- akintola  University of T echnology T eaching  Hospital, Ogbomoso, Oyo state,   nigeria correspondence: Olarinde Jeffrey  Ogunmola    98 Oluwatuyi Quarters, opposite  Rainbow Motel, PO Box 413, akure,  Ondo state, nigeria   Tel +234 803 388 0875   email joogunmola@yahoo.co mBackground:  There are few studies from Nigeria and Africa regarding the contribution of  obesity and hypertension to cardiovascular risk in HIV -infected patients.",Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
Available from:  http://www.who.int/gho/hiv/en /.,Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
"Available from: http://www.unaids.org/ en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/ UNAIDS_Global_Report_2013_en.pd f. Accessed February 3, 2014 .",Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
"Available from: http://data.unaids.org/Pub/report/2010/ nigeria_2010_country_progress_report_en.pd f. Accessed February 3,  2014.",OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
Available from: http://www.who.int/ hiv/amds/Nigeria_adult_2007.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
"http://www.mrc.ac.za/chronic/cdl1995-2005.pd f.  February 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
Available from: http://www.nbs.go.tz/tnada/index.php/catalog/6/ download/23 .,Non-OADS,/arxiv_data1/oa_pdf/ed/05/vhrm-10-129.PMC3964169.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 571–579Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  571Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4592 1Diagnosis and management   of neurotrophic keratitis Marta Sacchetti1 Alessandro Lambiase2 1Cornea and Ocular Surface Unit,   Ospedale San Raffaele di Milano- iRCCS, Milan, 2Ophthalmology,   University La Sapienza of Rome, italy Correspondence: Alessandro Lambiase   Ophthalmology, Dept.",Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
Available  from: http://clinicaltrials.gov/show/NCT01756456.,Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01794312.,Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
Available from: http://clinicaltrials.gov/show/NCT01165450.,Non-OADS,/arxiv_data1/oa_pdf/2b/87/opth-8-571.PMC3964170.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/77/vhrm-10-139.PMC3964171.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 139–144Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  139ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5835 1The “Pulse Time index of norm” highly   correlates with the left ventricular mass   index in patients with arterial hypertension igor n Posokhov1 natalya n Kulikova2 irina V starchenkova2 elena a grigoricheva3 Vitaly V evdokimov3 artemy V Orlov4 anatoly n  Rogoza5  On behalf of The BP lab- Vasotens Registry  collaborators 1Hemodynamic laboratory ltd,   nizhny  novgorod, Russia; 23rd  Republican Hospital, saransk, Russia;   3chelyabinsk state Medical academy,   chelyabinsk, Russia; 4national  Research nuclear University M ePhl,   Moscow, Russia; 5cardiology Research  center, Moscow, Russia correspondence: igor n Posokhov   PO Box 69, Hemodynamic laboratory  603009, nizhny  novgorod, Russia   Tel +7 915 939 6222   Fax +7 913 825 9111   email posokhov@24h-monitoring.co mBackground:  Arterial stiffness, as measured by the pulse wave velocity (PWV), is recommended  for routine use in clinical practice as an important parameter for the evaluation of cardiovascular  risk.1 New 24-hour monitors (eg, with Vasotens® technology; Petr Telegin Company, Nizhny  Novgorod, Russian Federation) provide single PWV measurements as well as several PWV mea - surements over a period of 24 hours.2 Such 24-hour pulse wave analysis led to the development  of the novel Pulse Time Index of Norm (PTIN), which is defined as the percentage of a 24-hour  period during which the PWV does not exceed the 10 m/second PWV threshold.",Non-OADS,/arxiv_data1/oa_pdf/07/77/vhrm-10-139.PMC3964171.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/07/77/vhrm-10-139.PMC3964171.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/77/vhrm-10-139.PMC3964171.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ott-7-457.PMC3964172.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 457–467OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  457Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5879 1Oncogene mutational profile in nasopharyngeal  carcinoma Zi-chen Zhang1,* sha Fu1,* Fang Wang1 hai-Yun Wang1 Yi-Xin Zeng2 Jian-Y ong shao1 1Department of Molecular  Diagnostics, 2Department of  experimental research, sun Yat-sen  University cancer center, state Key  laboratory of Oncology in south  china, collaborative innovation  center of cancer Medicine,   guangzhou, People’s republic   of china *These authors contributed equally to  this work correspondence: Jian-Yong shao   Department of Molecular Diagnostics,  sun Yat-sen University cancer center,  21 Qing cai gang road, guangzhou,  510060,  People’s republic of china   Tel +86 020 8734 5599   Fax +86 020 8734 5599   email shaojy@sysucc.org.c nAbstract:  Nasopharyngeal carcinoma (NPC) is a common tumor in Southern China, but the  oncogene mutational status of NPC patients has not been clarified.",Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ott-7-457.PMC3964172.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ott-7-457.PMC3964172.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ott-7-457.PMC3964172.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/61/ppa-8-353.PMC3964173.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 353–359Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  353OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5897 1Orthodontic treatment need for adolescents   in the campania region: the malocclusion   impact on self-concept letizia Perillo1 Maria esposito2 Alberto caprioglio3 stefania Attanasio1 Annamaria chiara santini2 Marco carotenuto2 1Department of Orthodontics, second  University of naples, naples, italy;   2clinic of child and Adolescent  neuropsychiatry, Department of  Mental health, Physical and Preventive  Medicine, second University of  naples, naples, italy; 3Department of  Orthodontics, University of insubria,   Varese, italy correspondence: Marco carotenuto   clinic of child and Adolescent  neuropsychiatry, Department of Mental  health, Physical and Preventive Medicine,  second University of naples, Via sergio  Pansini, 5, 80131, napoli, italy   Tel +39 81 566 6988   Fax +39 81 566 6694   email marco.carotenuto@unina2.i tBackground:  Dental malocclusions can be considered not only as an oral health problem,  because they are linked to quality of life perception.",Non-OADS,/arxiv_data1/oa_pdf/50/61/ppa-8-353.PMC3964173.pdf
"World Medical Association Declara - tion of Helsinki: ethical principles for medical research involv - ing human subjects, 2008 Available from: http://www.wma.net/ en/30publications/10policies/b3 /.",Non-OADS,/arxiv_data1/oa_pdf/50/61/ppa-8-353.PMC3964173.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/50/61/ppa-8-353.PMC3964173.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/61/ppa-8-353.PMC3964173.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/09/imcrj-7-053.PMC3964174.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 53–56International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  53Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5485 0a fatal case of congenital pulmonary airway   malformation with aspergillosis in an adult Hilary a enuh1 edward L arsura2 Zaza Cohen3 Keith t Diaz2 Jay M Nfonoyim2 phillip J Cosentino2 Jessie K saverimuttu4 1Department of Internal Medicine,   Richmond University Medical Center,   staten Island, NY, Usa; 2pulmonary  and Critical Care Medicine, Richmond  University Medical Center, staten  Island, NY, Usa; 3pulmonary and  Critical Care Medicine, Rutgers, the  state University of New Jersey, New  Jersey Medical school, Newark, NJ,   Usa; 4Infectious Disease Control Unit,   Richmond University Medical Center,   staten Island, NY, Usa Correspondence: Zaza Cohen   Division of pulmonary and Critical Care   Medicine, Rutgers, the state University   of New Jersey, New Jersey Medical   school, 150 Bergen street, UH I-354,   Newark, NJ 07103, Usa   email zazacohen@yahoo.co mAbstract:  Congenital cystic adenomatoid malformation, currently referred as congenital  pulmonary airway malformation (CPAM), is one of the rare lung malformations seen in adults.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/imcrj-7-053.PMC3964174.pdf
Available from: http://www.cincin - natichildrens.org/service/f/fetalcare/conditions/ccam/detail /.,Non-OADS,/arxiv_data1/oa_pdf/c9/09/imcrj-7-053.PMC3964174.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/imcrj-7-053.PMC3964174.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/09/imcrj-7-053.PMC3964174.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/0d/opth-8-581.PMC3964175.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 581–590Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  581Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4544 4Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Zeev et al Running head recto: Diagnosis of dry eye disease and emerging technologies DOI: http://dx.doi.org/10.2147/OPTH.S4544 4 Diagnosis of dry eye disease and emerging  technologies Maya Salomon-Ben Zeev1 Darby Douglas Miller2,3 Robert Latkany1,2 1The Dry eye Center at Physician  eyecare of New Y ork, 2New Y ork eye  and ear infirmary, 3Laser and Corneal  Surgery Associates, New Y ork,   NY, USAAbstract:  Dry eye is one of the most commonly encountered problems in ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/0d/opth-8-581.PMC3964175.pdf
Available from: http://www.revophth.com/content/t/ dry_eye/c/44198/.,Non-OADS,/arxiv_data1/oa_pdf/70/0d/opth-8-581.PMC3964175.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/0d/opth-8-581.PMC3964175.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 590Zeev et al  77.,Non-OADS,/arxiv_data1/oa_pdf/70/0d/opth-8-581.PMC3964175.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2013 |  80  | e50928 | Page 1 of 6Video Article Stretch in Brain Microvascular Endothelial Cells (cEND) as an In Vitro Traumatic Brain Injury Model of the Blood Brain Barrier Ellaine Salvador1, Winfried Neuhaus1,2, Carola Foerster1 1Klinik und Poliklinik für Anästhesiologie, Zentrum für operative Medizin der Universität Würzburg 2Department of Medicinal Chemistry, Faculty of Life Sciences, University of Vienna Correspondence to: Carola Foerster at Foerster_C@klinik.uni-wuerzburg.de URL: http://www.jove.com/video/50928 DOI: doi:10.3791/50928 Keywords: Medicine, Issue 80, stretch injury, traumatic brain injury, blood-brain barrier, brain microvascular endothelial cells (cEND) Date Published: 10/26/2013 Citation: Salvador, E., Neuhaus, W., Foerster, C. Stretch in Brain Microvascular Endothelial Cells (cEND) as an In Vitro Traumatic Brain Injury Model of the Blood Brain Barrier.",Non-OADS,/arxiv_data1/oa_pdf/db/1b/jove-80-50928.PMC3964201.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50928/ Introduction Traumatic brain injury (TBI) is one of the leading causes of death worldwide.,Non-OADS,/arxiv_data1/oa_pdf/db/1b/jove-80-50928.PMC3964201.pdf
"Accepted on February 4, 2014.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.117  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.will be influenced by many important factors including the  following: 1) Evidence (peer reviewed publications) that the selected  approach will be effective in decreasing both CRC mortality and incidence.",Non-OADS,/arxiv_data1/oa_pdf/6c/82/gnl-8-117.PMC3964261.pdf
Available from: http://nccrt.org/about/provider-education/fobt-clinicians-reference-resources.,Non-OADS,/arxiv_data1/oa_pdf/6c/82/gnl-8-117.PMC3964261.pdf
Available from: http://www.worldendo.org/assets/downloads/pdf/activities/fit_reports/gmec_fit_evaluation_report.pdf.,OADS,/arxiv_data1/oa_pdf/6c/82/gnl-8-117.PMC3964261.pdf
"Accepted on February 14, 2014.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.131  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.Anatomically, there are two types of gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/3a/8a/gnl-8-131.PMC3964262.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.140Sang Pyo Lee and Kang Nyeong Lee contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/44/7d/gnl-8-140.PMC3964263.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.148  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.decreased capacity for physical and/or mental work.1 Fatigue is  not simply a part of a psychological comorbidity or illness be-havior, but should be considered as a unique entity.",Non-OADS,/arxiv_data1/oa_pdf/57/b3/gnl-8-148.PMC3964264.pdf
"Published online on November 21, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.154  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.Key Words:  Gastroesophageal reflux; Agreement; Experience INTRODUCTION Gastroesophageal reflux disease (GERD) is a condition char- acterized by heartburn or regurgitation caused by esophageal exposure to acidic gastric content.",Non-OADS,/arxiv_data1/oa_pdf/9d/20/gnl-8-154.PMC3964265.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.160  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.condition which develops when the reflux of stomach contents  causes troublesome symptoms and/or complications.1 Based  on the Rome III diagnostic criteria, FD is a disorder in which bothersome postprandial fullness or epigastric pain persists for 3 months, without evidence of structural disease.",Non-OADS,/arxiv_data1/oa_pdf/a8/ad/gnl-8-160.PMC3964266.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.165  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.INTRODUCTION Gastroesophageal reflux disease (GERD) is a condition that  develops when reflux of stomach contents causes troublesome symptoms and/or complications.",Non-OADS,/arxiv_data1/oa_pdf/29/4a/gnl-8-165.PMC3964267.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.170  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.undergone colostomy or ileostomy and have no history of in- flammatory bower disease.1 Most patients who have had an os- tomy display the endoscopic features of diversion colitis in the distal colon and rectum of the ostomy, 2-5 and they often com- plain of abdominal pain, tenesmus, mucus, and hemorrhagic discharge.",Non-OADS,/arxiv_data1/oa_pdf/73/44/gnl-8-170.PMC3964268.pdf
"Published online on December 24, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.177  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.pected to increase in the future.1 Major risk factors for HCC are  hepatitis B virus (HBV) and hepatitis C virus infections, alco-holic liver disease, and nonalcoholic fatty liver disease.",Non-OADS,/arxiv_data1/oa_pdf/81/ed/gnl-8-177.PMC3964269.pdf
"Published online on December 24, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.186Ping Xu and Yong-Jing Chen contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/c5/4a/gnl-8-186.PMC3964270.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.196  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.to two cases per 100,000 in the Western world.1 In China and  Southeast Asia, the incidence of hilar-CCA is relatively higher.2  Although the annual incidence of this disease in the Western world is lower than that in Asia, the rate of hilar-CCA has sig-nificantly risen over the past several decades.",Non-OADS,/arxiv_data1/oa_pdf/d6/4a/gnl-8-196.PMC3964271.pdf
"Hilar-CCA cell line SNU-1196 and human perineural cell line human perineurial cells, cell line code of Sciencell USA were purchased from Korean Cell Bank and ScienCell Research Laboratories (http://www.sciencellonline.com; Catalog no.",Non-OADS,/arxiv_data1/oa_pdf/d6/4a/gnl-8-196.PMC3964271.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.205  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.INTRODUCTION Pancreatic cancer (PC) is a devastating disease that poses sig- nificant management challenges.",Non-OADS,/arxiv_data1/oa_pdf/70/12/gnl-8-205.PMC3964272.pdf
"Published online on November 5, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.215  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.doscope insertion and needle penetration through the gastroin- testinal mucosa into the pancreas, and bleeding and perforation after EUS-FNA cannot be completely avoided.",Non-OADS,/arxiv_data1/oa_pdf/f1/f4/gnl-8-215.PMC3964273.pdf
"Published online on December 24, 2013pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.219  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.a relatively uncommon computed tomography (CT) finding.",Non-OADS,/arxiv_data1/oa_pdf/fe/c9/gnl-8-219.PMC3964274.pdf
"Accepted on August 2, 2013.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.224  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.mon causes of acute pancreatitis are gallstones or alcoholism.",Non-OADS,/arxiv_data1/oa_pdf/ef/18/gnl-8-224.PMC3964275.pdf
"Accepted on July 27, 2013.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.2.228  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ff/e4/gnl-8-228.PMC3964276.pdf
"Stem Cell Reports Report In Vivo and In Vitro Dynamics of Undifferentiated Embryonic Cell T ranscription Factor 1 Christina Galonska,1,2,3Zachary D. Smith,1,2,3and Alexander Meissner1,2,3,* 1Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA 2Harvard Stem Cell Institute, Cambridge, MA 02138, USA 3Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA *Correspondence: alexander_meissner@harvard.edu http://dx.doi.org/10.1016/j.stemcr.2014.01.007 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/03/96/main.PMC3964277.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two movies and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/03/96/main.PMC3964277.pdf
"Stem Cell Reports Report Five T ranscription Factors and FGF Pathway Inhibition Efﬁciently Induce Erythroid Differentiation in the Epiblast Wei Weng1and Guojun Sheng1,* 1Laboratory for Early Embryogenesis, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan *Correspondence: sheng@cdb.riken.jp http://dx.doi.org/10.1016/j.stemcr.2014.01.019 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/40/41/main.PMC3964278.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.,Non-OADS,/arxiv_data1/oa_pdf/40/41/main.PMC3964278.pdf
"Stem Cell Reports Erratum Cell-Cycle Control of Developmentally Regulated T ranscription Factors Accounts for Heterogeneity in Human Pluripotent Cells Amar M. Singh, James Chappell, Robert Trost, Li Lin, Tao Wang, Jie Tang, Brittany K. Matlock, Kevin P. Weller, Hao Wu, Shaying Zhao, Peng Jin, and Stephen Dalton * *Correspondence: sdalton@uga.edu http://dx.doi.org/10.1016/j.stemcr.2014.02.009 (Stem Cell Reports 1, 532–544; December 5, 2013) Brittany K. Matlock and Kevin P. Weller were inadvertently omitted from the author list on the original article.",Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC3964279.pdf
"), chendh@ioz.ac.cn (D.C.) http://dx.doi.org/10.1016/j.stemcr.2014.01.012 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/76/de/main.PMC3964280.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.01.012 .,Non-OADS,/arxiv_data1/oa_pdf/76/de/main.PMC3964280.pdf
"Edge1,2,3,* 1Department of Otology and Laryngology, Harvard Medical School, Boston, MA 02115, USA 2Eaton-Peabody Laboratory, Massachusetts Eye and Ear Inﬁrmary, Boston, MA 02114, USA 3Program in Speech and Hearing Bioscience and Technology, Division of Health Sciences and Technology, Harvard and MIT, Cambridge, MA 02139, USA 4Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA 02114, USA *Correspondence: albert_edge@meei.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2014.01.008 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a2/a7/main.PMC3964281.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.",OADS,/arxiv_data1/oa_pdf/a2/a7/main.PMC3964281.pdf
"Stem Cell Reports Article Platform for Induction and Maintenance of T ransgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells Bahram Valamehr,1Megan Robinson,1Ramzey Abujarour,1Betsy Rezner,1Florin Vranceanu,1Thuy Le,1 Amanda Medcalf,1Tom Tong Lee,1Michael Fitch,1David Robbins,1and Peter Flynn1,* 1Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego, CA 92121, USA *Correspondence: peter.ﬂynn@fatetherapeutics.com http://dx.doi.org/10.1016/j.stemcr.2014.01.014 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/15/9e/main.PMC3964282.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.01.014 .",OADS,/arxiv_data1/oa_pdf/15/9e/main.PMC3964282.pdf
"Stem Cell Reports Article Quality Metrics for Stem Cell-Derived Cardiac Myocytes Sean P. Sheehy,1,2Francesco Pasqualini,1,2Anna Grosberg,1Sung Jin Park,1Yvonne Aratyn-Schaus,1 and Kevin Kit Parker1,* 1Disease Biophysics Group, Wyss Institute for Biologically Inspired Engineering and School of Engineering and Applied Sciences, Harvard Universit y, Cambridge, MA 02138, USA 2These authors contributed equally to this work *Correspondence: kkparker@seas.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2014.01.015 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1c/5d/main.PMC3964283.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, two tables, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/1c/5d/main.PMC3964283.pdf
http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Tissue/default.htm .,Non-OADS,/arxiv_data1/oa_pdf/1c/5d/main.PMC3964283.pdf
"http://dx.doi.org/10.1016/j.stemcr.2014.01.011 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/0d/05/main.PMC3964284.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, one ﬁgure, one table, and one movie and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.2014.",Non-OADS,/arxiv_data1/oa_pdf/0d/05/main.PMC3964284.pdf
"Stem Cell Reports Article Intrinsically Active and Pacemaker Neurons in Pluripotent Stem Cell-Derived Neuronal Populations Sebastian Illes,1,2Martin Jakab,3Felix Beyer,4Renate Gelfert,1,2Se´bastien Couillard-Despres,1,2,5 Alfons Schnitzler,4Markus Ritter,3and Ludwig Aigner1,2,* 1Institute of Molecular Regenerative Medicine, Paracelsus Medical University, 5020 Salzburg, Austria, Austria 2Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria 3Institute of Physiology and Pathophysiology, Paracelsus Medical University, 5020 Salzburg, Austria 4Institute of Clinical Neuroscience and Medical Psychology, Heinrich Heine University Du ¨sseldorf, 40225 Du ¨sseldorf, Germany 5Institute of Experimental Neuroregeneration, Paracelsus Medical University, 5020 Salzburg, Austria *Correspondence: ludwig.aigner@pmu.ac.at http://dx.doi.org/10.1016/j.stemcr.2014.01.006 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a4/22/main.PMC3964285.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/a4/22/main.PMC3964285.pdf
"Stem Cell Reports Article Modeling Hippocampal Neurogenesis Using Human Pluripotent Stem Cells Diana Xuan Yu,1Francesco Paolo Di Giorgio,2Jun Yao,1Maria Carolina Marchetto,1Kristen Brennand,3 Rebecca Wright,1Arianna Mei,1Lauren Mchenry,1David Lisuk,1Jaeson Michael Grasmick,1 Pedro Silberman,1Giovanna Silberman,1Roberto Jappelli,1and Fred H. Gage1,* 1The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA 2Neuroscience Discovery, Novartis Pharma AG, Novartis Institute for Biomedical Research, Postfach, Basel CH-4002, Switzerland 3Department of Neuroscience/Psychiatry, Mount Sinai School of Medicine, 1425 Madison Ave, New York, NY 10059, USA *Correspondence: gage@salk.edu http://dx.doi.org/10.1016/j.stemcr.2014.01.009 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c9/0b/main.PMC3964286.pdf
Images were acquired with MetaMorph 7.7 (MDS Analytical Technologies)and processed using ImageJ ( http://rsbweb.nih.gov/ij/ ) and custom-written routines in Matlab 7.2 (Mathworks).,OADS,/arxiv_data1/oa_pdf/c9/0b/main.PMC3964286.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimen- tal Procedures, two ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/c9/0b/main.PMC3964286.pdf
"Published online April 6, 2013. http://dx.doi.org/ 10.1111/bdi.12064.",Non-OADS,/arxiv_data1/oa_pdf/c9/0b/main.PMC3964286.pdf
"http://dx.doi.org/10.1016/j.stemcr.2014.01.005 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/56/00/main.PMC3964287.pdf
ACCESSION NUMBERS The Gene Expression Omnibus database ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/56/00/main.PMC3964287.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seven ﬁgures and six tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/00/main.PMC3964287.pdf
"http://dx.doi.org/10.1016/j.stemcr.2014.01.010 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
MINS is hosted athttp://katlab-tools.org .,OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
"Comparison of MINS to Semiautomated Methods and Related Software ToolsWe compared MINS against several popular tools inthe community, including ilastik ( http://www.ilastik.",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
"org), FARSIGHT ( http://www.farsight-toolkit.org/wiki/ FARSIGHT_Toolkit ), and CellSegmentation3D ( http:// www.biomedcentral.com/1471-2121/8/40/additional ).",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
"Second, in thefuture, the migration of the MINS software to the freelyavailable python platform ( http://www.python.org ) willbe important.",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
MINS software and a detailed user guide are hosted athttp://katlab-tools.org .,OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information for this article includes one ﬁgure, two tables, seven movies, and Supplemental Experimental Proceduresand can be found with this article online at http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
"Published online February 6, 2014. http://dx.doi.org/10.1242/dev.096875.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC3964288.pdf
"Stem Cell Reports Article Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful T ransplantation Daisuke Doi,1Bumpei Samata,1Mitsuko Katsukawa,1Tetsuhiro Kikuchi,1Asuka Morizane,1Yuichi Ono,2 Kiyotoshi Sekiguchi,3Masato Nakagawa,4Malin Parmar,5and Jun Takahashi1,6,7,* 1Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, 606-8507 Kyoto, Japan 2Group for Neuronal Differentiation and Development, KAN Research Institute, Inc., 650-0047 Kobe, Japan 3Laboratory of Extracellular Matrix Biochemistry, Institute for Protein Research, Osaka University, 565-0871 Osaka, Japan 4Department of Reprogramming Science, Center for iPS Cell Research and Application, Kyoto University, 606-8507 Kyoto, Japan 5Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, 221 84 Lund, Sweden 6Department of Biological Repair, Institute for Frontier Medical Sciences, Kyoto University, 606-8507 Kyoto, Japan 7Department of Neurosurgery, Kyoto University School of Medicine, 606-8507 Kyoto, Japan *Correspondence: jbtaka@cira.kyoto-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2014.01.013 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/b3/fa/main.PMC3964289.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and six tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2014.01.013 .,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/main.PMC3964289.pdf
Further information about the data can befound at http://2007study.sphsu.mrc.ac.uk/ .,OADS,/arxiv_data1/oa_pdf/6e/d4/12160_2013_Article_9539.PMC3964290.pdf
"All-cause deaths by depri- vation decile: directly age/sex standardised rates per 100,000 popu- lation, Scotland 2010. http://www.scotpho.or g.uk/population- dynamics/deaths/data/deaths-by-deprivation .",Non-OADS,/arxiv_data1/oa_pdf/6e/d4/12160_2013_Article_9539.PMC3964290.pdf
FDA Alerts and Notices (Medical Devices) - FDA safety communi- cation: UPDATE on serious comp lications associated with Transvaginal placement of surgical mesh for pelvic organ prolapse.http://www.fda.gov/medicaldevi ces/safety/alertsandnotices/ ucm262435.htm .,Non-OADS,/arxiv_data1/oa_pdf/82/9c/192_2013_Article_2230.PMC3964292.pdf
References 1.http://www.ispor.org/PEguidelines/index.asp : ISPOR; [22.12.2013].2.,Non-OADS,/arxiv_data1/oa_pdf/38/75/40273_2014_Article_136.PMC3964297.pdf
13.http://www.nets.nihr.ac.uk/programmes/hta : NIHR; [22.12.2013].,Non-OADS,/arxiv_data1/oa_pdf/38/75/40273_2014_Article_136.PMC3964297.pdf
http://www.crd.,Non-OADS,/arxiv_data1/oa_pdf/38/75/40273_2014_Article_136.PMC3964297.pdf
http://www.nice.org.uk/me dia/E4A/79/Supplementary AdviceTACEoL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/38/75/40273_2014_Article_136.PMC3964297.pdf
"These guidelines also men- tion the possibility of lasting beneﬁt from short-termtreatment with alefacept and the lack of long-term safety Table 3 Organizations with recent psoriasis guidelines Organization URL/other reference Publication dateAudience American Academy of Dermatology Menter et al., 2008; American Academy of Dermatology Work Group et al., 2011 [36,37]2008, 2011 Dermatologists Canadian Dermatology Association http://www.dermatology.ca/wp-content/ uploads/2012/01/cdnpsoriasisguidelines.",Non-OADS,/arxiv_data1/oa_pdf/67/22/40273_2014_Article_130.PMC3964298.pdf
"pdf[38]June 2009 Dermatologists European Academy of Dermatology and Venereology Pathirana et al., 2009 [ 39] 2009 Dermatologists, health insurers, health policymakers British Association of Dermatologists Smith et al., 2009 [ 40] 2009 Dermatologists National Clinical Guidelines Centre, commissioned by the National Institute for Health and Care Excellencehttp://guidance.nice.org.uk/CG153/ Guidance [41]October 2012Primary care providers and dermatologists German S3 Guidelines—update Nast et al., 2012 [ 42] 2012 Dermatologists, health insurers, health policymakers Spanish Academy of Dermatology and Venereology Puig et al., 2009a, b [ 43,44] 2009 Dermatologists Note: Guidelines identiﬁed but not included because the languages of the publication were for the Netherlands (2009) or Portugal (2012)Treatment Sequencing After Failure of the First Biologic in Cost-Effectiveness Models of Psoriasis 403",Non-OADS,/arxiv_data1/oa_pdf/67/22/40273_2014_Article_130.PMC3964298.pdf
2006. http://www.cadth.ca/media/pdf/186_Economic Guidelines_e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/22/40273_2014_Article_130.PMC3964298.pdf
2012. http://www.cadth.ca/media/pdf/htis/aug- 2012/RC0369%20Inﬂiximab%20Final.pdf .,OADS,/arxiv_data1/oa_pdf/67/22/40273_2014_Article_130.PMC3964298.pdf
"Enriched TF-binding motifs and binding-site mapping in the clusters To further examine these clusters, we performed TF motif analysis prediction for each cluster in Figure 2A, using Seqposand CEAS ( cis-regulatory element annotation system; Shin et al, 2009) softwares (http://liulab.dfci.harvard.edu/CEAS/ usermanual.html).",OADS,/arxiv_data1/oa_pdf/3d/c3/msb201328.PMC3964312.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by-nc-nd/3.0/.Genomic cluster speciﬁcation of ER aand ER bactions Z Madak-Erdogan et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 19,Non-OADS,/arxiv_data1/oa_pdf/3d/c3/msb201328.PMC3964312.pdf
"Theprogram was written in the programming language C þþ, and symbolic matrix operations were conducted with the GiNaC libraryversion 1.6 (http://www.ginac.de/).",OADS,/arxiv_data1/oa_pdf/36/bd/msb201329.PMC3964313.pdf
To viewa copy of this licence visit http://creativecommons.org/licenses/by-nc-sa/3.0/.Network quantiﬁcation of EGFR signaling B Klinger et al 14Molecular Systems Biology 2013 &2013 EMBO and Macmillan Publishers Limited,Non-OADS,/arxiv_data1/oa_pdf/36/bd/msb201329.PMC3964313.pdf
Z. mobilis is currently being used as part of a DuPont industrial-scale cellulosic ethanol process (http://www.ddce.,Non-OADS,/arxiv_data1/oa_pdf/64/24/msb201330.PMC3964314.pdf
"The complete,non-averaged data set can be found in Supplementary Dataset 1 and online (http://genomics.lbl.gov/supplemental/zm4hy- drolysate/).",OADS,/arxiv_data1/oa_pdf/64/24/msb201330.PMC3964314.pdf
Annotations were obtained from RefSeq (http://www.ncbi.nlm.nih.gov/ RefSeq/).Dissecting plant hydrolysate stress JM Skerker et al 8Molecular Systems Biology 2013 &2013 EMBO and Macmillan Publishers Limited,OADS,/arxiv_data1/oa_pdf/64/24/msb201330.PMC3964314.pdf
"Z. mobilis gene annotations for the main chromosome and ﬁve plasmids (pZZM401-pZZM405) wereobtained from RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) and arecent annotation paper (Yang et al , 2009a).",OADS,/arxiv_data1/oa_pdf/64/24/msb201330.PMC3964314.pdf
Gene and GO annotations for S288C wereobtained from the SGD database (http://www.yeastgenome.org/).,OADS,/arxiv_data1/oa_pdf/64/24/msb201330.PMC3964314.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by-nc-nd/3.0/.Dissecting plant hydrolysate stress JM Skerker et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 21,Non-OADS,/arxiv_data1/oa_pdf/64/24/msb201330.PMC3964314.pdf
"To view a copy of this licence visit http://creativecommons.org/ licenses/by-nc-sa/3.0/.rRNA synthesis, ribosome assembly and translation MC Jewett et al 8Molecular Systems Biology 2013 &2013 EMBO and Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d5/af/msb201331.PMC3964315.pdf
"Calculation of folding energy We used the Vienna RNA Package, version 1.8.5, available at http://www.tbi.univie.ac.at/%7Eivo/RNA/, to predict free energy of RNAsequences (Hofacker, 2009).",OADS,/arxiv_data1/oa_pdf/5b/7a/msb201332.PMC3964316.pdf
To viewa copy of this licence visit http://creativecommons.org/ licenses/by-nc-sa/3.0/.Translation initiation dictates codon usage K Bentele et al 10Molecular Systems Biology 2013 &2013 EMBO and Macmillan Publishers Limited,Non-OADS,/arxiv_data1/oa_pdf/5b/7a/msb201332.PMC3964316.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004183).,Non-OADS,/arxiv_data1/oa_pdf/d8/9a/bmjopen-2013-004183.PMC3964344.pdf
http://www.dsm5.org/ProposedRevision/ Pages/proposedrevision.aspx?rid=65#/Updated 2 June 2010.,Non-OADS,/arxiv_data1/oa_pdf/d8/9a/bmjopen-2013-004183.PMC3964344.pdf
2011. http://www.nice.org.uk/nicemedia/live/13476/54520/54520.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/d8/9a/bmjopen-2013-004183.PMC3964344.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9f/9f/thnov04p0460.PMC3964441.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/c8/thnov04p0475.PMC3964442.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5f/06/thnov04p0498.PMC3964443.pdf
"1 1      http://www.medsci.org  389  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(4): 389-390.  doi: 10.7150/ ijms.7613   Letter to Editor  Mutations in PRSS1  Put into Perspective   Philipp G. Sand   Department of Psychiatry, University of Regensburg, Germany .",Non-OADS,/arxiv_data1/oa_pdf/16/c1/ijmsv11p0389.PMC3964445.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/c1/ijmsv11p0389.PMC3964445.pdf
11     http://www.medsci.org  390  References   1.,Non-OADS,/arxiv_data1/oa_pdf/16/c1/ijmsv11p0389.PMC3964445.pdf
"1 1      http://www.medsci.org  391  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(4): 391-403. doi: 10.7150/ ijms.7697   Research Paper   Different Isolation Methods Alter the Gene Expression  Profiling o f Adipose Derived Stem Cells    Nareshwaran Gnanasegaran1, Vijayendran Govindasamy2, Sabri Musa1,3, Noor Hayaty Abu Kasim1,4  1.",Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"11     http://www.medsci.org  392  able to differentiate into adipogenic, osteogenic,  chondrogenic, neurogenic and myogenic cells [6].",Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"The pellet was re-suspended and filtered through a 100 -um mesh  filter (BD Pharmingen, San Diego CA, USA; http://www.bdbiosciences.com) to remove debris.",Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
11     http://www.medsci.org  393  the remaining cells were transferred onto plates.,Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"1 1      http://www.medsci.org  394  Senescence associated β-galactosidase  (SA-β-gal) Assay   The senescence -associated β-galactosidase  (SA-β-gal) assay was carried out using senescence  β-galactosidase staining kit (Cell Signaling Techno l- ogy, Danvers, MA, USA, htt p://www.cellsignal.com)  according to the manufacturer's instructions.",Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
11     http://www.medsci.org  395  tions and was stored at -80 °C.,OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"Ingenuity Pathway Analysis (IPA)   The ''Core Analysis' function included in  IPA  (Ingenuity® Systems Inc., California, USA; http://www.ingenuity.com)  [20] was used to interpret  the data in the context of biological processes, pat h- ways and networks.",OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"The descriptive statistical tests were performed  using the SPSS software for Windo ws (version 11.0,  SPSS Predictive Analytics, Chicago, IL and http://www.spss.com).",OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"1 1      http://www.medsci.org  396  Results   Basic characterizations of BM -MSCs, ASCs  (liposuction) and ASCs (biopsy)   ASCs from both liposuction and biopsy tech- nique showed a spindle and elongated morphology  resembling fibroblastic appearance of BM- MSCs (Fig.",OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
1 1      http://www.medsci.org  397  The senescence assay as s hown in Figure 2E d e- scribes the activity of β -galactosidase due to cell ag e- ing.,Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"1 1      http://www.medsci.org  398  Further validation was carried out b y means of  gene expression study of both reverse- transcription  and real -time PCR to detect as well as quantify the  presence of related genes to mesodermal differenti a- tion, namely Runx2, Osteoclacin, PPAR -gamma -2,  LPL, Aggrecan and Collagen 2A1.",Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
1 1      http://www.medsci.org  399  Pathway Analysis   Network analysis was performed using only the  genes that were up -regulated in both ASCs from li p- osuction and biopsy and which exhibited more than  two-fold expression changes compared to BM -MSCs.,OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
"1 1      http://www.medsci.org  400  Confirmation of array analysis   Pluripotent markers such as POU5F1, NANOG  and RUNX2 were shown to be comparable across all  the cell lines.",OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
11     http://www.medsci.org  401    Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
11     http://www.medsci.org  402  Gene expressions in ASCs (liposuction) wer e  focused towards endoderm lineage.,Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
11     http://www.medsci.org  403  References   1.,Non-OADS,/arxiv_data1/oa_pdf/2e/83/ijmsv11p0391.PMC3964446.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1910/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/9d/62/1002.PMC3964484.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Ching-Wei Tsai,1Morgan E. Grams,2 Lesley A. Inker,3Josef Coresh,1,2 and Elizabeth Selvin1,21002 Diabetes Care Volume 37, April 2014EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/9d/62/1002.PMC3964484.pdf
"Lower extremity disease procedures manual [Internet], 2001.Available from http://www.cdc.gov/nchs/ data/nhanes/le.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9d/62/1002.PMC3964484.pdf
Available from http://www.cdc.gov/nchs/data_access/data_linkage/mortality/ nhanes_99_04_linkage.htm#description.,OADS,/arxiv_data1/oa_pdf/9d/62/1002.PMC3964484.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1332/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8d/30/993.PMC3964485.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Joseph A. Simonetti,1Michael J. Fine,2,3 Yi-Fan Chen,4Deborah Simak,5 and Rachel Hess2Diabetes Care Volume 37, April 2014 993EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/8d/30/993.PMC3964485.pdf
Available from http://www.ncqa.org/tabid/1256/default.aspx.,OADS,/arxiv_data1/oa_pdf/8d/30/993.PMC3964485.pdf
Availablefrom http://www.ncqa.org.reportcards/ healthplans/stateofhealthcarequality.aspx.,Non-OADS,/arxiv_data1/oa_pdf/8d/30/993.PMC3964485.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1527/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/18/56/1083.PMC3964486.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Joshua I. Barzilay,1Kathleen A. Jablonski,2 Vivian Fonseca,3Steven E. Shoelson,4 Allison B.",Non-OADS,/arxiv_data1/oa_pdf/18/56/1083.PMC3964486.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-2359/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e5/aa/979.PMC3964487.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Jay M. Sosenko,1Jay S. Skyler,1 Jeffrey Mahon,2Jeffrey P. Krischer,3 Carla J. Greenbaum,4Lisa E. Rafkin,1 Craig A. Beam,3David C. Boulware,3 Della Matheson,1David Cuthbertson,5 Kevan C. Herold,6George Eisenbarth,7 Jerry P. Palmer,8and the Type 1 Diabetes TrialNet and Diabetes PreventionTrial-Type 1 Study Groups*Diabetes Care Volume 37, April 2014 979EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/e5/aa/979.PMC3964487.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Nancy Wei,1Hui Zheng,2 and David M. Nathan11048 Diabetes Care Volume 37, April 2014EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/9d/78/1048.PMC3964488.pdf
"A Desktop Guide to Type 1 (Insulin-Dependent Diabetes) [Internet], 1998.Available from http://www.staff.ncl.ac.uk/philip.home/t1dg1998.htm.",Non-OADS,/arxiv_data1/oa_pdf/9d/78/1048.PMC3964488.pdf
Available from http://www.idf.org.Accessed 20 December 2013 5.,Non-OADS,/arxiv_data1/oa_pdf/9d/78/1048.PMC3964488.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Walter Palmas,1Sally E. Findley,2 Miriam Mejia,3Milagros Batista,3 Jeanne Teresi,4Jian Kong,4 Stephanie Silver,4Elaine M. Fleck,5 Jose A. Luchsinger,5and Olveen Carrasquillo6Diabetes Care Volume 37, April 2014 963CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/63/3e/963.PMC3964489.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1982/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/1d/ab/1052.PMC3964490.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Ezra I. Fishman, Andrew Stokes, and Samuel H. Preston1052 Diabetes Care Volume 37, April 2014EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/1d/ab/1052.PMC3964490.pdf
"Survey questionnaires, datasets,and related documentation, 2012.Available from http://www.cdc.gov/nchs/ nhanes/nhanes_questionnaires.htm.Accessed 1 May 2013 16.",OADS,/arxiv_data1/oa_pdf/1d/ab/1052.PMC3964490.pdf
Available from http://www.cdc.gov/nchs/nhanes/analytic_guidelines.htm.,OADS,/arxiv_data1/oa_pdf/1d/ab/1052.PMC3964490.pdf
"Hyattsville, MD,National Center for Health Statistics, 2009.Available from http://www.cdc.gov/nchs/data_access/data_linkage/mortality/nhis_linkage.htm.",OADS,/arxiv_data1/oa_pdf/1d/ab/1052.PMC3964490.pdf
Available from http://www.cdc.gov/diabetes/ statistics/incidence/ ﬁg2.htm.,Non-OADS,/arxiv_data1/oa_pdf/1d/ab/1052.PMC3964490.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0604/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/de/95/1069.PMC3964491.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Tihamer Orban,1Brian Bundy,2 Dorothy J. Becker,3Linda A. DiMeglio,4 Stephen E. Gitelman,5Robin Goland,6 Peter A. Gottlieb,7Carla J. Greenbaum,8 Jennifer B. Marks,9Roshanak Monzavi,10 Antoinette Moran,11Mark Peakman,12 Philip Raskin,13William E. Russell,14 Desmond Schatz,15Diane K. Wherrett,16 Darrell M. Wilson,17Jeffrey P. Krischer,2 Jay S. Skyler,9and the Type 1 Diabetes TrialNet Abatacept Study GroupDiabetes Care Volume 37, April 2014 1069EMERGING TECHNOLOGIES AND THERAPEUTICS",Non-OADS,/arxiv_data1/oa_pdf/de/95/1069.PMC3964491.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Ranganath Muniyappa,1 Rebecca J. Brown,1Andrea Mari,2 Jalaja Joseph,1Mary A. Warren,1 Elaine K. Cochran,1Monica C. Skarulis,1 and Phillip Gorden1Diabetes Care Volume 37, April 2014 1101PATHOPHYSIOLOGY/COMPLICATIONS",Non-OADS,/arxiv_data1/oa_pdf/99/c7/1101.PMC3964492.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Annis M. Marney,1Nancy J. Brown,2 Robyn Tamboli,3and Naji Abumrad3e70 Diabetes Care Volume 37, April 2014eLETTERS –OBSERVATIONS",Non-OADS,/arxiv_data1/oa_pdf/c2/4b/e70.PMC3964493.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0700/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/81/92/909.PMC3964494.pdf
See http://creativecommons.org/licenses/by- nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/81/92/909.PMC3964494.pdf
See http://creativecommons.org/licenses/by- nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/16/4b/943.PMC3964495.pdf
The Medicare Diabetes Prevention Act of 2012. http://www.franken.senate.gov/ﬁles/documents/120731_Medicare_ Diabetes_Prevention_Act.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/4b/943.PMC3964495.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0215/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/1009.PMC3964496.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Elizabeth R. Mayeda,1Andrew J. Karter,2 Elbert S. Huang,3Howard H. Moffet,2 Mary N. Haan,1and Rachel A. Whitmer2Diabetes Care Volume 37, April 2014 1009EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/52/8e/1009.PMC3964496.pdf
Available from http://www.cdc.gov/diabetes/statistics/prev/national/ ﬁgageadult.htm.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/1009.PMC3964496.pdf
Available from http://www.healthypeople.gov/2020/about/.Accessed 6 December 2012 14.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/1009.PMC3964496.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/01/e1/1198.PMC3964499.pdf
The tools are avail- able: 1) human islets can be obtained from the Integrated Islet Distribution Program (http://iidp.coh.org) in theU.S.,OADS,/arxiv_data1/oa_pdf/01/e1/1198.PMC3964499.pdf
Available from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376516.htm.,Non-OADS,/arxiv_data1/oa_pdf/f5/dd/1174.PMC3964500.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/11/6f/1191.PMC3964508.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ec/24/1194.PMC3964509.pdf
"Sample size calculations were performed using G *Power 3.1 (http://www.gpower.hhu.de/)43, based on our previous report that showed the fre- quency of common alleles of the six VEGF SNPs to range between 60 and 90% and the prevalence of BPD to be approximately 50% in the studied population28.",OADS,/arxiv_data1/oa_pdf/a8/07/srep04459.PMC3964511.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4459 | DOI: 10.1038/srep04459 5",Non-OADS,/arxiv_data1/oa_pdf/a8/07/srep04459.PMC3964511.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bf/d3/srep04458.PMC3964512.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4458 | DOI: 10.1038/srep04458 4",Non-OADS,/arxiv_data1/oa_pdf/bf/d3/srep04458.PMC3964512.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/6d/srep04454.PMC3964513.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4454 | DOI: 10.1038/srep04454 6",Non-OADS,/arxiv_data1/oa_pdf/14/6d/srep04454.PMC3964513.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4457 | DOI: 10.1038/srep04457 9,Non-OADS,/arxiv_data1/oa_pdf/64/8b/srep04457.PMC3964514.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4457 | DOI: 10.1038/srep04457 10",Non-OADS,/arxiv_data1/oa_pdf/64/8b/srep04457.PMC3964514.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4453 | DOI: 10.1038/srep04453 5",Non-OADS,/arxiv_data1/oa_pdf/9c/46/srep04453.PMC3964515.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4456 | DOI: 10.1038/srep04456 5",Non-OADS,/arxiv_data1/oa_pdf/eb/9c/srep04456.PMC3964516.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/0b/srep04465.PMC3964518.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Table I |The sample names of precursors and Sr-122 tapes PrecursorsOrdinary tapes (unpressed)Hot pressed tapes One-step sintered precursors (1S) OR-1S HP-1S Two-step sintered precursors (2S) OR-2S HP-2Swww.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4465 | DOI: 10.1038/srep04465 5",Non-OADS,/arxiv_data1/oa_pdf/11/0b/srep04465.PMC3964518.pdf
This work was funded by the EU FP7 Large-scale integrating project ‘PluriMes’ (http://www.plurimes.eu/)as well as a EURYI award to M.P.L.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/srep04462.PMC3964519.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/srep04462.PMC3964519.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4462 | DOI: 10.1038/srep04462 6",Non-OADS,/arxiv_data1/oa_pdf/77/d8/srep04462.PMC3964519.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4463 | DOI: 10.1038/srep04463 9",Non-OADS,/arxiv_data1/oa_pdf/bb/83/srep04463.PMC3964520.pdf
"Acta 54, 7141–7147, doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/90/38/srep04452.PMC3964521.pdf
"6, 232–236, doi:http://www.nature.com/nnano/journal/v6/n4/abs/nnano.2011.13.html#supplementary- information (2011).",OADS,/arxiv_data1/oa_pdf/90/38/srep04452.PMC3964521.pdf
"Power Sources 159, 361–364, doi:http://dx.doi.org/10.1016/j.jpowsour.2006.04.",OADS,/arxiv_data1/oa_pdf/90/38/srep04452.PMC3964521.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/38/srep04452.PMC3964521.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4452 | DOI: 10.1038/srep04452 9",Non-OADS,/arxiv_data1/oa_pdf/90/38/srep04452.PMC3964521.pdf
"(b), Infrared image from Multi-functional Transport Satellite-1R (MTSAT-1R) of Japan Meteorological Agency (obtained with permission from http://agora.ex.nii.ac.jp/digital-typhoon/globe/color/2010/2048x2048/MTS110101800.globe.1.jpg).",OADS,/arxiv_data1/oa_pdf/a4/c1/srep04451.PMC3964559.pdf
The 6-hourly NCEP/NCAR Reanalysis 1 (for TCs before 1979) and Reanalysis 2 (only available from 1979) data on 2.5 u32.5ulatitude/longitude grids are used in the analysis of CAI associated to the TC recurvature during 1975–2012 (http://www.esrl.,OADS,/arxiv_data1/oa_pdf/a4/c1/srep04451.PMC3964559.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Peng, S.Q.",Non-OADS,/arxiv_data1/oa_pdf/a4/c1/srep04451.PMC3964559.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4451 | DOI: 10.1038/srep04451 8",Non-OADS,/arxiv_data1/oa_pdf/a4/c1/srep04451.PMC3964559.pdf
The gene set can be viewed at http://esharkgenome.imcb.a-star.edu.sg/.,Non-OADS,/arxiv_data1/oa_pdf/55/e6/41586_2014_Article_BFnature12826.PMC3964593.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-sa/3.0ARTICLE RESEARCH 9 JANUARY 2014 | VOL 505 | NATURE | 179 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/55/e6/41586_2014_Article_BFnature12826.PMC3964593.pdf
"Metabolism, 2005 ,54(5 Suppl 1),  20-3. http://dx.doi.org/10.1016/j.metabol.2005.01.008 [2] Kolb, B., Mychasiuk, R., Muhammad, A., Li, Y., Frost, D.O.,  Gibb, R. Experience and the developing prefrontal cortex.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neurosci., 2011 ,125(3), 282-96. http://dx.doi.org/10.1037/  a0023165  [4] Koenig, J.I., Kirkpatrick, B., Lee, P. Glucocorticoid hormones and  early brain development in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Stress, 2009 , 12(2), 167-77. http://dx.doi.org/10.1080/10253890802234168  [7] Tang, V.M., Young, A.H., Tan, H., Beasley, C., Wang, J.F.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Psychiatry ,2007 , 12(12), 1089-102. http://dx.doi.org/10.1038/sj.mp.4002095  [10] Sandi, C., Bisaz, R. A model for the involvement of neural cell  adhesion molecules in stress-related mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neuro-  endocrinology, 2007 ,85(3), 158-76. http://dx.doi.org/10.1016/  j.biopsych.2004.12.034  [11] Fatemi, S.H., Folsom, T.D.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Schizophr Bull., 2009 ,35(3), 528-48.  http://dx.doi.org/10.1093/schbul/sbn187  [12] Joazeiro, C.A., Hunter, T. Biochemistry.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Science, 2000 ,289( 5487), 2061-2. http://dx.doi.org/  10.1126/science.289.5487.2061  [13] Wojcik, C., Di Napoli, M. Ubiquitin-proteasome system and  proteasome inhibition: new strategies in stroke therapy.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Stroke , 2004 ,35(6), 1506-18. http://dx.doi.org/10.1161/01.STR.0000126891.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Biochem .,1998 ,67, 425-79. http://dx.doi.org/10.1146/annurev.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Dis .,  2010 ,39(3), 327-33. http://dx.doi.org/10.1016/j.nbd.2010.04.017  [20] Rajkowska, G., Goldman-Rakic, P.S.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"http://dx.doi.org/  10.1371/journal.pone.0020198  [22] David, D.J., Samuels, B.A., Rainer, Q., Wang, J.W., Marsteller, D.,  Mendez, I., Drew, M., Craig, D.A., Guiard, B.P., Guilloux, J.P.,  Artymyshyn, R.P., Gardier, A.M., Gerald, C., Antonijevic, I.A.,  Leonardo ED, Hen R. Neurogenesis- dependent and -independent  effects of fluoxetine in an animal model of anxiety/depression.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"http://dx.doi.org/10.1371/journal.pone.0026153  [24] Paxinos, G., Franklin, K.B.J.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Biochem., 2001 ,70, 503-33. http://dx.doi.org/10.1146/annurev.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Nature, 2001 ,412(6845), 449-452.  http://dx.doi.org/10.1038/35086595  [29] Keleman, K., Rajagopalan, S., Cleppien, D., Teis, D., Paiha, K.,  Huber, L.A., Technau, G.M., Dickson, B.J.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Cell, 2002 , 110(4), 415-27. http://dx.doi.org/10.1016/S0092-8674(02)00901-7  [30] Myat, A., Henry, P., McCabe V., Flintoft, L., Rotin, D., Tear, G.  Drosophila Nedd4, a ubiquitin ligase, is recruited by Commissureless  to control cell surface levels of the roundabout receptor.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neuron,  2002 ,35(3), 447-59. http://dx.doi.org/10.1016/S0896-6273(02)  00795-X  [31] Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C.,  Wacker, M., Klose, J., Shen, J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neurochem., 2005 ,95(5), 1259- 76. http://dx.doi.org/10.1111/j.1471-4159.2005.03442.x  [33] Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele,  G., Ricard, S., Teive, H, Fraix, V., Vidailhet, M., Nicholl, D.,  Barone, P., Wood, N.W., Raskin, S., Deleuze, J.F., Agid, Y., Dürr,  A., Brice, A. French Parkinson's Disease Genetics Study Group;  European Consortium on Genetic Susceptibility in Parkinson's  Disease.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neuron ,2002 ,36(6), 1007-19.  http://dx.doi.org/10.1016/S0896-6273(02)01125-X  [36] Darios, F., Corti, O., Lücking, C.B., Hampe, C., Muriel, M.P.,  Abbas, N., Gu, W.J., Hirsch, E.C., Rooney, T., Ruberg, M., Brice, A. Parkin prevents mitochondrial swe lling and cytochrome c  release in mitochondria-dependent cell death.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Genet .,  2003 ,12(5), 517-26. http://dx.doi.org/10.1093/hmg/12.5.517 [37] Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B.,  Demireva, E., Abeliovich, A. Parkin is a component of an SCF-like  ubiquitin ligase complex and protects postmitotic neurons from  kainate excitotoxicity.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neuron, 2003 ,37(5), 735-49. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Genet., 2004 ,13(16), 1745-54. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Genet .,2004 ,13(1), 117-35. http://dx.doi.org/10.1093/hmg/ddh012  [40] Henn, I.H., Bouman, L., Schlehe, J.S., Schlierf, A., Schramm, J.E.,  Wegener, E., Nakaso, K., Culmsee, C., Berninger, B., Krappmann,  D., Tatzelt, J., Winklhofer, K.F.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neurosci., 2007 ,27( 8), 1868-78. http://dx.doi.org/  10.1523/JNEUROSCI.5537-06.2007  [41] Marini, A.M., Jiang, X., Wu, X., Tian, F., Zhu, D., Okagaki, P.,  Lipsky, R.H. Role of brain-derived neurotrophic factor and NF- kappaB in neuronal plasticity and survival: From genes to  phenotype.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Cell Death Differ,  2011, 18(5), 769-82. http://dx.doi.org/10.1038/cdd.2010.142  [43] Nakahara, T., Gotoh, L., Motomura, K., Kawanami, N., Ohta, E.,  Hirano, M., Uchimura, H. Acute and chronic haloperidol treatments  increase parkin mRNA levels in the rat brain.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Lett., 2001 , 306(1-2), 93-6. http://dx.doi.org/10.1016/S0304-3940(01)01880-8  [44] Bunney, W.E., Bunney, B.G.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Rev., 2000 ,31(2-3), 138-46. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Neurochem., 1995 ,65, 1740-1751. http://dx.doi.org/  10.1046/j.1471-4159.1995.65041740.x  [51] Dudek, E.J., Shang, F., Valverde, P., Liu, Q., Hobbs, M., Taylor,  A. Selectivity of the ubiquitin pathway for oxidatively modified",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Chem., 1997 ,272(37), 23086- 93. http://dx.doi.org/10.1074/jbc.272.37.23086  [53] Marques, C., Pereira, P., Taylor, A., Liang, J.N., Reddy, V.N.,  Szwed, L.I., Shang, F. Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Sci., 2008 ,49(8), 3622-30. http://dx.doi.org/  10.1167/iovs.07-1559  [55] Yao, D., Gu, Z., Nakamura, T., Shi, Z. Q., Ma, Y., Gaston,   B., Palmer, L.A., Rockenstein, E.M., Zhang, Z., Masliah, E.,   Uehara, T., Lipton, S.A. Nitrosative stress linked to sporadic  Parkinson's disease: S-nitrosylation of parkin regulates its E3  ubiquitin ligase activity.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Chem., 1999 ,274(34),  23787-93. http://dx.doi.org/10.1074/jbc.274.34.23787  [57] Cha, G.H., Kim, S., Park, J., Lee, E., Kim, M., Lee, S.B., Kim,  J.M., Chung, J., Cho, K.S.",OADS,/arxiv_data1/oa_pdf/df/45/CN-12-100.PMC3964742.pdf
"Med .,  2013 ,8,1-14. http://dx.doi.org/10.1017/S0033291713002419  [2] Skolnick, P. Beyond monoamine-based therapies: clues to new  approaches.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Biochem Behav., 2013 ,105C, 63-70. http://dx.doi.org/10.1016/  j.pbb.2013.01.020  [5] Aboul-Fotouh, S. Coenzyme Q10 displays antidepressant-like  activity with reduction of hippocampal oxidative/nitrosative DNA  damage in chronically stressed rats.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Cell Biol., 2007 , 39(1), 44-84.  http://dx.doi.org/10.1016/j.biocel.2006.07.001  [7] Halliwell, B. Biochemistry of oxidative stress.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"http://dx.doi.org/10.1016/j.neuroscience.2012.10.014  [11] Kasote, D.M., Hegde, M.V., Katyare, S.S. Mitochondrial  dysfunction in psychiatric and neurological diseases: Cause(s),  consequence(s), and implications of antioxidant therapy.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"http://dx.doi.org/  10.1002/biof.1093  [12] Mällo, T., Matrov, D., Kõiv, K., Harro, J.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuroscience ,2009 ,164, 963-74. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neurosci., 1993 ,4(4), 407-416. http://dx.doi.org/10.1515/  REVNEURO.1993.4.4.407",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
", 2010 , 10(1), 59-76. http://dx.doi.org/10.1586/ern.09.144  [17] Liou, H.C., Baltimore, D. Regulation of the NF-kappa B/rel  transcription factor and I kappa B inhibitor system.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Brain Res., 2004 ,154(2), 577-584. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"J. Hepatol ., 2012 , 2012 , 853175. http://dx.doi.org/10.1155/2012/853175  [21] Jesmin, J., Rashid, M.S., Jamil, H., Hontecillas, R., Bassaganya-R. J.  Gene regulatory network reveals oxidative stress as the underlying  molecular mechanism of type 2 diabetes and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Genomics ,2010 ,3, 45. http://dx.doi.org/10.1186/1755-8794- 3-45  [22] Kotani, K., Taniguchi, N. Correlation Between High-sensitivity C- reactive Protein and Reactive Oxygen Metabo lites During A One- year Period Among Asymptomatic Subjects.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Res., 2012 ,4(1), 52-55.  http://dx.doi.org/10.4021/jocmr755w  [23] Terlecky, S.R., Terlecky, L.J., Giordano, C.R.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Chem ., 2012 , 3(5), 93-97. http://dx.doi.org/10.4331/wjbc.v3.i5.93  [24] Haeri, S., Baker, A.M., Ruano, R. Do pregnant women with  depression have a pro-inflammatory profile?",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
12017. http://dx.doi.org/10.1111/jog.,Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
http://dx.doi.org/10.1016/j.psyneuen.,OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Immun .,2013 , pii:  S0889-1591(13)00125-6.  http://dx.doi.org/10.1016/j.bbi.2013.02.003  [27] Chen, J., Song, Y., Yang, J., Zhang, Y., Zhao, P., Zhu, X.J., Su,  H.C.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"http://dx.doi.org/10.1016/j.neulet.2013.02.005  [28] Wadee, A.A., Kuschke, R.H., Wood, L.A., Berk, M., Ichim, L.,  Maes, M. Serological observations in patients suffering from acute  manic episodes.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychopharmacol .,2002 ,17(4), 175-179.  http://dx.doi.org/10.1002/hup.390  [29] Karson, A., Demirta /g3, T., Bayramgürler, D., Balcı, F., Utkan, T.  Chronic Administration of Infliximab (TNF-/g4 Inhibitor) Decreases  Depression and Anxiety-like Behaviour in Rat Model of Chronic  Mild Stress.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"http://dx.doi.org/10.1002/da.22084  [31] Gao, X., Zheng, C.Y., Qin, G.W., Tang, X.C., Zhang, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuropsychopharmacology ,2008 ,33(11), 2551-2565.  http://dx.doi.org/10.1038/sj.npp.1301671  [34] Fattal, O., Budur, K., Vaughan, A.J., Franco, K. Review of the  literature on major mental disorders in adult patients with  mitochondrial diseases.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychiatry, 2006 ,11(6), 577-93, 523,http://dx.doi.org/10.1038/  sj.mp.4001824  [40] Graziewicz, M.A., Bienstock, R.J., Copeland, W.C.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
",2007 ,16(22),2729-2739. http://dx.doi.org/10.2210/  pdb2c2e/pdb  [41] Lauritzen, K.H., Moldestad, O., Eide, L., Carlsen, H., Nesse, G.,  Storm J.F., Mansuy, I.M., Bergersen, L.H., Klungland, A.  Mitochondrial DNA toxicity in forebrain neurons causes apoptosis,  neurodegeneration, and impaired behavior.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"2008 , 4(4), 223-235. http://dx.doi.org/10.7150/ijbs.4.223  [44] Leonard, B., Maes, M. Mechanistic explanations how cell-mediated  immune activation, inflammation and oxidative and nitrosative  stress pathways and their sequels and concomitants play a role in  the pathophysiology of unipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuropharmacology ,2012 ,62(4), 1607-1618.  http://dx.doi.org/10.1016/j.neuropharm.2011.10.006  [46] Baum, A.E., Hamshere, M., Green, E., Cichon, S., Rietschel, M.,  Noethen, M.M., Craddock, N., McMahon, F.J. Meta-analysis of  two genome-wide association studies of bipolar disorder reveals  important points ofagreement.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuropsychopharmacology ,2008 ,33(1),110-133.  http://dx.doi.org/10.1038/sj.npp.1301575  [48] Einat, H., Manji, H.K.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Lett., 2007 , 421(1), 33-36. http://dx.doi.org/10.1016/j.neulet.2007.05.016  [50] Wu, A., Ying, Z., Gomez-Pinilla, F. The interplay between  oxidative stress and brain-derived neurotrophic factor modulates  the outcome of a saturated fat diet on synaptic plasticity and  cogn ition.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"/g2 2004 ,6(21),1-18. http://dx.doi.org/10.1017/S1462399404008385  [53] McCubrey, J.A /g3, Lahair, M.M /g3, Franklin, R.A. Reactive oxygen  species-induced activation the MAP kinase signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Physiol., 2000 ,529 Pt 1, 57-68. http://dx.doi.org/  10.1111/j.1469-7793.2000.00057.x  [55] Carter, C.J.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
",2007 ,50(3), 461-490.  http://dx.doi.org/10.1016/j.neuint.2006.11.009  [56] Zarate, C.A.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Gen. Psychiatry ,2006 , 63(8), 856-64.  http://dx.doi.org/10.1001/archpsyc.63.8.856  [57] da Silva, F.C., do Carmo, de Oliveira, Cito, M., da Silva, M.I.,  Moura, B.A., de Aquino, Neto, M.R., Feitosa, M.L., de Castro,  Chaves, R., Macedo, D.S., de Vasconcelos, S.M., de França, F.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Bull .,2010 , 83(1-2), 9-15.  http://dx.doi.org/10.1016/j.brainresbull.2010.05.011  [58] Gao, C., Chen, Y.G.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Development ,2005 ,132(20), 4421-4436. http://dx.doi.org/  10.1242/dev.02068  [61] van Amerongen, R., Nusse, R. Towards an integrated view of Wnt  signaling in development.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Development,  2009 ,136(19), 3205-3214.  http://dx.doi.org/10.1242/dev.033910  [62] Boutros, M., Mlodzik, M. Dishevelled: at the crossroads of divergent  intracellular signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Dev., 1999 ,83(1-2), 27-37.  http://dx.doi.org/10.1016/S0925-4773(99)00046-5  [63] Clevers, H. Wnt/beta-catenin signaling in development and disease.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Aging , 2010 ,31, 1937-49.  http://dx.doi.org/10.1016/j.neurobiolaging.2008.10.016  [65] Wang, H., Zhang, R., Wen, S., McCafferty, D-M., Beck, P.L.,  MacNuaghton, W.K.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Cell, Signal 2008 ,20, 1697-704. http://dx.doi.org/10.1016/j.cellsig.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neurosci .,2009 ,63(2), 202-208. http://dx.doi.org/10.1111/  j.1440-1819.2008.01918.x  [68] Hooper, C., Markevich, V., Plattner, F., Killick, R., Schofield, E.,  Engel, T., Hernandez, F., Anderton, B., Rosenblum, K., Bliss, T.,  Cooke, S.F., Avila, J., Lucas, J.J., Giese, K.P., Stephenson, J.,  Lovestone, S. Glycogen synthase kinase-3 inhib ition is integral to  long-term potentiation.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neurosci., 2007 ,25, 81-86.  http://dx.doi.org/10.1111/j.1460-9568.2006.05245.x  [69] Takeichi, M., Abe, K. Synaptic contact dynamics controlled by  cadherin and catenins.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuropsychopharmacology, 2008 , 33(1), 88-109.  http://dx.doi.org/10.1038/sj.npp.1301574  [73] Duman, R.S., Monteggia, L.M.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuroscience , 2011 ,196, 203-214. http://dx.doi.org/10.1016/j.neuroscience.2011.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"J. Neuro-  psychopharmacol., 2012 ,15(6), 7497-7466. http://dx.doi.org/  10.1017/S1461145711000836  [76] Anbrin, M., Ahmed, N. S., Jamal, M., James, M. O’Donnell.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"http://dx.doi.org/10.1124/jpet.108.137208  [77] Anbrin, M., Ying, H., Hassan, H., Lan, X., Hao, L., Wei, W, Adel,  H., Chang-Guo, Z., James, M. O'Donnell.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"2008 ,132, 645-660.   http://dx.doi.org/10.1016/j.cell.2008.01.033  [79] Atmaca, M., Tezca, E., Kuloglu, M., Ustundag, B., Tunckol, H.  Antioxidant enzyme and malondialdehyde values in social phobia  before and after citalopram treatment.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neurosci., 2004 ,254, 231-235. http://dx.doi.org/10.1007/s00406- 004-0484-3  [80] Ng, F., Berk, M., Dean, O. Bush, A.I.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Pharmacol., 2010 ,626(1), 49-56. http://dx.doi.org/10.1016/  j.ejphar.2009.10.014  [84] Yi, C., Jun-Feng, W, L., Shao, L., Trevor, Y. Oxidative damage to  RNA but not DNA in the hippocampus of patients with major  mental illness.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"http://dx.doi.org/10.1503/jpn.090083  [85] Peluffo, H., Acarin, L., Faiz, M., Castellano, B., Gonzalez, B.,.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"/g12000 ,58(3), 241-246.  http://dx.doi.org/10.1016/S0165-0327(99)00121-4  [90] Tsuboi, H, Tatsumi, A., Yamamoto, K., Kobayashi, F., Shimoi, K.,  Kinae, N. Possible connections among job stress, depressive  symptoms, lipid modulation and antioxidants.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Disord., 2006 ,91(1), 63-70. http://dx.doi.org/10.1016/j.jad.2005.12.010  [91] Sarandol, A., Kirli, S., Akkaya, C., Ocak, N., Eroz, E., Sarandol, E.  Coronary artery disease risk factors in patients with schizophrenia:  effects of short term antipsychotic treatment.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"J. Psychopharmacol ., 2007 ,21(8), 857-863. http://dx.doi.org/10.1177/0269881107077609  [92] Bisgaard, C.F., Bak, S., Christensen, T., Jensen, O.N., E nghild,   J.J., Wiborg, O. Vesicular signalling and immune m odulation as  hedonic fingerprints: proteomic prof iling in the chronic mild stress  depression model.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"/g12012 ,26(12), 1569-1583.  http://dx.doi.org/10.1177/0269881112460110  [93] Zafir, A., Ara, A., Banu, N. Invivo  antioxidant status: a putative  target of antidepressant action.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
",2010 ,76(14), 1497-1505. http://dx.doi.org/10.1055/s-0029- 1240953  [95] Eren, I., Naziro /g5lu, M., Demirda/g6, A., Celik, O., U /g5uz, A.C.,  Altunba/g6ak, A., Ozmen, I., Uz, E. Venlafaxine modulates depression- induced oxidative stress in brain and medulla of rat.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"/g12009 ,123(1), 55-60. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
",2012 ,32, 9690-9. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Neuroscience ,2007 ,144(4), 1447-1453. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Redox Rep. ,2003 ,8(6), 365-370. http://dx.doi.org/10.1179/  135100003225003393  [105] Ozcan, M.E., Gulec, M., Ozerol, E., Polat, R., Ak yol, O.  Antioxidant enzyme activities and oxidative stress in affective  disorders.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychopharmacol., 2004 ,19(2), 89-95.   http://dx.doi.org/10.1097/00004850-200403000-00006  [106] Galecki, P., Szemraj, J., Zboralski, K., Florkowski, A., Lewinski,  A.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychopharmacol., 2007 ,22(2), 67- 73.  http://dx.doi.org/10.1002/hup.829  [108] Schmidt, A.J., Heiser, P., Hemmeter, U.M., Krieg, J.C., Vedder, H.  Effects of antidepressants on mRNA levels of antioxidant enzymes  in human monocytic U-937 cells.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychiatry, 2008 ,32(6), 1567-73. http://dx.doi.org/10.1016/  j.pnpbp.2008.05.024  [109] Andreazza, A.C., Frey, B.N., Erdtmann, B., Salvador, M.,  Rombaldi, F., Santin, A., Gonçalves, C.A., Kapczinski, F. DNA  damage in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychiatry Res .,2007 , 153 (1), 27-32.  http://dx.doi.org/10.1016/j.psychres.2006.03.025  [110] Frey, B.N., Andreazza, A.C., Kunz, M., Gomes, F.A., Quevedo, J.,  Salvador, M., Gonçalves, C.A., Kapczinski, F. Increased oxidative  stress and DNA damage in bipolar disorder: a twin-case report.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Psychiatry ,2007 ,31(1), 283- 285. http://dx.doi.org/10.1016/j.pnpbp.2006.06.011  [111] Shao, L., Young, L.T., Wang, J.F.",OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"2005 ,19, (2), 296-297.  http://dx.doi.org/10.1096/fj.04-2400fje",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Gerontol .,2007 ,42, 37-45. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Behav ./g12012 ,106(4), 491-498. http://dx.doi.org/10.1016/  j.physbeh.2012.03.025  [121] Bouayed, J. Polyphenols: a potential new strategy for the prevention  and treatment of anxiety and depression.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"2010,  6: 13-18. http://dx.doi.org/10.2174/157340110790909608  [122] Viggiano, A., Viggiano, A., Monda, M., Turco, I., Incarnato, L.,  Vinno ,V., Viggiano, E, Baccari, M.E., De Luca, B. Annurca,  apple-rich diet restores long-term potentiation and induces behavioral modifications in aged rats.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Hypertens., 2006 ,19(6), 573-578.  http://dx.doi.org/10.1016/j.amjhyper.2005.10.027  [124] Kinrys, G., Coleman, E., Rothstein, E. Natural remedies for anxiety  disorders: potential use and clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"Res., 2007 ,38(2), 247-252. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/5f/CN-12-108.PMC3964743.pdf
"The overexpression of GLO1 decreases dicarbonyl-dependent advanced glycation endproduct (AGE) formation [69], whereas GLO1  inhibition  increases AGE formation [70]http://www.sciencedirect.com/ science/article/pii/S1471491406000621 - bib9.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2003 ,10, 2495-2505.  http://dx.doi.org/10.2174/0929867033456477  [2] Bergendi, L.; Benes, L.; Duracková, Z.; Ferencik, M. Chemi stry,  physiology and pathology of free radicals.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2004 ,266, 37-56. http://dx.doi.org/10.1023/B:  MCBI.0000049134.69131.89  [4] Gupta, M.; Dobashi, K.; Greene, E.L.; Orak, J.K.; Singh, I.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Biochem .1997 ,176, 337-347. http://dx.doi.org/10.1007/  978-1-4615-5765-4_42  [5] Stamler, J.S.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2000 ,304, 55-68.  http://dx.doi.org/10.1006/  jmbi.2000.4173  [7] Archer, S. Measurement of nitric oxide in biological models .",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2005 ,26, 190-195. http://dx.doi.org/  10.1016/j.tips.2005.02.005  [10] Ridnour, L.A .",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2004 ,385, 10. http://dx.doi.org/10.1515/BC.2004.001  [11] Valko, M.; Morris, H.; Cronin, M.T.D.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"B  1990 ,97, 417-427.  http://dx.doi.org/10.1016/0305-0491(90)90138-J  [14] Sipe, D.M.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1999 ,32, 595-603.  http://dx.doi.org/10.1016/S0009-9120(99)00075-2  [17] McCall, M.R.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2009 ,16, 2965-2976.  http://dx.doi.org/10.2174/092986709788803060  [20] Liu, C.F.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2008 ,14, 303-307. http://dx.doi.org/  10.1089/acm.2006.6064  [21] Hovatta, I.; Juhila, J.; Donner, J. Oxidative stress in anxiety and  comorbid disorders.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2010 ,68, 261-275.  http://dx.doi.org/10.1016/j.neures.2010.08.007  [22] Gaeta, A.; Hider, R.C.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2007 ,42, 37-45.   http://dx.doi.org/10.1016/j.exger.2006.05.018  [24] Desrumaux, C.; Risold, P.Y.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2005 ,19, 296-297.  http://dx.doi.org/10.1096/fj.04-2400fje  [25] Bouayed, J.; Rammal, H.; Younos, C.; Soulimani, R. Pos itive  correlation between peripheral blood granulocyte oxidative status and level of anxiety In mice.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Neurotoxicology 2007 ,6, 1191-1199. http://dx.doi.org/10.1016/  j.neuro.2007.07.008  [27] Salim, S.; Sarraj, N.; Taneja, M.; Saha, K.; Tejada-Simon, M.V.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2007 ,81, 198-203.   http://dx.doi.org/10.1016/j.lfs.2007.05.001  [30] Masood, A.; Nadeem, A.; Mustafa, S.J.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Neuro-  psychobiology 2002 ,46, 27-32. http://dx.doi.org/10.1159/000063573  [33] Kuloglu, M.; Atmaca, M.; Tezcan, E.; Gecici, O.; Ustundag, B.;  Bulut, S. Antioxidant enzyme and malondialdehyde levels in  patients with panic disorder.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2010 ,3, 2-12. http://dx.doi.org/10.4161/oxim.3.1.10476  [36] Ko, S.H.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2008 , 1233 , 137-145.  http://dx.doi.org/10.1016/j.brainres.2008.07.044  [39] Landeira-Fernandez, J.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"http://www.ncbi.nlm.n ih.gov/pmc/articles/  PMC407804  [41] Hassan, W.; Gomes, V.C.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2005 ,1042 , 17-22.  http://dx.doi.org/10.1016/  j.brainres.2005.02.002  [43] Gabbita, S.P.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/23596160  [46] Butterfield, D.A.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2006 ,86, 72-81. http://dx.doi.org/  10.1016/j.nlm.2006.01.002  [48] Yoon, T.; Otto T. Differential contributions of dorsal vs. ventral  hippocampus to auditory trace fear cond itioning.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2007 ,87, 464-475. http://dx.doi.org/10.1016/j.nlm.2006.12.006  [49] Dias, G.P.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2008 ,438, 196-199. http://dx.doi.org/  10.1016/j.neulet.2008.04.024  [51] Arai, M.; Yuzawa, H.; Nohara, I.; Ohnishi, T.; Obata, N., Iwayama,  Y.; Haga, S.; Toyota, T.; Ujike, H.; Arai, M.; Ichikawa, T.;  Nishida, A.; Tanaka, Y.; Furukawa, A.; Aikawa, Y.; Kuroda, O.;  Niizato, K.; Izawa, R.; Nakamura, K.; Mori, N.; Matsuzawa, D.;  Hashimoto, K.; Iyo, M.; Sora, I.; Matsushita, M.; Okazaki, Y.;  Yoshikawa, T.; Miyata, T.; Itokawa, M.. E nhanced carbonyl stress  in a subpopulation of schizophrenia.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"J. Psychiatry 2010 ,199, 245-246.  http://dx.doi.org/10.1192/bjp.bp.111.093849  [53] Politi, P.; Minoretti, P.; Falcone, C.; Martinelli, V.; Emanuele, E.  Association analysis of the functional Ala111Glu polymorphism of  the glyoxalase I gene in panic disorder.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"A 2004 ,131, 11-17. http://dx.doi.org/  10.1002/ajmg.a.30349  [55] Barua, M.; Jenkins, E.C.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2007 ,357, 639-647. http://dx.doi.org/  10.1056/NEJMoa072743  [57] Winkelmann, J.; Schormair, B.; Lichtner, P.; Ripke, S.; Xiong, L.;  Jalilzadeh, S.;  Fulda, S.; Pütz, B.; Eckstein, G.; Hauk, S.;  Trenkwalder, C.; Zimprich, A.; Stiasny-Kolster, K.; Oertel, W.;  Bachmann, C.G.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2012 ,221, 297-315. http://dx.doi.org/  10.1007/s00213-011-2574-z  [63] Ditzen, C.; Jastorff, A.M.; Ke /g2ler, M.S.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2007 ,31, 89-102.  http://dx.doi.org/10.1016/j.neubiorev.2006.07.003  [66] Thornalley, P.J.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"http://dx.doi.org/10.1371/journal.pone.0004649  [68] Abordo, E.A.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1999 ,58, 641-648. http://dx.doi.org/10.1016/  j.marenvres.2004.03.114  [69] Shinohara, M.; Thornalley, P.J.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1996 ,51, 1365-1372. http://dx.doi.org/10.1016/0006-2952(96)00059- 7 [71] Cryan, J.F.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Gene 1999 ,240, 149-155. http://dx.doi.org/10.1016/  S0378-1119(99)00420-5  [73] Knable, M.B.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Psychiatry 2004 ,9, 609-620.  http://dx.doi.org/10.1038/sj.mp.4001471  [74] Perlman, W.R.; Webster, M.J.; Kleinman, J.E.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Psychiatry 2002 ,7, 985-994.  http://dx.doi.org/10.1038/sj.mp.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2011 ,45, 60-63. http://dx.doi.org/10.1016/j.jpsychires.2010.05.008  [77] Bradwejn, J.; Koszycki, D. Cholecystokinin and panic disorder:  past and future clinical research strategies.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2001 ,234, 19-27. http://dx.doi.org/10.1080/clb.61.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2007 ,192, 479-487. http://dx.doi.org/  10.1007/s00213-007-0738-7  [79] Rupprecht, R.; Rammes, G.; Eser, D.; Baghai, T.C.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1999 ,110, 145-175.  http://dx.doi.org/10.1016/S0378-4274(99)  00160-5  [84] Kalapos, M.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1993 ,67, 369-372. http://dx.doi.org/10.1007/  BF01973710 [85] Okado, A.; Kawasaki, Y.; Hasuike, Y.; Takahashi, M.; Teshima,  T.; Fujii, J.; Taniguchi, N. Induction of apoptotic cell death by  methylglyoxal and 3-deoxyglucosone in macrophage-derived cell  lines.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1996 ,225, 219-224.   http://dx.doi.org/10.1006/bbrc.1996.1157  [86] Chang, T.; Wang, R.; Wu, L. Methylglyoxal-induced nitric oxide  and peroxynitrite production in vascular smooth muscle cells.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2001 ,31, 469-478. http://dx.doi.org/10.1016/S0891-5849(01)00611- 6 [91] Che, W.; Asahi, M.; Takahashi, M.; Kaneto, H.; Okado, A.;  Higashiyama, S.; Taniguchi, N. Selective induction of heparin- binding epidermal growth factor-like growth factor by  methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle  cells: the involvement of reactive oxygen species formation and a  possible implication for atherogenesis in diabetes.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1997 ,272, 18453-18459. http://dx.doi.org/10.1074/jbc.272.29.18453  [92] Okado, A.; Kawasaki, Y.; Hasuike, Y.; Takahashi, M.; Teshima,  T.; Fujii, J.; Taniguchi, N. Induction of apoptotic cell death by  methylglyoxal and 3-deoxyglucosone in macrophage-derived cell  lines.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1996 ,225, 219-224.  http://dx.doi.org/10.1006/bbrc.1996.1157  [93] Du, J.; Suzuki, H.; Nagase, F.; Akhand, A.A.; Ma, X.Y.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2001 ,31, 469-478.  http://dx.doi.org/10.1016/S0891-5849(01)00611-6  [94] Kroemer, G.; Reed, J.C. Mitochondrial control of cell death.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1989 ,7, 65-70. http://dx.doi.org/10.1002/cbf.290070111  [96] Shamsi, F.A.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Hyper-  tension 2002 ,39, 809-814. http://dx.doi.org/10.1161/hy0302.105207  [98] Kalapos, M.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2004 ,26, 987-990.  http://dx.doi.org/10.1016/0020-711X(94)90069-8  [102] Kalapos, M.P.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1991 ,58, 181-191.  http://dx.doi.org/10.1016/0378-4274(91)90172-3  [103] Kalapos, M.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1999 ,109, 61-67.  http://dx.doi.org/10.1016/S0378-4274(99)00114-9  [107] Kalapos, M.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1994 ,73, 3-24.  http://dx.doi.org/10.1016/0378-4274(94)90184-8  [109] Wu, L.; Juurlink, B.H.J.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Hypertension  2002 ,39, 809-814.  http://dx.doi.org/10.1161/hy0302.105207  [110] Kalapos, M.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1997 ,53, 1133-1140.  http://dx.doi.org/10.1016/S0006-2952(97)00090-7  [113] Poynter, M.E.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1998 ,273, 32833-32841.  http://dx.doi.org/10.1074/jbc.273.49.32833  [114] Inoue, I.; Noji, S.; Awata, T.; Takahashi, K.; Nakajima, T.; Sonoda,  M.; Komoda, T.; Katayama, S. Bezafibrate has an antioxidant  effect: peroxisome proliferator-activated receptor /g1 is associated  with Cu2+, Zn2+-superoxide dismutase in the liver.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Med., 2003 ,35, 856-871. http://dx.doi.org/10.1016/  S0891-5849(03)00438-6  [119] Wu, L.; Juurlink, B.H.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Hyper-  tension 2002 ,39, 809-814. http://dx.doi.org/10.1161/hy0302.105207  [120] Corbett, R.; Dunn, R.W.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Neuro-  pharmacology 1993 ,32, 461-466. http://dx.doi.org/10.1016/0028- 3908(93)90170-8  [122] Dunn, R.W.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1989 ,169, 1- 10.  http://dx.doi.org/10.1016/0014-2999(89)90811-X  [123] Jessa, M.; Nazar, M.; Bidzinski, A.; Plaznik, A.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1996 ,6, 55-61. http://dx.doi.org/10.1016/0924-977X(95)00068-Z  [124] Plaznik, A.; Palejko, W.; Nazar, M.; Jessa, M. Effects of  antagonists at the NMDA receptor complex in two models of  anxiety.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1992 ,43, 471-477. http://dx.doi.org/10.1016/0091-3057(92)  90178-I  [127] Bertoglio, L.J.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Neuroreport 2005 ,16, 307-310. http://dx.doi.org/10.1097/00001756-200502280- 00021  [133] Mombereau, C.; Kaupmann, K.; Froestl, W.; Sansig, G.; van der  Putten, H.; Cryan, J.F.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Nature 2002 ,416, 396-400. http://dx.doi.org/10.1038/416396a  [139] Clément, Y.; Calatayud, F.; Belzung, C. Genetic basis of anxiety- like behaviour: a cr itical review.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2002 ,57, 57-71.   http://dx.doi.org/10.1016/S0361-9230(01)00637-2  [140] Gingrich, J.A.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2011 ,1, 11-21. http://dx.doi.org/  10.1093/med/9780199557837.003.0005  [147] Bouayed, J.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2010 ,44, 1216-1262. http://dx.doi.org/10.3109/  10715762.2010.508495  [149] Bouayed, J.; Bohn, T. Exogenous antioxidants—double-edged  swords in cellular redox state: health beneficial effects at  physiologic doses versus deleterious effects at high doses.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2009 ,97, 359-368.  http://dx.doi.org/10.1016/j.physbeh.2009.03.001  [154] Singh, R.P.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2011 ,85, 1313-1359.  http://dx.doi.org/10.1007/s00204- 011-0720-3  [160] Nogueira, C.W.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2004 ,104, 6255-6285.  http://dx.doi.org/10.1021/cr0406559  [161] Rocha, J.B.T.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1984 ,33, 3247-3250.  http://dx.doi.org/  10.1016/0006-2952(84)90085-6  [163] Wendel, A.; Fausel, M.; Safayhi, H.; Tiegs, G.; Otter, R. A novel  biologically active seleno-organic compound: II.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1992 ,114, 9737-9743.  http://dx.doi.org/10.1021/ja00051a002  [166] Iwaoka, M.; Tomoda, S. A model study on the effect of an amino  group on the antioxidant activity of glutathione peroxidase.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1994 ,116, 2557-2561.  http://dx.doi.org/10.1021/  ja00085a040  [167] Li, J.; Chen, J.J.; Zhang, F.; Zhang, C. Ebselen protection against  hydrogen peroxide-induced cytotoxi city and DNA damage in   HL-60 cells.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"43 , 1762-1769.  http://dx.doi.org/10.1021/jm991019j  [169] Hassan, W.; Ibrahim, M.; Deobald, A.M.; Braga, A.L.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2009 ,1258 , 71-77. http://dx.doi.org/10.1016/j.brainres.2008.12.046  [171] Sies, H.; Klotz, L.O.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2002 ,277, 39456-39462.   http://dx.doi.org/10.1074/jbc.M206452200  [173] Zhao, R.; Masayasu, H.; Holmgren, A. Ebselen: a substrate for  human thioredoxin reductase strongly stimulating its hydroperoxide  reductase activity and a superfast thioredoxin oxidant.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1999 ,12, 264-269. http://dx.doi.org/  10.1021/tx980223r  [176] Mugesh, G.; Klotz, L.O.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2003 ,52, 56-63. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2008 ,60, 1679-1686. http://dx.doi.org/10.1211/jpp/  60.12.0015  [184] Zasso, F.; Goncales, C.E.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2005 ,19, 283-289. http://dx.doi.org/10.1016/j.etap.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2009 ,36, 272-277. http://dx.doi.org/10.1111/j.1440-1681.2008.05056.x  [186] Savegnago, L.; Pinto, L.G.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Toxicology 2005 , 210, 1-8. http://dx.doi.org/10.1016/j.tox.2005.01.002  [190] Wilhelm, E.A.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Pathophysiology 2009 ,16, 31-37.  http://dx.doi.org/10.1016/j.pathophys.2008.12.002  [191] Ibrahim, M.; Prigol, M.; Hassan, W.; Nogueira, C.W.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2010 ,28, 258-265.  http://dx.doi.org/10.1002/cbf.1645 [192] Ohta, Y.; Kobayashi, T.; Inui, K.; Yoshino, J.; Nakazawa, S.  Protective effect of ebselen, a seleno-organic compound, against  the progression of acute gastric mucosal lesions induced by  compound 48/80, a mast cell degranulator, in rats.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2002 ,90, 295-303. http://dx.doi.org/10.1254/jjp.90.295  [193] Ineu, R.P.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2011 ,63, 331-335.  http://dx.doi.org/10.1016/j.etp.2010.02.007  [198] Brandão, R.; Acker, C.I.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2000 ,191, 209-220.  http://dx.doi.org/10.1620/tjem.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Diphenyl  diselenide, a simple glutathione peroxidase mimetic, inhibits  human LDL oxidation in vitro .Atherosclerosis 2008 ,201, 92-100.  http://dx.doi.org/10.1016/j.atherosclerosis.2008.02.030  [204] Ho rt, M.A.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2009 ,105, 17-23.  http://dx.doi.org/10.1111/j.1742-7843.2009.00414.x  [206] da Rocha, J.T.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2009 ,61, 1673-1679. http://dx.doi.org/10.1211/jpp/  61.12.0013  [207] Barbosa, N.B.V.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2006 ,163, 230-238. http://dx.doi.org/10.1016/  j.cbi.2006.08.004",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2008 ,31, 2200-2204. http://dx.doi.org/10.1248/  bpb.31.2200  [210] Vince ti, M.; Maraldi, T.; Bergomi, M.; Malagoli, C. Risk of  chronic low-dose selenium overexposure in humans: insights from  epidemiology and biochemistry.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"BMC Public Health 2010 ,10, 564.   http://dx.doi.org/10.1186/1471-2458-10-564  [212] Saito, I.; Asano, T.; Sano, K.; Takakura, K.; Abe, H.; Yoshimoto,  T.; Ki kuchi, H.; Ohta, T.; Ishibashi, S. Neuroprotective effect of an  antioxidant, ebselen, in patients with delayed neurological deficits  after aneurysmal subarachnoid hemorrhage.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1997 ,122, 1251-1256.    http://dx.doi.org/10.1038/sj.bjp.0701426   [215] Dawson, D.A.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1995 ,185, 65-69. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Lancet 2000 ,356, 943.  http://dx.doi.org/10.1016/S0140-6736(05)73927-1  [220] Sher, L. Possible role of selenium deficiency in the neurobiology of  depression and suicidal behavior in patients with alcohol use  disorders.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Lancet, 2000 ,356, 233-241. http://dx.doi.org/10.1016/S0140-6736(00)  02490-9  [222] Benton, D. Selenium intake, mood and other aspects of  psychological functioning.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"2002 ,5, 363-374.  http://dx.doi.org/10.1016/0006-3223(91)90251-G  [223] Benton, D.; Cook, R. The impact of selenium supplementation on  mood.",OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"Psychiatry, 1991 ,29, 1092-1098. http://dx.doi.org/  10.1016/j.pnpbp.2007.05.006  [224] Savegnago, L.; Jesse, C.R.",Non-OADS,/arxiv_data1/oa_pdf/38/03/CN-12-120.PMC3964744.pdf
"1281-1282. http://dx.doi.org/  10.1038/nm1205-1281  [3] Irie, M.; Asami, S.; Ikeda, M.; Kasai, H. Depressive state relates to  female oxidative DNA damage via neutrophil activation.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2002 ,30(6), 620-650.  http://dx.doi.org/10.1080/01926230290166724  [12] Halliwell, B. Phagocyte-derived r eactive species: salvation or  suicide?",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Sci ,2006 ,31(9), 509-515. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2007 , 39(1), 44-84. http://dx.doi.org/10.1016/j.biocel.2006.07.001  [14] Griendling, K.K.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2003 ,28(1),  57-60. http://dx.doi.org/10.1007/BF02970132  [16] Lockwood, T.D.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Amino Acids , 2003 ,25(3-4), 207-218. http://dx.doi.org/10.1007/s00726-003-0011- 2 [18] Horton, A.A.; Fairhurst, S. Lipid peroxidation and mechanisms of  toxicity.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",1987 ,18(1), 27-79. http://dx.doi.org/  10.3109/10408448709089856  [19] Raha, S.; Robinson, B.H.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2001 ,106(1), 62-70. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2005 ,2(1), 73-89.  http://dx.doi.org/10.2174/1567202052773463  [21] Berk, M.; Ng, F.; Dean, O.; Dodd, S.; Bush, A.I.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2007 ,82, 297-325. http://dx.doi.org/  10.1016/S0074-7742(07)82016-2  [27] Ng, F.; Berk, M.; Dean, O.; Bush, A.I.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2008 ,11(6), 851-876. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2009 ,2(2), 63-67. http://dx.doi.org/10.4161/oxim.2.2.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Gen. Psychiatry ,2005 ,62(6), 617-627. http://dx.doi.org/10.1001/  archpsyc.62.6.617  [30] McCord, J.M.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",1988 ,5(5-6), 363-369.  http://dx.doi.org/10.1016/0891-5849(88)90109-8  [31] Chelikani, P.; Fita, I.; Loewen, P.C.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
DOI: http://dx.doi.org/10.1111/j.1432-1033.,Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI:  http://dx.doi.org/10.1172/JCI200421625  [34] Poulsen, H.E.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
DOI:  http://dx.doi.org/10.1016/j.freeradbiomed.2012.01.009  [35] American Psychiatric Association.,Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Diagnostic and Statistical  Manual of Mental Disorders 2000.  http://dx.doi.org/10.1007/  SpringerReference_179660  [36] Hovatta, I.; Tennant, R.S.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.1016/j.lfs.2007.05.001  [39] Bouayed, J.; Rammal, H.; Younos, C.; Soulimani, R. Pos itive  correlation between peripheral blood granulocyte oxidative status  and level of anxiety in mice.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI:  http://dx.doi.org/  10.1016/j.neuro.2007.07.008  [41] Salim, S.; Asghar, M.; Chugh, G.; Taneja, M.; Xia, Z.; Saha, K.  Oxidative stress: a potential recipe for anxiety, hypertension and  insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.1016/j.brainres.2011.06.024  [46] Patki, G.; Allam, F.H.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.1371/  journal.pone.0074522  [47] Chugh, G.; Asghar, M.; Patki, G.; Bohat, R.; Jafri, F.; Allam, F.;  Dao, A.T.; Mowrey, C.; Alkadhi, K.; Salim, S. A high-salt diet further impairs age-associated declines in cognitive, behavioral,  and cardiovascular functions in male Fischer brown norway rats.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2013 ,143(6), 835-842. http://dx.doi.org/10.3945/jn.113.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
http://dx.doi.org/10.1111/j.1600-0404.,Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Psychiatry ,1999 ,23(3), 359-376. http://dx.doi.org/10.1016/  S0278-5846(99)00002-0  [51] Serrano, F.; Klann, E. Reactive oxygen species and synaptic  plasticity in the aging hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2008 ,43(1), 55-63. http://dx.doi.org/10.1016/  j.jpsychires.2008.01.018  [53] Mazzucchelli, C.; Brambilla, R. Ras-related and MAPK signalling  in neuronal plasticity and memory formation.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2006 ,175(2), 233-240.  http://dx.doi.org/10.1016/j.bbr.2006.08.035  [55] Reul, J.M.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"http://dx.doi.org/10.1016/j.psyneuen.2007.03.016  [56] Shin, J.A.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"http://dx.doi.org/10.1007/s11064- 012-0858-2  [57] Yousuf, S.; Atif, F.; Ahmad, M.; Hoda, N.; Ishrat, T.; Khan, B.;  Islam, F. Resveratrol exerts its neuroprotective effect by  modulating mitochondrial dysfunctions and associated cell death  during cerebral ischemia.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Brain Res ,2009 ,1250 , 242-253.  http://dx.doi.org/10.1016/j.brainres.2008.10.068 [58] Gard, P.R.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Targets ,2004 , 8(1), 7-14. http://dx.doi.org/10.1517/eott.8.1.7.26409  [59] Sorce, S.; Krause, K.H.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
", 2009 ,34(4), 263-271. http://dx.doi.org/10.1007/s00406-008-0862- 3 [62] Tsaluchidu, S.; Cocchi, M.; Tonello, L.; Puri, B.K.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"http://dx.doi.org/10.1186/1471-244X-8-S1-S5  [63] Yumru, M.; Savas, H.A.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
DOI: http://dx.doi.org/10.1016/j.pnpbp.,OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI:  http://dx.doi.org/10.1007/s11064-010-0195-2  [65] Nair, D.; Dayyat, E.A.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2008 ,358(1), 55-68. http://dx.doi.org/10.1056/NEJMra073096  [70] Maes, M.; Galecki, P.; Chang, Y.S.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Psychiatry ,2011 ,35 (3), 676-692. http://dx.doi.org/10.1016/  j.pnpbp.2010.05.004  [71] Maes, M. An intriguing and hitherto unexplained co-occurrence:  Depression and chronic fatigue syndrome are manifestations of  shared inflammatory, oxidative and nitrosative (IO&NS) pathways.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
DOI: http://dx.doi.org/10.1017/S1461145710000805,Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
DOI:  http://dx.doi.org/10.1016/j.pnpbp.2012.,OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2013 ,206(2-3), 213-216.  http://dx.doi.org/10.1016/j.psychres.2012.10.018  [80] Hoffer, A.; Osmond, H.; Smythies, J. Schizophrenia; a new  approach.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.1192/bjp.100.418.29  [81] Pandya, C.D.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.2174/157015911795596595  [84] Dean, O.M.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Prog Neuro-  psychopharmacol Biol Psychiatry ,2006 ,30(3), 512-515.  http://dx.doi.org/10.1016/j.pnpbp.2005.11.009  [86] Herken, H.; Uz, E.; Ozyurt, H.; Akyol, O.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Psychiatry ,1991 ,30(4), 409-412. http://dx.doi.org/10.1016/  0006-3223(91)90298-Z  [88] Sarandol, A.; Sarandol, E.; Eker, S.S.; Erdinc, S.; Vatansever, E.;  Kirli, S. Major depressive disorder is accompanied with oxidative  stress: short-term antidepressant treatment does not alter oxidative- antioxidative systems.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.1002/hup.829  [89] Wu, J.Q.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI:  http://dx.doi.org/10.1016/S0022-3956(98)00028-4 [91] Zhang, X.Y.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",1996 ,19(1), 19-26. http://dx.doi.org/10.1016/  0920-9964(95)00048-8  [94] Ranjekar, P.K.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/10.1097/  00041444-200409000-00012  [101] Buckman, T.D.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Psychiatry ,1987 ,22(11), 1349-1356.  http://dx.doi.org/10.1016/0006-3223(87)90069-2  [102] Buckman, T.D.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI:  http://dx.doi.org/10.1523/JNEUROSCI.4457-08.2008  [105] Bruce-Keller, A.J.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2010 ,12(12), 1371-1382.  http://dx.doi.org/10.1089/ars.2009.2823",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI: http://dx.doi.org/  10.1016/j.conb.2009.05.001  [107] Hikida, T.; Jaaro-Peled, H.; Seshadri, S.; Oishi, K.; Hookway, C.;  Kong, S.; Wu, D.; Xue, R.; Andrade, M.; Tankou, S.; Mori, S.;  Gallagher, M.; Ishizuka, K.; Pletnikov, M.; Kida, S.; Sawa, A.  Dominant-negative DISC1 transgenic mice display schizophrenia- associated phenotypes detected by measures translatable to  humans.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
", 2008 ,111(2-3), 135-144. http://dx.doi.org/10.1016/j.jad.2008.04.013  [110] Machado-Vieira, R.; Andreazza, A.C.; Viale, C.I.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Lett.,2007 ,421(1), 33-36. http://dx.doi.org/10.1016/j.neulet.2007.",OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"Psychiatry , 2006 ,7(1), 51-55. http://dx.doi.org/10.1080/15622970510029993  [112] Magalhaes, P.V.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
"DOI:  http://dx.doi.org/10.1590/S1516-44462011000400011  [113] Sarris, J.; Mischoulon, D.; Schweitzer, I. Adjunctive nutraceuticals  with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
",2011 ,13(5-6), 454-465.  http://dx.doi.org/10.1111/j.1399-5618.2011.00945.x  [114] Berk, M.; Dean, O.; Cotton, S.M.",Non-OADS,/arxiv_data1/oa_pdf/54/8c/CN-12-140.PMC3964745.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci .,2006 ,9, 1218-1220.  http://dx.doi.org/10.1038/nn1770  [3] Sanders, S.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Epidemiol., 2009 , 38, 1224-1234.  http://dx.doi.org/10.1093/ije/ dyp261  [9] Abdallah, M.W.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Derg., 2012 ,23(4), 229-236.  http://dx.doi.org/10.5080/u6847  [10] Hallmayer, J.; Cleveland, S.; Torres, A.; Phillips, J.; Cohen, B.;  Torigoe, T.; Miller, J.; Fedele, A.; Collins, J.; Smith, K.; Lotspeich,  L.; Croen, L.A.; Oz onoff, S.; Lajonchere, C.; Grether, J.K.; Risch,  N. Genetic heritability and shared environmental factors among  twin pairs with autism.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"J. Psychiatry, 2009 ,195, 7-14. http://dx.doi.org/10.1192/bjp.bp.108.051672  [13] Gardener, H.; Spiegelman, D.; Buka, S.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Gynecol., 2010 ,22, 452-457. http://dx.doi.org/10.1 097/GCO.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Psychiatr., 2013 ,42, 5-19. http://dx.doi.org/  10.1016/j.pnpbp.2012.06.014  [20] Goines, P.E.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Autism , 2011 , 2, 13. http://dx.doi.org/10.1186/2040-2392-2-13  [21] Arrode-Brusés, G.; Brusés, J.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
",2012 ,9, 83. http://dx.doi.org/  10.1186/1742-2094-9-83  [22] Hsiao, E.Y.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci.,  2007 , 27(41), 11075-11082. http://dx.doi.org/10.1523/JNEUROSCI.3542- 07.2007  [27] Parker, K.E.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Behav., 2010 ,97(2), 262-266.  http://dx.doi.org/10.1016/j.pbb.2010.08.008  [28] Naleid, A.M.; Grace, M.K.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1152/ajpregu.00675.2006  [29] Egan, A.M.; Dreyer, M.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Disabil ., 2011 , 116(5), 371-80. http://dx.doi.org/10.1352/1944-7558-116.5.371  [32] Kim, E.K.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci.,  2003 , 117(3), 446-454. http://dx.doi.org/10.1037/  0735-7044.117.3.446  [34] Barr, C.S.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuropsychopharmacol.,  1999 , 9(4), 361-366. http://dx.doi.org/  10.1016/S0924-977X(99)00010-3  [39] Tan, M.; Groszer, M.; Tan, A.M.; Pandya, A.; Liu, X.; Xie,   C.W.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Autism,  2010 , 1(1), 11.8. http://dx.doi.org/10.1186/2040-2392-1-11  [41] Auyeung, B.; Ahluwalia, J.; Thomson, L.; Taylor, K.; Hac kett, G.;  O'Donnell, K.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Autism,  2012 , 3(1), 17. http://dx.doi.org/  10.1186/2040-2392-3-17  [42] Lutchmaya, S.; Baron-Cohen, S.; Raggatt, P. Foetal testosterone  and eye contact in 12 month old infants.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurol.,   2005 , 47, 551-555. http://dx.doi.org/10.1017/S0012162205001076  [51] Croen, L.A.; Grether, J.K.; Yoshida, C.K.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Med.,  2005 , 159(2), 151-157. http://dx.doi.org/  10.1001/archpedi.159.2.151  [52] Rai, D.; Lee, B.K.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"BMJ, 2013 , 346, 2059. http://dx.doi.org/  10.1136/bmj.f2059  [53] Kinney, D.K.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Hypotheses,   2010 , 74(1), 102-106. http://dx.doi.org/10.1016/j.mehy.2009.07.052  [54] Dealberto, M.J.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Scand , 2011 ,  123(5), 339-348. http://dx.doi.org/10.1111/j.1600-0447.2010.01662.x  [55] Grant, W.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Paediatr.,  2010 , 99(5), 743-747.  http://dx.doi.org/10.1111/j.1651-2227.2010.01755.x  [57] Meguid, N.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1007/s10803- 012-1709-3  [59] Napoli, E.; Wong, S.; Giulivi, C. Evidence of reactive oxygen  species-mediated damage to mitochondrial DNA in children with  typical autism.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Autism.,  2013 , 4(1), 2. http://dx.doi.org/  10.1186/2040-2392-4-2  [60] Wallace, A.E.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Disord.,  2008 , 38(8), 1542-1554. http://dx.doi.org/  10.1007/s10803-007-0536-4  [61] Laks, D.R.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Biometals,  2009 , 22, 1103. http://dx.doi.org/  10.1007/s10534-009-9261-0  [62] Nyland, J.F.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res.,  2011 , 111 , 584-589.  http://dx.doi.org/10.1016/  j.envres.2011.02.010  [63] Ilbäck, N.G.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Lett.,  1996 , 89,19-28. http://dx.doi.org/10.1016/S0378-4274(96)03777-0",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Environ., 2007 , 381, 88-98. http://dx.doi.org/10.1016/j.scitotenv.2007.03.025  [66] Rose, S.; Melnyk, S.; Savenka, A.; Hubanks, A.; Jernigan, S.;  Cleves, M.; James, S.J.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Biotechnol., 2008 ,4, 85-94. http://dx.doi.org/10.3844/  ajbbsp.2008.85.94  [67] Cheslack-Postava, K.; Rantakokko, P.V,; Hinkka-Yli-Salomäki, S.;  Surcel, H.M.; McKeague, I.W.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Teratol., 2013 , 38C , 1-5. http://dx.doi.org/10.1016/j.ntt.2013.04.001  [68] Roberts, A.L.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1289/ehp.1206187  [69] Flashner, B.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Disord., 2011 , 41, 938-944.  http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1371/journal.pone.0017116  [73] Mamrut, S.; Harony, H.; Sood, R.; Shahar-Gold, H.; Gainer, H.;  Shi, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1371/journal.pone.0056869  [74] Grafodatskaya, D., Chung, B., Szatmari, P., Weksberg, R. Autism  spectrum disorders and epigenetics.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2011 ,19, 1-13. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Hypotheses,  2011 , 76, 54-60. http://dx.doi.org/10.1016/j.mehy.2010.08.029  [82] Fuxe, K.; Jacobsen, K.X.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Gen. Psychiatry, 2012 ,69(1), 53-61.  http://dx.doi.org/10.1001/archgenpsychiatry.2011.145  [85] Baron-Cohen, S., Ring, H.A., Bullmore, E.T., Wheelwright, S.,  Ashwin, C., Williams, S.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Treat., 2012 ,2012 , 652408.  http://dx.doi.org/10.1155/2012/652408  [87] Tottenham, N.; Hertzig, M.E.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Funct., 2012 ,8, 19. http://dx.doi.org/10.1186/1744-9081-8-19  [93] Gillberg, C.; Svennerholm, L. CSF m onoamines in autistic  syndromes and other pervasive developmental disorders of early  childhood.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"J. Psychiatry, 1987 ,151, 89-94. http://dx.doi.org/  10.1192/bjp.151.1.89  [94] Ernst, M., Zametkin, A.J., Matochik, J.A., Pascualvaca, D., Cohen,  R.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Lancet ,1997 , 350, 638. http://dx.doi.org/10.1016/S0140- 6736(05)63326-0  [95] Zmarowski, A.; Wu, H.Q.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Genet., 2011 , 20(22), 4311-4323. http://dx.doi.org/10.1093/hmg/ddr357  [97] Perry, E.K., Lee, M.L., Martin-Ruiz, C.M., Court, J.A., Volsen,  S.G., Merrit, J., Folly, E., Iversen, P.E., Bauman, M.L., Perry,  R.H., Wenk, G.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"J. Psychiatry, 2001 , 158(7), 1058-1066. http://dx.doi.org/10.1176/appi.ajp.158.7.1058  [98] Markus, R.P.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Ther., 2010 ,126(3), 251-262. http://dx.doi.org/10.1016/j.pharmthera.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci., 2008 , 154(2),701-709. http://dx.doi.org/10.1016/  j.neuroscience.2008.04.031  [100] Linderholm, K.R.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroscience, 2012 ,201,184-198. http://dx.doi.org/10.1016/  j.neuroscience.2011.11.011  [103] Force lli, P.A.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci., 2012 ,126(2), 290-300. http://dx.doi.org/10.1037/  a0026898  [104] Kohl, S., Heekeren, K., Klosterkötter, J., Kuhn, J. Prepulse  inhibition in psychiatric disorders - Apart from schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1007/s12311-013-0462-2  [109] Benes, F.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res.,  2010 ,1309 , 83-94. http://dx.doi.org/10.1016/j.brainres.2009.09.120  [112] Domes, G.; Heinrichs, M.; Kumbier, E.; Grossmann, A.;   Hauenstein, K.; Herpertz, S.C.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Rep., 2011 ,16(5), 216-222.  http://dx.doi.org/10.1179/1351000211Y.0000000012  [117] Meguid, N.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res.,  2011,143(1), 58-65.  http://dx.doi.org/10.1007/s12011-010-8840-9  [118] Ming, X.; Stein, T.P.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci., 2004 , 254 (3), 143-147. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Acta, 2011 ,412(11-12), 1036-1042.   http://dx.doi.org/10.1016/j.cca.2011.02.021  [122] Sajdel-Sulkowska, E.M.; Xu, M.; McGinnis, W.; Koibuchi, N.  Brain region-specific changes in oxidative stress and neurotrophin  levels in autism spectrum disorders (ASD).",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Cerebellum, 2011 , 10(1), 43-48. http://dx.doi.org/10.1007/s12311-010-0223-4  [123] Chauhan, A.; Audhya, T.; Chauhan, V. Brain region-specific  glutathione redox imbalance in autism.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Pharmacopsychiatry,  2012,45(6),  241-243.  http://dx.doi.org/10.1055/s-0032-1301914  [127] Essa, M.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Treat., 2012 , 2012 , 190930. http://dx.doi.org/10.1155/  2012/190930",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Med., 2012 ,52(10), 2128-2141. http://dx.doi.org/  10.1016/j.freeradbiomed.2012.03.011  [131] Rose, S;, Melnyk, S.; Trusty, T.A.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Treat., 2012 ,2012,  986519. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Electronic Journal of  Applied Psychology: Innovations in Autism,  2009 ,5, 2-10.  http://dx.doi.org/10.7790/ejap.v5i1.141  [133] Rose, S.; Melnyk, S.; Pavliv, O.; Bai, S.; Nick, T.G.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1038/  tp.2012.61  [134] James, S.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"FASEB J ,2009 ,23(8), 2374-2383. http://dx.doi.org/  10.1096/fj.08-128926  [135] Bowers, K.; Li, Q.; Bressler, J.; Avramopoulos, D.; Newschaffer,  C.; Fallin, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2009 ,34(2), 386-393.  http://dx.doi.org/10.1007/s11064-008-9782-x  [137] Tro tti, D.; Da nbolt, N.C.; Volterra, A. Glutamate transporters are  oxidant-vulnerable: a molecular link between oxidative and  excitotoxic neurodegeneration?",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurochem., 2006 , 98(3), 916-925. http://dx.doi.org/10.1111/j.1471-4159.2006.03921.x  [140] Gegg, M.E.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurochem., 2003 , 86(1), 228-237.  http://dx.doi.org/10.1046/  j.1471-4159.2003.01821.x  [141] Cao, F.; Yin, A.; Wen, G.; Sheikh, A.M.; Tauqeer, Z..; Malik, M.;  Nagori, A.; Schirripa, M.; Schirripa, F.; Merz, G.; Brown, W.T.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Pathophysiology, 2006 ,13(3), 171-181. http://dx.doi.org/10.1016/  j.pathophys.2006.05.007  [143] Chauhan, A.; Chauhan, V.; Brown, W.T.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflamm., 2012 ,9, 74.  http://dx.doi.org/10.1186/1742-2094- 9-74  [145] Kern, J.K.; Geier, D.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2011 , 223 (1), 107-18.  http://dx.doi.org/10.1016/j.bbr.2011.04.026  [147] Sharpe, M.A.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Brain, 2012 ,5, 30. http://dx.doi.org/10.1186/1756-6606-5-30  [150] Laugeray, A.; Launay, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2010 ,210(1), 84-91. http://dx.doi.org/  10.1016/j.bbr.2010.02.014  [151] Zhang, Y.; Sun, Y.; Wang, F.; Wang, Z.; Peng, Y.; Li, R.  Downregulating the canonical Wnt/ /g1-catenin signaling pathway  attenuates the susceptibility to autism-like phenotypes by decreasing  oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"(Lond)., 2011 ,8(1), 34.  http://dx.doi.org/10.1186/1743-7075-8-34  [159] Comi, A.M.; Zimmerman, A.W.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurol., 1999 ,14, 388-394.   http://dx.doi.org/10.1177/088307389901400608  [160] Atladó ttir, H.O.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurol., 1997 ,17, 88-90. http://dx.doi.org/10.1016/S0887- 8994(97)00045-3",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflamm., 2012 ,9(1), 54. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroimmunol., 2013 ,255(1-2), 70-74. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflamm., 2012 ,9, 201. http://dx.doi.org/  10.1186/1742-2094-9-201  [167] Liu, X.; Karnell, J.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuropsychobiol., 2002 ,45(1), 1-6. http://dx.doi.org/10.1159/  000048665  [169] Jyonouchi, H.; Sun, S.; Le, H. Proinflammatory and regulatory  cytokine production associated with innate and adaptive immune  responses in children with autism spectrum disorders and  developmental regression.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroimmunol., 2001 , 120(1-2), 170- 179. http://dx.doi.org/10.1016/S0165-5728(01)00421-0  [170] Ashwood, P.; Kra kowiak, P.; Hertz-Picciotto, I.; Hansen, R.;  Pessah, I.N.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurol., 2005 ,57, 67-81.  http://dx.doi.org/10.1002/ana.20315  [175] Sweeten, T.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immun., 2011 ,25, 40-45. http://dx.doi.org/10.1016/j.bbi.2010.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immun., 2012 , 26, 383-392. http://dx.doi.org/10.1016/j.bbi.2011.08.007  [178] Heuer, L.; Ashwood, P.; Schauer, J.; Goines, P.; Krakowiak, P.;  Hertz-Picciotto, I.; Hansen, R.; Croen, L.A.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci., 2012 ,30(2), 121-127. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflam., 2012 ,9, 4. http://dx.doi.org/  10.1186/1742-2094-9-4  [181] Sweeten, T.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
",2010 ,24(1), 64-71.  http://dx.doi.org/10.1016/j.bbi.2009.08.001  [183] Hewison, M. Vitamin D and the immune system: new perspectives  on an old theme.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immunol., 2008 ,38(4),1138-1147.  http://dx.doi.org/10.1002/eji.200737898  [185] Hughes, J.E.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2008 ,102(8), 950-958.   http://dx.doi.org/10.1161/ CIRCRESAHA.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1371/journal.pone.0019299  [190] Torres, A.R.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immun., 2012 ,26(7), 1122-1127. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Genomics, 2008 ,91(1), 22-29. http://dx.doi.org/10.1016/j.ygeno.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Virol., 2012 , 86(22), 12304-12312.  http://dx.doi.org/10.1128/JVI.01269-12  [196] Mandal, M.; Marzouk, A.C.; Donnelly, R.; Ponzio, N.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Chem.,  2010 ,285(50), 38751-38755.  http://dx.doi.org/10.1074/jbc.C110.185777  [198] Chen, L.; Cencioni, M.T.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immunol., 2009 ,83(1-2),101- 5. http://dx.doi.org/10.1016/j.jri.2009.08.005  [202] Shibata, K.; Yamada, H.; Sato, T.; Dejima, T.; Nakamura, M.;  Ikawa, T.; Hara, H.; Yamasaki, S.; Kageyama, R.; Iwakura, Y.;  Kawamoto, H.; Toh, H.; Yoshikai, Y. Notch-Hes1 pathway is  required for the development of IL-17-producing /g5/g4 T cells.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immun., 2013 , 31, 69-75. http://dx.doi.org/10.1016/j.bbi.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Acta, 2012 ,1822 (1), 34- 41. http://dx.doi.org/10.1016/j.bbadis.2010.12.017  [205] Angelidou A.; Francis, K.; Vasiadi, M.; Alysandratos, K.D.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflamm., 2010 ,7, 48.  http://dx.doi.org/10.1186/1742-2094-7-48  [206] Kempuraj, D.; Asadi, S.; Zhang, B.; Manola, A.; Hogan, J.;  Peterson, E.; Theoharides, T.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflamm., 2010 , 7, 20. http://dx.doi.org/10.1186/1742-2094-7-20  [207] Asadi, S.; Theoharides, T.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuroinflamm., 2012 ,9, 85. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Ther., 2002 , 303 , 1061-1066. http://dx.doi.org/  10.1124/jpet.102.038497  [209] Theoharides, T.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Immunol., 2010 , 185(1), 588-596. http://dx.doi.org/10.4049/jimmunol.0902227  [211] Quik, M.; Perez, X.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurosci., 2011 ,197, 1-7. http://dx.doi.org/10.1016/  j.neuroscience.2011.10.005  [214] Croen, L.A.; Grether, J.K.; Yoshida, C.K.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Gen. Psychiatry ,2011 ,68, 1104-1112.  http://dx.doi.org/10.1001/archgenpsychiatry.2011.73  [215] Cook, E.H.; Leventhal, B.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Gen. Psychiatry,  1996 ,53, 993-1000. http://dx.doi.org/10.1001/archpsyc.1996.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Antropol., 2008 ,32 Suppl  1, 75-80. http://dx.doi.org/10.1038/sj.mp.4001409  [222] Arieff, Z.; Kaur, M.; Gameeldien, H.; Merwe, L.V.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Life  Sci., 2005 ,76(19), 2171-2183.  http://dx.doi.org/10.1016/j.lfs.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Metab., 2011 ,102(3), 368-373.  http://dx.doi.org/10.1016/j.ymgme.2010.11.162  [227] Azm itia, E.C.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neuropharmacol., 2011 ,60(7-8), 1347-1354. http://dx.doi.org/10.1016/j.neuropharm.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1038/tp.2012.44  [229] Nabi, R.; Serajee, F.J.; Chugani, D.C.; Zhong, H.; Huq, A.H.  Association of tr yptophan 2,3 dioxygenase gene polymorphism",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Genet., 2004 , 125B(1), 63-68. http://dx.doi.org/10.1002/ajmg.b.20147  [230] Funakoshi, H.; Kanai, M.; Nakamura, T. Modulation of tryptophan  metabolism, promotion of neurogenesis and alteration of anxiety- related behavior in tryptophan 2,3-dioxygenase-deficient mice.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res,, 2011 , 4, 7-18. http://dx.doi.org/10.4137/IJTR.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"JAMA Psychiatry ,2013 ,70(1), 49-58. http://dx.doi.org/  10.1001/jamapsychiatry.2013.272  [232] Morgan, J.T.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Disord., 2012 ,42(12), 2569-2584.  http://dx.doi.org/10.1007/s10803-012-1513-0  [234] Zimmerman, A.W.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Biol., 2011 , 7(1), 85-97. http://dx.doi.org/10.1017/S1740925  X1200004X  [239] Voineagu, I.; Wang, X.; Johnston, P.; Lowe, J.K.; Tian, Y.;  Horvath, S.; Mill, J.; Cantor, R.M.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Nature, 2011 ,474, 380-384. http://dx.doi.org/  10.1038/nature10110  [240] Laugeray, A.; Launay, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Biophys., 2000 ,377(1), 195-203.  http://dx.doi.org/10.1006/abbi.2000.1755  [242] Spratt, E.G.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
",2012 ,42(1), 75-81. http://dx.doi.org/10.1007/s10803-011- 1214-0  [243] Hamza, R.T.; Hewedi, D.H.; Ismail, M.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Pediatr., 2010 , 36, 71. http://dx.doi.org/10.1186/1824-7288-36-71  [244] Corbett, B.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1186/2040-2392-1-13 [245] Marinovi/g3 -Curin, J.; Marinovi/g3-Terzi/g3, I.; Bujas-Petkovi/g3, Z.;  Zekan, L.; Skrabi/g3, V.; Dogas, Z.; Terzi/g3, J.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Psychiatry, 2008 ,17(1), 39-43. http://dx.doi.org/  10.1007/s00787-007-0632-1  [246] Gabriels, R.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Biol., 2012 ,88, 27-48.  http://dx.doi.org/10.1007/s10803-006-0255-2 [251] Ghanizadeh, A.; Berk, M.; Farrashbandi, H.; Alavi, S. A.;  Villa gonzalo, K.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/  10.1016/j.mito.2012.10.001  [252] Rossignol, D.A.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1371/journal.pone.0042357  [258] Prozorovski, T.; Schulze-Topphoff, U.; Glumm, R.; Baumgart, J.;  Schröter, F.; Ninnemann, O.; Siegert, E.; Bendix, I.; Brüstle, O.;  Nitsch, R.; Zipp, F.; Aktas, O. Sirt1 contributes critically to the  redox-dependent fate of neural progenitors.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Genet., 2013 , 77(1), 9-21. http://dx.doi.org/10.1111/j.1469-1809.2012.00736.x",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Neurobiol., 2011 ,44(1), 83-92. http://dx.doi.org/10.1007/s12035- 011-8192-2  [262] Krey, J.F.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Autism, 2012 , 3(1), 12. http://dx.doi.org/10.1186/  2040-2392-3-12  [264] Tordjman, S.; Anderson, G.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Mol Psychiatry, 2008 , 13(1), 90-98.  http://dx.doi.org/10.1038/sj.mp.4002016  [266] Wang, L.; Li, J.; Ruan, Y.; Lu, T.; Liu, C.; Jia, M.; Yue, W.; Liu,  J.; Bourgeron, T.; Zhang, D. Sequencing ASMT Identifies Rare  Mutations in Chinese Han Patients with Autism.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1371/journal.pone.0052010  [269] Derecki, N.C.; Cronk, J.C.; Lu, Z.; Xu, E.; Abbott, S.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Nature, 2012 , 484(7392), 105-109.  http://dx.doi.org/10.1038/nature10907  [270] Chen, X.; Qin, Z. Post-transcriptional regulation by microrna-  21 and let-7a microRNA in paediatric cholesteatoma.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2009 , 1250 , 49-62.  http://dx.doi.org/10.1016/j.brainres.2008.11.013  [275] Ghanizadeh, A. Hydrogen as a novel hypothesized emerging  treatment for oxidative stress in autism.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Pediatr .,2011 ,11, 111.  http://dx.doi.org/10.1186/1471-2431-11-111  [278] Elchaar, G.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"(Buchar)., 2012 ,7(3), 214-221.  http://dx.doi.org/10.1016/S0924-9338(12)74419-X  [280] Ghanizadeh, A.; Derakhshan, N. N-acetylcysteine for treatment of  autism, a case report.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Sci., 2012 , 17(10), 985-987.  http://dx.doi.org/10.1111/j.1365-2559.2012.04264.x  [281] Kumar, B.; Prakash, A.; Sewal, R.K.; Medhi, B.; Modi, M. Drug  therapy in autism: a present and future perspective.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"http://dx.doi.org/10.1007/s40263- 013-0119-1  [283] Malow, B.; Adkins, K.W.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Psychiatr., 2009 , 195, 7-14. http://dx.doi.org/10.1192/bjp.bp.108.051672  [285] G itto, E.; Pellegrino, S.; Gitto, P.; Barberi, I.; Reiter, R.J. Oxidative  stress of the newborn in the pre- and postnatal period and the  clinical utility of melatonin.",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res ., 2009 ,46,128-139.  http://dx.doi.org/10.1111/j.1600-079X.2008.00649.x  [286] Jindal, M.; Garg, G.R.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Toxicol., 2011 , 30(10), 1489-1500.  http://dx.doi.org/10.1177/0960327110391685  [287] Rao, M.V.",OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"Res., 2009 , 37(20), 6681-6690. http://dx.doi.org/10.1093/nar/gkp723  Received: August 18, 2013 Revised: August 18, 2013 Accepted: November 02, 2013",Non-OADS,/arxiv_data1/oa_pdf/bc/c1/CN-12-148.PMC3964746.pdf
"BMC Med .,2013 , 11, 64. http://dx.doi.org/  10.1186/1741-7015-11-64  [3] Maes, M.; Mihaylova, I.; De Ruyter, M. Lower serum zinc in  Chronic Fatigue Syndrome (CFS): relationships to immune  dysfunctions and relevance for the oxidative stress status in CFS.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Disord., 2006 ,90(2-3), 141-147. http://dx.doi.org/10.1016/  j.jad.2005.11.002  [4] Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N.,  Bosmans, E. Coenzyme Q10 deficiency in Myalgic ncephalomyelitis/  chronic fatigue syndrome (ME/CFS) is related to fatigue,  autonomic and neurocogn itive symptoms and is another risk factor  explaining the early mortality in ME/CFS due to cardiovascular  disorder.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"BMC Med., 2010 , 8, 35. http://dx.doi.org/10.1186/1741- 7015-8-35  [6] Maes, M.; Twisk, F.N.M.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Disord., 2011 ,136(3), 933-939.  http://dx.doi.org/10.1016/j.jad.2011.09.004  [7] Manuel y Keenoy, B.; Moorkens, G.; Vertommen, J.; De Leeuw, I.  Antioxidant status and lipoprotein peroxidation in chronic fatigue  syndrome.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"lett., 2003 ,335(3), 151-154.  http://dx.doi.org/10.1016/S0304-3940(02)01058-3  [9] Smirnova, I.V.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Cardiol., 2009 ,136(2), 238-239. http://dx.doi.org/  10.1016/j.ijcard.2008.04.051  [11] Jason, L.; Sorenson, M.; Sebally, K.; Alk azemi, D.; Lerch, A.;  Porter, N.; Kubow, S. Increased HDAC in association with  decreased plasma cortisol in older adults with chronic fatigue  syndrome.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Nutr., 2000 , 19(3), 374-382. http://dx.doi.org/10.1080/07315724.2000.10718934  [15] Richards, R.S.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Res., 2007 ,38(1),  94-8. http://dx.doi.org/10.1016/j.arcmed.2006.06.008  [17] Kurup, R.K.; Kurup, P.A.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Heart Vessels., 2010 ,25(4), 319-323. http://dx.doi.org/10.1007/s00380-009-1206-6  [19] Maes, M.; Mihaylova, I.; Kubera, M.; Bosmans, E. Not in the mind  but in the cell: increased production of cyclo-oxygenase-2 and  inducible NO synthase in chronic fatigue syndrome.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Psychiatry  Res., 2012 ,200(2-3), 754-760. http://dx.doi.org/10.1016/j.psychres.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Med., 2012 , 272(1), 74-84.  http://dx.doi.org/10.1111/j.1365-2796.2011.02488.x  [24] Fulle, S.; Pietrangelo, T.; Mancinelli, R.; Saggini, R.; Fanò, G.  Specific correlations between muscle oxidative stress and chronic  fatigue syndrome: a working hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Disord., 2012 , 136(3), 933-939.  http://dx.doi.org/10.1016/j.jad.2011.09.004  [28] Maes, M.; Twisk, F.N.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Immun., 2010 , 24(7), 1209-1217.  http://dx.doi.org/10.1016/j.bbi.2010.04.012  [32] Vermeulen, R.C.W.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Med., 2010 ,8, 93.  http://dx.doi.org/10.1186/1479-5876-8-93  [33] Myhill, S.; Booth, N.E.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neuropathologica, 1991 , 83(1), 61-65. http://dx.doi.org/10.1007/BF00294431  [36] Plioplys, A.V.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"1995 ,32(4), 175-181. http://dx.doi.org/10.1159/  000119233  [37] Arnold, D.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Disord., 1998 ,8(3-4), 204-209. http://dx.doi.org/10.1016/S0960- 8966(98)00021-2  [39] Paul, L.; Wood, L.; Behan, W.M.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurol., 1999 ,6(1), 63-69.  http://dx.doi.org/  10.1046/j.1468-1331.1999.610063.x  [40] Lane, R.J.M.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Rev., 2008 ,88(1), 287-332.  http://dx.doi.org/10.1152/physrev.00015.2007  [42] Adam-Vizi, V.; Chinopoulos, C. Bioenergetics and the Formation  of Mitochondrial Reactive Oxygen Species.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"2010 ,1201 , 96-103. http://dx.doi.org/10.1111/j.1749-6632.2010.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"NMR Biomed., 2011 ,24(10), 1302-1312.  http://dx.doi.org/10.1002/nbm.1692  [53] Puri, B.K.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"2003 ,14(2), 225-228.  http://dx.doi.org/10.1097/00001756-200302100-00013  [56] Tomoda, A.; Miike, T.; Yamada, E.; Honda, H.; Moroi, T.; Ogawa, M.;  Ohtani, Y.; Morishita, S. Chronic fatigue syndrome in childhood.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Brain Dev., 2000 ,22(1), 60-64. http://dx.doi.org/10.1016/S0387- 7604(99)00111-4  [57] Narayana, P.A.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"http://dx.doi.org/10.1177/1051228405284200  [58] Wehrl, H.F.; Schwab, J.; Hasenbach, K.; Reischl, G.; Tabatabai,  G.; Quintanilla-Martinez, L.; Jiru, F.; C hughtai, K.; Kiss, A.; Cay,  F.; Bukala, D.; Heeren, R.M.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurol., 2002 ,249(10), 1382-1390.  http://dx.doi.org/10.1007/s00415-002-0846-6  [63] Narayana, P.A.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurol., 1998 ,43(1), 56-71. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Child., 2005 ,90(11), 1188-1189. http://dx.doi.org/10.1136/adc.2005.075317  [65] Cui, H.; Kong, Y.; Zhang, H. Oxidative Stress, Mitochondrial  Dysfunction, and Aging .J.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"DOI: 10.1186/  1471-2377-5-22  [68] Fang, H.; Xie, Q.; Boneva, R.; Fostel, J.; Perkins, R.; Tong, W.  Gene expression profile exploration of a large dataset on  chronhttp://dx.doi.org/10.2217/14622416.7.3.429ic fatigue syndrome.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Rheumatol., 1997 ,26(4), 301-307.  http://dx.doi.org/10.3109/03009749709105320  [71] Tyagi, N.; Kumar, M.; S.B.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"FEBS Lett.,  2006 ,580(13), 2994-3005. http://dx.doi.org/  10.1016/j.febslet.2006.04.088  [74] Chacón, I.J.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"JCFS., 2008 ,14(4), 5-17. http://dx.doi.org/10.1080/  10573320802091809  [77] Seishima, M.; Mizutani, Y.; Shibuya, Y.; Arakawa, C. Chronic  fatigue syndrome after human parvovirus B19 infection without  persistent viremia.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Pathol., 2008 , 61(1), 43-48. http://dx.doi.org/10.1136/jcp.2007.050054  [79] Nicolson, G.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"APMIS, 2003 ,111, 557-566. http://dx.doi.org/10.1034/  j.1600-0463.2003.1110504.x  [80] Maes, M.; Mihaylova, I.; Leunis, J.C.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Pathog., 2009 ,1(1), 6.  http://dx.doi.org/10.1186/1757-4749-1-6",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"1990 ,159(1), 79-84. http://dx.doi.org/10.1016/S0002-9610(05)  80610-5  [89] Marchetti, G.; Tincati, C.; Silvestri, G. Microbial translocation in  the pathogenesis of HIV infection and AIDS.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Rev., 2013 , 26(1), 2-18. http://dx.doi.org/10.1128/CMR.00050-12  [90] Appay, V.; Sauce, D. Immune activation and inflammation in HIV- 1 infection: causes and consequences.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Med.,  2006 ,12(12), 1365-1371. http://dx.doi.org/10.1038/nm1511  [92] Cardoso, F.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"http://dx.doi.org/10.1371/journal.pone.0035919  [93] Block, M.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurosci., 2007 , 8(1), 57-69. http://dx.doi.org/10.1038/nrn2038  [94] Lehnardt, S. Innate immunity and neuroinflammation in the CNS:  the role of microglia in Toll-like receptor-mediated neuronal injury.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Invest., 2012 ,122(4), 1164-1171.  http://dx.doi.org/10.1172/JCI58644  [97] Saijo, K.; Glass, C.K.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Immunol., 2011 , 11(11), 775-787.  http://dx.doi.org/10.1038/nri3086  [98] Gallego, C.; Golenbock, D.; Gomez, M.A.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurosci., 2005 ,25(7), 1788-1796. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Genom, 2009 ,2, 38. http://dx.doi.org/  10.1186/1755-8794-2-38  [104] Light, A.R.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Trends Immunol., 2007 ,28(10), 429-436. http://dx.doi.org/10.1016/  j.it.2007.08.004 [106] Lotze, M.T.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Rev., 2007 ,220, 60-81. http://dx.doi.org/10.1111/j.1600-065X.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Redox Biol., 2013 , 1(1), 94-96. http://dx.doi.org/10.1016/j.redox.2012.12.005  [108] M iller, Y.I.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Immunol., 2010 ,11(12), 1136-1142.  http://dx.doi.org/10.1038/ni.1960  [113] Maes, M.; Mihaylova, I.; Leunis, J.C.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biochem., 2010 , 21(5), 357-363. http://dx.doi.org/10.1 016/j.jnutbio.2009.09.010  [115] Behan, P.O.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Pract., 2004 , 58(3), 297-299. http://dx.doi.org/10.1111/  j.1368-5031.2004.00073.x  [117] Narayanan, A.; Popova, T.; Turell, M.; Kidd, J.; Chertow, J.;  Popov, S.G.; Bailey, C.; Kashanchi, F.; Kehn-Hall, K. Alteration in  superoxide dismutase 1 causes oxidative stress and p38 MAPK  activation following RVFV infection.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Brain, 2012 ,5, 11.  http://dx.doi.org/10.1186/1756-6606-5-11  [121] Federico, A.; Cardaioli, E.; Da Pozzo, P.; Formichi, P.; Gallus, G.N.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Lett., 1992 ,142(2), 128-130.  http://dx.doi.org/10.1016/0304-3940(92)90355-B  [123] Cristalli, D.O., Arnal, N., Marra FA, de Alaniz MJ, Marra CA.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurosci., 1997 ,17(18), 7166-7179. http://dx.doi.org/10.1111/  j.1460-9568.2008.06296.x  [137] Marty, V.; El Hachmane M.; Amédée, T. Dual modulation of  synaptic transmission in the nucleus tractus solitarius by  prostaglandin E2 synthesized downstream of IL-1beta.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Trends Immunol., 2007 , 28 (1), 5-11. http://dx.doi.org/  10.1016/j.it.2006.11.007  [140] Lacroix, S.; Feinstein, D.; Rivest, S. The bacterial endotoxin  lipopolysaccharide has the ab ility to target the brain in upregulating  its membrane CD14 receptor within specific cellular populations.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neuroscience, 2006 ,140(4), 1415-1434.  http://dx.doi.org/10.1016/j.neuroscience.2006.03.048  [145] Marvel, F.A.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Immun., 2008 , 22(7), 1078-1086.  http://dx.doi.org/10.1016/j.bbi.2008.03.007  [147] Watkins, L.R.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Lett., 1995 , 183(1-2), 27-31. http://dx.doi.org/10.1016/0304-3940(94)11105-R  [150] Johnston, G.R.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Glia., 2005 , 50(1), 21-31. http://dx.doi.org/10.1002/glia.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"2    181 2008 ,19(13), 1317-1320. http://dx.doi.org/10.1097/WNR.0b013  e32830b3677  [156] Pascual, O.; Ben, A. S.; Rostaing, P.; Tr iller, A.; Bessis, A.  Microglia activation triggers astrocyte-mediated modulation of  excitatory neurotransmission.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Adv., 2012 ,30 (1), 261-271. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Chem., 2012 , 287(9), 6454-6468. http://dx.doi.org/10.1074/jbc.M111.327874  [160] Möller, T. Neuroinflammation in Huntington's disease.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Transm., 2012 ,117(8), 1001-1008. http://dx.doi.org/10.1007/  s00702-010-0430-7  [161] Graeber, M.B; Li, W.; Rodriguez, M.L.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neuropathol., 2010 ,119(1), 7-35.  http://dx.doi.org/10.1007/  s00401-009-0619-8  [164] Kuboyama, K.; Harada, H.; Tozaki-Saitoh, H.; Tsuda, M.;  Ushijima, K.; I noue, K. Astrocytic P2Y(1) receptor is involved in  the regulation of cytokine/chemokine transcription and cerebral  damage in a rat model of cerebral ischemia.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Blood Flow  Metab., 2011 ,31(9), 1930-1941. http://dx.doi.org/10.1038/  jcbfm.2011.49  [165] McGraw, J.; Hiebert, G.W.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Res., 2001 ,63 (2), 109-115.  http://dx.doi.org/10.1002/1097-4547(20010115)63:2<109::AID- JNR1002>3.0.CO;2-J  [166] North, R.A.; Verkhratsky, A. Purinergic transmission in the central  nervous system.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Arch., 2006 ,452(5), 479-485.  http://dx.doi.org/10.1007/s00424-006-0060-y  [167] Rodríguez, J.J.; Olabarria, M.; Chvatal, A.; Verkhratsky, A.  Astroglia in dementia and Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"http://dx.doi.org/10.1016/S1353-8020(11)70065-7  [174] Sekiyama, K.; Sugama, S.; Fujita, M.; Sekigawa, A.; Takamatsu,  Y.; Waragai, M.; Takenouchi, T.; Hashimoto, M. Neuro- inflammation in Parkinson's Disease and Related Disorders: A  Lesson from Genetically Manipulated Mouse Models of /g1 - Synucleinopathies.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Int., 2012 ,2012 , 803701. http://dx.doi.org/  10.1155/2012/803701  [178] Frank-Cannon, T.C.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neurodegener., 2009 , 4, 47. http://dx.doi.org/10.1186/1750- 1326-4-47  [179] Nataf, S. Neuroinflammation responses and neurodegeneration in  multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"(Paris)., 2009 ,165(12), 1023-1028.  http://dx.doi.org/10.1016/j.neurol.2009.09.012  [180] Agius, L.M.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Blood Flow Metab., 1995 ,15(3), 378-384.  http://dx.doi.org/10.1038/jcbfm.1995.47  [183] Yu, Z.; Kone, B.C.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neuroendocrinology., 2004 , 79(1), 43-53.  http://dx.doi.org/10.1159/000076044  [190] Kolo, L.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"http://dx.doi.org/  10.1152/ajpheart.00668.2003  [191] Shelkovnikov S.; Merlic, C.A.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Shock., 1996 ,6(2),  79-88. http://dx.doi.org/10.1097/00024382-199608000-00001  [195] Nathan, C. Specificity of a third kind: reactive oxygen and nitrogen  intermediates in cell signaling.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Nature, 1990 ,345(6270),  27-28. http://dx.doi.org/10.1038/345027b0  [197] Beckman, J.S.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
http://dx.doi.org/10.1152/ajpheart.01030.,Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"1997 ,272(44), 27652-27659.  http://dx.doi.org/10.1074/jbc.272.44.27652  [210] Zou, M.H.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Endothelium., 2004 , 11(2), 89-97.  http://dx.doi.org/10.1080/10623320490482619  [211] Crow, J.P.; Beckman, J.S.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Chem., 2005 , 12(3), 267-275. http://dx.doi.org/10.2174/  0929867053363207  [214] Rork, T.H.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"2002 ,53(1), 165-174. http://dx.doi.org/10.1016/  S0008-6363(01)00445-X  [216] Gürsoy-Ozdemir, Y.; Can, A.; Dalkara, T. Reperfusion-induced  oxidative/nitrative injury to neurovascular unit after focal cerebral  ischemia.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Stroke., 2004 ,35(6), 1449-1453. http://dx.doi.org/  10.1161/01.STR.0000126044.83777.f4  [217] Ischiropoulos, H.; Zhu, L.; Chen, J.; Tsai, M.; Martin, J.C.; Smith,  C.D.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biophys., 1999 , 366(1), 82-88. http://dx.doi.org/10.1006/abbi.1999.1202  [219] Yamakura, F.; Taka, H.; Fujimura, T.; Murayama, K. Inactivation  of human manganese-superoxide dismutase by peroxynitrite is  caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Care Med., 1999 , 27(8), 1524-1532.  http://dx.doi.org/10.1097/00003246-199908000-00021  [225] Jonnala, R.R.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Res., 2001 , 63(1), 27-34.  http://dx.doi.org/10.1002/1097-4547(20010101)63:1<27::AID- JNR4>3.3.CO;2-R  [226] Good, P.F.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Chem., 2003 ,278(15), 12813-12819. http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Commun., 1999 ,257(3), 651-656. http://dx.doi.org/10.1006/  bbrc.1999.0434  [237] Smith, K.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Brain Pathol., 1999 ,9(1),  69-92. http://dx.doi.org/10.1111/j.1750-3639.1999.tb00212.x   [238] van der Veen, R.C.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Neuroimmunol., 1999 ,95(1-2), 1-7. http://dx.doi.org/10.1016/  S0165-5728(98)00239-2  [239] Burney, S., Caulfield, J.L., Niles, J.C., Wishnok, J.S., Tannenbaum,  S.R., 1999.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Res., 424  (1-2), 37-49. http://dx.doi.org/  10.1016/S0027-5107(99)00006-8  [240] Niles, J.C.; Wishnok, J.S.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Nitric Oxide., 2006 , 14(2), 109-121. http://dx.doi.org/10.1016/  j.niox.2005.11.001  [241] Yu, H.; Venkatarangan, L.; Wishnok, J.S.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Toxicol., 2005 ,18(12), 1849-1857. http://dx.doi.org/10.1021/tx050146h  [242] Buchczyk, D.P.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"FEBS Lett., 1998 , 427(2), 171-174. http://dx.doi.org/10.1016/S0014-5793(98)00413-X  [245] Brown, G.C.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Acta., 2004 ,1658 (1-2), 44-49.  http://dx.doi.org/  10.1016/j.bbabio.2004.03.016  [246] Bolaños, J.P.; Heales, S.J.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Lett., 2005 ,0(2), 78-81. http://dx.doi.org/  10.1016/j.neulet.2005.04.089  [251] Takakura, K.; Beckman, J.S.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biophys., 1999 ,369(2), 197-207. http://dx.doi.org/10.1006/  abbi.1999.1374  [252] Cassina, A.M.; Hodara, R.; Souza, J.M.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Chem., 2000 ,275(28), 21409-21415.   http://dx.doi.org/10.1074/jbc.M909978199  [253] Jang, B.; Han, S. Biochemical properties of cytochrome c nitrated  by peroxynitrite.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biochimie., 2006 ,88(1), 53-58. http://dx.doi.org/  10.1016/j.biochi.2005.06.016  [254] Han, D.; Canali, R.; Garcia, J.; Aguilera, R.; Gallaher, T.K.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biophys., 1996 ,336(1), 113-120. http://dx.doi.org/  10.1006/abbi.1996.0538  [256] Scarlett, J.L.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Pharmacol., 1996 ,52(7), 1047-1055. http://dx.doi.org/  10.1016/0006-2952(96)99426-5  [257] Vieira, H.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Artery Dis., 2003 , 14 (2), 115-122.  http://dx.doi.org/10.1097/00019501-200304000-00004  [261] Szabó, C. Multiple pathways of peroxynitrite cytotoxicity.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Care, 2003 , 9(2), 152-158. http://dx.doi.org/10.1097/00075198-200304000-00012  [264] Griendling, K.K.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Signal., 2005 , 7(9-10), 1315-1326. http://dx.doi.org/10.1089/ars.2005.7.1315  [266] Paravicini, T.M.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biol., 2006 ,7(11), 833-846.  http://dx.doi.org/10.1038/nrm2039  [268] Mallozzi, C.; Di Stasi, A.M.; Mine tti, M. Per oxynitrite modulates  tyrosine-dependent signal transduction pathway of human  erythrocyte band 3.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Commun.,  2003 ,305(3), 541-547. http://dx.doi.org/10.1016/S0006-291X(03)  00762-9  [273] Di Stasi, A.M.; Mallozzi, C.; Macchia, G.; Petrucci, T.C.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Immunol., 2001 ,20, 55-72. http://dx.doi.org/  10.1146/annurev.immunol.20.091301.131133  [276] Kang, K.W.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biophys., 2000 ,376(2), 365-370. http://dx.doi.org/  10.1006/abbi.2000.1728  [281] Kaji, T.; Kaieda, I.; Hisatsune, T.; Kaminogawa, S. 3- Morpholinosydnonimine hydrochloride induces p53-dependent  apoptosis in murine primary neural cells: a critical role for p21(ras)- MAPK-p19(ARF) pathway.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"FEBS Lett., 1999 ,456(1), 201-206.  http://dx.doi.org/10.1016/S0014-5793(99)00945-X  [284] Mallozzi, C.; Di Stasi, M.A.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Med., 2001 , 30(10), 1108-1117. http://dx.doi.org/  10.1016/S0891-5849(01)00509-3 [285] Mallozzi, C.; De Franceschi, L.; Brugnara, C.; Di Stasi, A.M.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Med., 2005 , 38(12), 1625-1636.  http://dx.doi.org/10.1016/j.freeradbiomed.2005.02.021  [286] Hainaut, P.; Milner, J. Redox modulation of p53 conformation and  sequence-specific DNA binding in vitro .Cancer Res., 1993 , 53(19), 4469-4473.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"http://dx.doi.org/  10.1038/cddis.2013.13  [289] Cobbs, C.S.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Med., 2005 , 39(10), 1353-1361. http://dx.doi.org/  10.1016/j.freeradbiomed.2005.06.015  [291] He, G.; Yu, G.Y.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Cancer Cell, 2010 , 17(3), 286-297.  http://dx.doi.org/  10.1016/j.ccr.2009.12.048  [292] Bartoli, M.; Platt, D.H.; Lemtalsi, T.; El Remessy, A.; Rojas, M.;  Caldwell, R.W.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Physiol., 2002 , 192(1), 1-15. http://dx.doi.org/10.1002/jcp.10119  [294] Lee, H.; Herrmann, A.; Deng, J.H.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Cytokine Growth  Factor Rev., 2010 ,21(1), 11-19.  http://dx.doi.org/10.1016/  j.cytogfr.2009.11.005  [296] Ak, P.; Levine, A.J.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"FASEB J., 2010 , 24(10), 3643-3652. http://dx.doi.org/10.1096/fj.10-160549  [297] Johnson, R.F.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Cancer Res., 2011 ,71(16), 5588-5597. http://dx.doi.org/10.1158/  0008-5472.CAN-10-4252  [298] Mauro, C.; Leow, S.C.; Anso, E.; Rocha, S.; Thotakura, A.K.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biol., 2011 , 13(10), 1272-1279. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Cancer Cell., 2006 ,10  (1), 4-6. http://dx.doi.org/10.1016/j.ccr.2006.06.014   [300] Park, J.Y.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"2    185 Genomics., 2009 ,37(1), 58-66. http://dx.doi.org/10.1152/  physiolgenomics.90346.2008  [302] Kawauchi, K.; Araki, K.; Tobiume, K.; Tanaka, N. P53 regulates  glucose metabolism through an IKK-NF-kappaB pathway and  inhibits cell transformation.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Biol., 2008 ,10(5), 611-618.  http://dx.doi.org/10.1038/ncb1724  [303] Johnson, R.F.",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Sci., 2012 ,37(8), 317-324. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Hypotheses., 2012 ,79(5), 607-613.  http://dx.doi.org/10.1016/j.mehy.2012.07.034  [306] Ma, W.; Sung, H.J.",OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Cancer Biol., 2009 , 19(1), 32-41. http://dx.doi.org/10.1016/j.semcancer.2008.11.005  Received: July 12, 2013 Revised: July 12, 2013 Accepted: November 02, 2013",Non-OADS,/arxiv_data1/oa_pdf/4b/3b/CN-12-168.PMC3964747.pdf
"Disord.,  2012 ,13(2), 109-119. http://dx.doi.org/10.1007/s11154-012-9215-7  [2] Lee, B.C.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
"Amino Acids , 2012 ,43(2), 505-517. http://dx.doi.org/10.1007/s00726-011-1175-9  [4] Miller, A.L.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
", 2012 ,1484 , 29-38. http://dx.doi.org/10.1016/j.brainres.2012.09.026  [11] Baydas, G.; Ozer, M.; Yasar, A.; Tuzcu, M.; Koz, S.T.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2008 ,8,14.  http://dx.doi.org/10.1186/1471-2210-8-14  [14] Viollet, B.; Guigas, B.; Sanz Garcia, N.; Leclerc, J.; Foretz, M.;  Andreelli, F. Cellular and molecular mechanisms of metformin: an  overview.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
"(Lond) ,2012 ,122(6), 253-270. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2012 ,91(11-12), 409-414.  http://dx.doi.org/10.1016/j.lfs.2012.08.017  [16] Li, J.; Deng, J.; Sheng, W.; Zuo, Z. Metformin attenuates Alzheimer's  disease-like neuropathology in obese, leptin-resistant mice.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2006 ,84(5), 944-953. http://dx.doi.org/10.1002/  jnr.21014  [19] Diamond, D.M.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2007 ,25(3), 133-139. http://dx.doi.org/10.1016/  j.ijdevneu.2007.03.001  [26] Vuaden, F.C.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2006 ,580(13), 2994-3005. http://dx.doi.org/  10.1016/j.febslet.2006.04.088  [28] McCully, K.S.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",1996 ,98(1), 5-7. http://dx.doi.org/10.1172/JCI118776  [31] Heinecke, J.W.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2008 ,4(4), 358-364.  http://dx.doi.org/10.2174/157340608784872299  [34] Wang, J.; Gallagher, D.; DeVito, L.M.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
"Cell Stem  Cell,2012 ,11(1), 23-35. http://dx.doi.org/10.1016/j.stem.2012.03.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
"Neuropsychologia ,1979 ,17(6), 669-682. http://dx.doi.org/10.1016/  0028-3932(79)90042-3  [37] Olton, D.S.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
"Hippocampus ,2000 ,10(2), 143-152.  http://dx.doi.org/10.1002/(SICI)1098-1063(2000)10:2<143::AID- HIPO3>3.0.CO;2-G  [39] Matte, C.; Pereira, L.O.",Non-OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
"CrossRef DOI:  http://dx.doi.org/10.1016/j.bbr.2011.09.017 [45] Bhutada, P.; Mundhada, Y.; Bansod, K.; Tawari, S.; Pa til, S.; Dixit,  P.; Umathe, S.; Mundhada, D. Protection of cholinergic and  antioxidant system contributes to the effect of berberine  ameliorating memory dysfunction in rat model of streptozotocin- induced diabetes.",OADS,/arxiv_data1/oa_pdf/0f/63/CN-12-186.PMC3964748.pdf
",2001 ,344(16), 1247-9. http://dx.doi.org/10.1056/  NEJM200104193441612  [3] Hovatta, I., Tennant, R.S., Helton, R., Marr, R.A., Singer, O.,  Redwine J.M., Ellison, J.A., Schadt, E.E., Verma, I.M., Lockhart,  D.J., Barlow, C. Glyoxalase 1 and glutathione reductase 1 regulate  anxiety in mice.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Nature ,2005 ,438(7068), 662-6. http://dx.doi.org/  10.1038/nature04250  [4] Krolow, R., Noschang, C.G., Arcego, D., Andreazza, A.C., Peres,  W., Goncalves, C.A., Dalmaz, C. Consumption of a palatable diet  by chronically stressed rats prevents effects on anxiety-like  behavior but increases oxidative stress in a sex-specific manner.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
",2007 ,81(3), 198-203.  http://dx.doi.org/10.1016/j.lfs.2007.05.001  [6] Noschang, C.G., Pettenuzzo, L.F., von Pozzer ,T. E., Andreazza,  AC., Krolow, R., Fachin, A., Avila, M.C., Arcego, D., Crema,  L.M., Diehl, L.A., Goncalvez, C.A., Vendite, D., Dalmaz, C. Sex- specific differences on caffeine consumption and chronic stress- induced anxiety-like behavior and DNA breaks in the hippocampus.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Behav .,2009 ,94(1), 63-9. http://dx.doi.org/  10.1016/j.pbb.2009.07.007  [7] Halliwell, B. Oxidative stress and neurodegeneration: where are we  now?",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Neurochem .,2006 ,97(6), 1634-58. http://dx.doi.org/  10.1111/j.1471-4159.2006.03907.x",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Neurosci .,1991 , 57(1-2), 1-17. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Hypotheses .,1994 , 43(4), 223- 30. http://dx.doi.org/10.1016/0306-9877(94)90070-1  [10] Tsaluchidu, S., Cocchi, M., Tonello, L., Puri, B.K.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"http://dx.doi.org/10.1186/1471-244X-8-S1-S5  [11] Dudkina, N.V., Sunderhaus, S., Boekema, E.J., Braun, H.P.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
",2007 , 39(1), 44-84. http://dx.doi.org/10.1016/j.biocel.2006.07.001  [13] Aksenova, M.V., Aksenov, M.Y., Mactutus, C.F., Booze, R.M.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res .,2005 ,2(1),73-89.  http://dx.doi.org/10.2174/1567202052773463  [14] Gutteridge, J.M., Halliwell, B.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Sci.,2000 ,899, 136-47. http://dx.doi.org/10.1111/j.1749-6632.2000.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Lett., 2005 ,383(3), 278-83. http://dx.doi.org/  10.1016/j.neulet.2005.04.037  [17] Oishi, K., Yokoi, M., Maekawa ,S., Sodeyama, C., Shiraishi, T,  Kondo, R., Kuriyama, T., Machida, K. Oxidative stress and  haematological changes in immob ilized rats.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
",2001 ,39(1),  33-8. http://dx.doi.org/10.1016/S0197-0186(01)00003-1  [19] Esterbauer, H., Schaur, R.J., Zollner, H. Chemistry and biochemistry  of 4-hydroxynonenal, malonaldehyde and related aldehydes.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Med .,1991 , 11(1), 81-128. http://dx.doi.org/10.1016/  0891-5849(91)90192-6  [20] Guichardant, M., Valette-Talbi, L., Cavadini, C., Crozier, G.,  Berger, M. Malondialdehyde measurement in urine.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res .,2007 , 62(1), 1-8. http://dx.doi.org/10.1016/j.jpsychores.2006.07.030  [26] Bilici, M., Efe, H., Koroglu, M.A, U ydu, H.A., Bekaroglu, M.,  Deger, O. Antioxidative enzyme activities and lipid peroxidation in  major depression: alterations by antidepressant treatments.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Affect Disord .,2001 ,64(1), 43-51. http://dx.doi.org/10.1016/S0165-0327  (00)00199-3  [27] Galecki, P., Szemraj, J., Bienkiewicz, M., Florkowski, A.,   Galecka, E. Lipid peroxidation and antioxidant protection in  patients during acute depressive episodes and in remission   after fluoxetine treatment.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Biochem ., 2009 ,42(13-14), 1368-74. http://dx.doi.org/10.1016/j.clinbiochem.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychiatry , 2009 , 33(1), 62-5. http://dx.doi.org/10.1016/j.pnpbp.2008.10.004  [31] Hazneci, E., Karabulut, A.B., Ozturk, C., Batcioglu, K., Dogan, G.,  Karaca, S., Esrefoglu, M. A comparative study of superoxide  dismutase, catalase, and glutathione peroxidase activities and  nitrate levels in vitiligo patients.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neurosci .,2004 ,254(4), 231-5. http://dx.doi.org/10.1007/s00406- 004-0484-3  [33] Kuloglu, M., Atmaca, M., Tezcan, E., Gecici, O., Tunckol, H.,  Ustundag, B. Antioxidant enzyme activ ities and malondialdehyde  levels in patients with obsessive-compulsive disorder.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neuro-  psychobiology ,2002 ,46(1), 27-32. http://dx.doi.org/10.1159/  000063573  [34] Eskiocak, S., Gozen, A.S., Yapar, S.B., Tavas, F., Kilic, A.S.,  Eskiocak, M. Glutathione and free sulphydryl content of seminal  plasma in healthy medical students during and after exam stress.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Reprod .,2005 ,20(9), 2595-600. http://dx.doi.org/10.1093/  humrep/dei062  [35] Tezcan, E., Atmaca, M., Kuloglu, M., Ustundag, B.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neuropharmacology, 2012 ,62(4), 1607-18.  http://dx.doi.org/10.1016/j.neuropharm.2011.10.006  [38] Merzoug, S., Toumi, M.L., Boukhris, N., Baudin, B, Tahraoui, A.  Adriamycin-related anxiety-like behavior, brain oxidative stress  and myelotoxicity in male Wistar rats.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Behav .,2011 ,99(4), 639-47. http://dx.doi.org/10.1016/j.pbb.2011.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res .,2009 ,34(9), 1568-74. http://dx.doi.org/  10.1007/s11064-009-9945-4  [45] Ciobica, A., Hritcu, L., Padurariu, M., Dobrin, R., Bild, V. Effects  of serotonin depletion on behavior and neuronal oxidative stress  status in rat: relevance for anxiety and affective disorders.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
",2012 ,45(4), 292-8.  http://dx.doi.org/10.1590/S0100-879X2012007500041  [47] Faravelli, C., Lo Sauro, C., Lelli, L., Pietrini, F, L azzere tti, L,  Godini L, Benni, L., Fioravanti, G., Talamba, G.A., Castellini, G.,  Ricca, V. The role of life events and HPA axis in anxiety disorders:  a review.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Brain Res .,2010 ,1359 , 178-85. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res., 2009 ,34(6), 1021-9. http://dx.doi.org/10.1007/s11064-008- 9865-8  [56] Shao, L., Martin, M.V., Watson SJ, Schatzberg, A., Akil, H., Myers,  R.M., Jones, E.G., Bunney, W.E., Vawter, M.P.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Med .,2008 ,40(4), 281- 95. http://dx.doi.org/10.1080/07853890801923753  [57] Jou, S.H, Chiu, N.Y., Liu, C.S.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Genet .,2001 ,106(1), 27-36. http://dx.doi.org/10.1002/  ajmg.1425  [59] Koopman WJ, N ijtmans LG, Dieteren CE, Roestenberg P,  Valsecchi F, Sme itink JA, Willems PH.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Antioxid Redox Signal .,2010 ,12(12), 1431-70.  http://dx.doi.org/10.1089/ars.2009.2743  [60] Moro, M.A., Almeida, A., Bolanos, J.P., Lizasoain, I. Mitochondrial  respiratory chain and free radical generation in stroke.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Med ., 2005 ,39(10), 1291-304. http://dx.doi.org/10.1016/  j.freeradbiomed.2005.07.010 [61] Rodriguez-Enriquez, S., Kai, Y., Maldonado, E., Currin, R.T.,  Lemasters, J.J.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Autophagy ,2009 ,5(8), 1099-106. http://dx.doi.org/10.4161/auto.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Neurochem .,1992 ,58(5), 1730-5.  http://dx.doi.org/10.1111/j.1471-4159.1992.tb10047.x  [66] McEwen, B.S.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Chem .,  2012 ,12(4), 270-85. http://dx.doi.org/10.2174/156802612799078720  [70] Taliani, S., Da Settimo, F., Da Pozzo, E., Chelli, B., Martini, C.  Translocator protein ligands as promising therapeutic tools for  anxiety disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Chem ., 2009 ,16(26), 3359-80.  http://dx.doi.org/10.2174/092986709789057653  [71] Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L.,  Weisinger, G., Weizman, A. Enigma of the peripheral benzodiazepine  receptor.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Pharmacol ., 2008 ,3(1), 38-45.  http://dx.doi.org/10.2174/157488408783329878  [74] Veenman, L., Papadopoulos, V., Gavish, M. Channel-like functions  of the 18-kDa translocator protein (TSPO): regulation of apoptosis  and steroidogenesis as part of the host-defense response.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychiatry Res .,2003 ,118(2), 107-16.  http://dx.doi.org/10.1016/S0165-1781(03)00077-5  [77] Heydari, B., Le Melledo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Cell  Neurosci ., 2005 ,30(2), 228-37. http://dx.doi.org/10.1016/j.mcn.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Ther .,2007 ,322(2), 709-20. http://dx.doi.org/10.1124/jpet.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Behav .,2005 ,82(4), 712-20. http://dx.doi.org/10.1016/j.pbb.2005.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Ther .,2002 ,301(3), 1067- 78. http://dx.doi.org/10.1124/jpet.301.3.1067  [83] Veiga, S., Azcoitia, I., Garcia-Segura, L.M.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res .,2005 ,80(1), 129-37. http://dx.doi.org/10.1002/  jnr.20430  [84] Veiga, S., Carrero, P., Pernia, O., Azcoitia, I., Garcia-Segura, L.M.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Glia,2007 , 55(14), 1426-36. http://dx.doi.org/  10.1002/glia.20558  [85] Soustiel, J.F., Zaaroor, M., Vlodavsky, E., Veenman, L., Weizman,  A., Gavish, M. Neuroprotective effect of Ro5-4864 following brain  injury.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Int ., 2009 ,55(1-3), 164-73.  http://dx.doi.org/10.1016/j.neuint.2009.01.024  [87] Parker, M.A., Bazan, H.E., Marchese lli, V., Rodriguez de, T.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res ., 2002 ,69(1), 39-50. http://dx.doi.org/10.1002/  jnr.10235  [88] Papadopoulos, V., Lecanu, L. Translocator protein (18 kDa) TSPO:  an emerging therapeutic target in neurotrauma.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neurol .,2009 , 219(1), 53-7. http://dx.doi.org/10.1016/j.expneurol.2009.04.016  [89] Serra, M., Madau, P., Chessa, M.F., Caddeo, M., Sanna, E.,  Trapani, G, Franco, M., Liso, G., Purdy, R,H., Barbaccia, M.L.,  Biggio, G. 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands  for peripheral benzodiazepine receptors: stimulation of neurosteroid  synthesis and anticonflict action in rats.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychopharmacology (Berl) ., 2000 ,151(1), 64-71. http://dx.doi.org/10.1007/s002130000471  [91] Korneyev, A., Pan, B.S., Polo, A., Romeo, E., Guidotti, A., Costa,  E. Stimulation of brain pregnenolone synthesis by mitochondrial  diazepam binding inhibitor receptor ligands in vivo .J Neurochem ., 1993 ,61(4), 1515-24. http://dx.doi.org/10.1111/j.1471-4159.1993.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Neurosci .,2006 ,24(1), 32-6. http://dx.doi.org/  10.1111/j.1460-9568.2006.04906.x  [95] Fuxe, K., Rivera, A., Jacobsen, K.X., Hoistad, M., Leo, G.,  Horvath, T.L., Staines, W., De la Calle, A., Agnati, L.F. Dynamics  of volume transmission in the brain.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Transm .,2005 ,112(1), 65-76. http://dx.doi.org/10.1007/  s00702-004-0158-3  [96] Rohleder, N., Joksimovic, L., Wolf, J.M., Kirschbaum, C.  Hypocortisolism and increased glucocorticoid sens itivity of pro- Inflammatory cytokine production in Bosnian war refugees with  posttraumatic stress disorder.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Biol Psychiatry .,2004 ,55(7), 745-51.  http://dx.doi.org/10.1007/s00702-004-0158-3  [97] Gill, J., Vythilingam, M., Page, G.G.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Trauma Stress ,2008 ,21(6), 530-9. http://dx.doi.org/  10.1002/jts.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Care ,2009 ,45(4), 262-77. http://dx.doi.org/10.1111/  j.1744-6163.2009.00229.x  [99] von Kanel, R., Begre, S., Abbas, C.C, Saner, H., Gander,   M.L., Schmid, J.P.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neuroimmunomodulation ,2010 , 17(1), 39-46. http://dx.doi.org/10.1159/000243084  [100] Pace, T.W., Heim, C.M.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Immun .,2011 ,25(1), 6-13.  http://dx.doi.org/10.1016/j.bbi.2010.10.003  [101] Denys, D., Fluitman, S., Kavelaars, A., Heijnen, C., Westenberg,  H. Decreased TNF-alpha and NK activity in obsessive-compulsive  disorder.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neuropathology,  2010 ,30(6), 597-605.  http://dx.doi.org/10.1111/j.1440-1789.2010.01114.x  [107] Sun, G.Y., Xu, J., Jensen, M.D., Simonyi, A. Phospholipase A2 in  the central nervous system: implications for neurodegenerative  diseases.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J Lipid Res .,2004 ,45(2), 205-13. http://dx.doi.org/  10.1111/j.1440-1789.2010.01114.x  [108] O'Donovan, A., Hughes, B.M., Slavich, G.M., Lynch, L., Cronin,  M.T., O'Farrelly, C., Malone, K.M.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Behav ., 1994 , 56(3), 609-17. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"DOI: http://dx.doi.org/10.1016/S0024- 3205(97)00990-9  [119] Fiore, M., Alleva, E., Probert, L., Ko llias, G., Angelucci, F.,   Aloe, L. Exploratory and displacement behavior in transgenic mice  expressing high levels of brain TNF-alpha.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Sci., 2004 ,1032 , 141-53. http://dx.doi.org/10.1196/annals.1314.011  [121] Schneiderman, N., Ironson, G., Siegel, S.D.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J.  Neuroimmune Pharmacol .,2006 , 1(4), 421-7. http://dx.doi.org/  10.1007/s11481-006-9036-0  [124] Pariante, C.M., Miller, A.H. Glucocorticoid receptors in major  depression: relevance to pathophysiology and treatment.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychiatry ,2010 , 15(5), 535-47.  http://dx.doi.org/10.1038/mp.2008.58  [126] Leonard.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychopharmacol ., 2009 , 24(3), 165-75. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res .,2012 ,24, 103-8.  http://dx.doi.org/10.1007/s12640-012-9364-1  [128] Chen, J., Song, Y., Yang, J., Zhang, Y., Zhao, P., Zhu, X.J., Su,  H.C.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Lett .,2013 ,541, 275-80. http://dx.doi.org/10.1016/j.neulet.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Toxicol .,2011 ,109(5), 350-6. http://dx.doi.org/  10.1111/j.1742-7843.2011.00738.x  [130] Musavi, S., Kakkar, P. Diazepam induced early oxidative changes  at the subcellular level in rat brain.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Life Sci .,  2011 ,89(17-18), 650-4. http://dx.doi.org/10.1016/j.lfs.2011.07.027  [133] Goyal, R., Anil, K. Protective effect of alprazolam in acute  immob ilization stress-induced certain behavioral and biochemical  alterations in mice.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Res .,2008 ,60(4), 372-9. http://dx.doi.org/  10.1016/j.neures.2007.12.003  [135] Williams, R.t., Lim, J.E., Harr, B., Wing, C., Walters, R., Distler,  M.G., Teschke, M., Wu, C., Wiltshire, T., Su, A.I., Sokoloff ,G.,  Tarantino, L.M., Borevitz, J.O., Palmer, A.A. A common and  unstable copy number variant is associated with differences in Glo1  expression and anxiety-like behavior.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J.  Neurosci .,2005 ,25(17), 4375-84. http://dx.doi.org/10.1523/  JNEUROSCI.0115-05.2005  [138] Ditzen, C., Jastorff, A.M., Kessler, M.S., Bunck, M., Teplytska, L.,  Erhardt, A., Kromer, S.A., Varadarajulu, J., Targosz, B.S., Sayan- Ayata, E.F., Holsboer, F., Landgraf, R., Turck, C.W.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Cell  Proteom .,2006 ,5(10), 1914-20. http://dx.doi.org/10.1074/mcp.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neuropsychopharmacol ., 2010 ,20(2), 96-111. http://dx.doi.org/10.1016/j.euroneuro.2009.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Cell  Longev .,2009 ,2(2), 63-7. http://dx.doi.org/10.4161/oxim.2.2.7944  [142] Kurrikoff, T., Lesch, K.P., Kiive, E., Konstabel, K., Herterich, S.,  Veidebaum, T., Reif, A., Harro, J.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychopathol .,2012 , 24(4), 1225-35.  http://dx.doi.org/10.1017/S0954579412000661  [143] Pacher, P., Beckman, J.S., Liaudet, L. Nitric oxide and per oxynitrite  in health and disease.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Suppl ., 2007 ,72, 69-85. http://dx.doi.org/10.1007/  978-3-211-73574-9_10  [147] Dringen, R. Metabolism and functions of glutathione in brain.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Neurosci ., 2010 ,30(7), 2547-58. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Methods ., 2012 ,22(8), 597-604. http://dx.doi.org/10.3109/  15376516.2012.704957  [152] Harrison, F.E., May, J.M., McDonald, M.P.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neurol .,1998 ,397(4), 549-60.  http://dx.doi.org/10.1002/(SICI) 1096-9861(19980810)397:4<549::  AID-CNE7>3.0.CO;2-1  [157] Finkel, T., Holbrook, N.J. Oxidants, oxidative stress and the biology  of ageing.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Gerontol ., 2007 , 42(1-2), 37-45. http://dx.doi.org/10.1016/j.exger.2006.05.018  [160] Park, H., Poo, M.M.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neurosci .,2013 ,14(1), 7-23.  http://dx.doi.org/10.1038/nrn3379  [161] Cowansage, K.K., LeDoux, J.E., Monfils, M.H.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Pharmacol ., 2010 , 3(1), 12-29. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Brain Res .,2001 ,915(2), 227-33. http://dx.doi.org/10.1016/S0006- 8993(01)02855-4  [163] Gomez-Palacio-Schjetnan, A., Escobar, M.L.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Neuroscience ,2013 ,239, 214-27. http://dx.doi.org/  10.1016/j.neuroscience.2012.08.034  [166] Montag, C., Reuter, M., Jurkiewicz, M., Marke tt, S., Panks epp, J.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Psychopharmacol .,2013 ,28(1), 102-5. http://dx.doi.org/10.1002/  hup.2281  [168] Kim, S., Kwon, J.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Neuro-  psychopharmacol .,2009 ,12(7), 905-15. http://dx.doi.org/10.1097/  FBP.0b013e32834ecb14  [171] Casarotto, P.C., de Bortoli, V.C., Zangrossi, H, Jr. Intrahippocampal  injection of brain-derived neurotrophic factor increases anxiety- related, but not panic-related defensive responses: involvement of  serotonin.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Pharmacol .,2012 , 23(1), 80-8. http://dx.doi.org/  10.1097/FBP.0b013e32834ecb14  [172] Dalle, M.R., Portella, A.K., Goldani, M.Z., Kapczinski, F.P.,  Leistner-Segala, S., Salum, G.A., Manfro, G.G., Silveira, P.P.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Brain Res .,2008 ,1211 , 37-43. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Behav Neurosci ., 2004 , 118(6), 1378-90. http://dx.doi.org/10.1037/0735-7044.118.6.1378  [177] Duman, C.H., Schlesinger, L., Russell, D.S., Duman, R.S.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"Brain Res ., 2008 , 1199 , 148-58. http://dx.doi.org/10.1016/  j.brainres.2007.12.047 [178] Tillfors, M., Furmark, T., Marteinsdottir, I., Fischer, H., Pissiota,  A., Langstrom, B., Fredrikson, M. Cerebral blood flow in subjects  with social phobia during stressful speaking tasks: a PET study.",OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J. Psychiatry ,2001 ,158(8), 1220-6. http://dx.doi.org/10.1176/  appi.ajp.158.8.1220  [179] Allam, F., Dao, A.T., Chugh, G., Bohat, R., Jafri, F., Patki, G.,  Mowrey, C., Asghar, M., Alkadhi, K.A., Salim, S. Grape Powder  Supplementation Prevents Oxidative Stress-Induced Anxiety-Like  Behavior, Memory Impairment, and High Blood Pressure in Rats.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
"J Nutr., 2013 , Apr 17. http://dx.doi.org/10.3945/jn.113.174649  Received: May 15, 2013 Revised: May 15, 2013 Accepted: November 02, 2013",Non-OADS,/arxiv_data1/oa_pdf/55/3f/CN-12-193.PMC3964749.pdf
